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Preface 
My PhD work and dissertation is aimed at making significant contribution in the field 
of biopharmaceuticals and particularly in the downstream processing of biotherapeutics. 
Downstream processing is the recovery and purification of the target biomolecules as 
antibodies, enzymes, viruses etc. from animal or plant protein contaminants following the 
fermentation step (upstream processing). Downstream processing also holds the 
responsibility of maintaining the functionality of the molecule. My work is focused on 
improving virus purification for vaccine development and virus removal for water 
purification by understanding viruses and specially their surface characteristics. 
Additionally I have also performed work on virus detection mechanism through 
mammalian cells for creation of antiviral compounds.  
Chapter 2 is the literature review detailing the current practices available for viral 
vaccines recovery and water purification from viruses and the need to improve them. 
The figures 2.9, 2.10, 2.11, 2.12, 2.13 and 2.14 have been used with permission from 
relevant journals.  
Chapter 3 is virus purification using chromatography strategies and characterization 
of virus using a panel of standard proteins. The chapter comprises a total of 18 figures. 
Reverse phase chromatography and the experimental work for figures 3.11, 3.12 and 
3.14 was performed by an undergraduate student Ms. Amna Zahid (Chemical 
Engineering, Michigan Technological University). My advisor Dr. Caryn Heldt analyzed 
and plotted figure 3.12. All the figures in chapter 3 except figure 3.12 was analyzed and 
plotted by me. I also collected data for figures where Ms. Zahid was not involved. A part 
of the chapter is planned for submission and the paper will be written by my advisor.  
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Chapter 4 is virus trafficking and using immunohistochemistry for identifying antivirals 
(osmolytes) compounds. The first author in this work is a graduate student Ms. Maria 
Tafur (Chemical Engineering, Michigan Technological University). She collected data, 
analyzed and plotted figures to show the antiviral activity using osmolytes and wrote the 
peer reviewed journal paper. The immunohistochemistry work was crucial to show the 
action or function of osmolytes against infection. The immunohistochemistry work was 
performed, analyzed and plotted by me and as shown in the figures 4.9, 4.10 and 4.11. 
The permission for these figures have been obtained from Tafur et al. (2013). The third 
and corresponding author was my advisor. She guided in the paper writing process.  
Chapter 5 is improving vaccine production systems for non-enveloped porcine 
parvovirus virus using aqueous two-phase system. The complete chapter has been used 
with permission from Vijayaragavan et al. (2014). I am the first author of the publication 
and the article was written by me. Co-author and undergraduate student Ms. Amna 
Zahid (Chemical Engineering, Michigan Technological University) collected data for 
figure 5.7 and 5.8. Co-author and undergraduate student Mr. Jonathan Young (Chemical 
Engineering, Michigan Technological University) was an invaluable support in collecting 
data for figure 5.3 and 5.4. Transfer student from the MICUP program and a current 
undergraduate student Ms. Sarah Corrion (Chemical Engineering, Michigan 
Technological University) was an invaluable support in collecting data for figure 5.1 (A). 
All the figures were analyzed and plotted by me. My advisor Dr. Caryn Heldt was the 
corresponding author.  
Chapter 6 is virus removal using chitosan membrane matrix for potable water. The 
chapter is planned for submission and all of the work including figures, texts was 
performed, analyzed and plotted by me.  
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Abstract 
 
The biopharmaceutical industry has a growing demand and an increasing need to 
improve the current virus purification technologies, especially as more and more 
vaccines are produced from cell-culture derived virus particles. Downstream purification 
strategies can be expensive and account for 70% of the overall manufacturing costs. 
The economic pressure and purification processes can be particularly challenging when 
the virus to be purified is small, as in our model virus, porcine parvovirus (PPV). Our 
efforts are focused on designing an easy, economical, scalable and efficient system for 
virus purification, and we focused on aqueous two-phase systems. Industry acceptable 
standards for virus vaccine recovery can be as low as 30% due to demand of high final 
titer, virus transduction inhibitors and presence of empty or defective virus capsids as 
impurities. We have overcome these shortcomings by recovering a high 64% of 
infectious virus using an aqueous two-phase system. We used high molecular weight 
polymer and citrate salt to achieve a good yield and eliminated the major contaminant 
bovine serum albumin.    
Viruses are also studied for ensuring pure and safe drinking water. Low pressure 
microfiltration are continuously being investigated for water filters as they allow high 
permeate flux and low fouling. Viruses such as PPV are small enough to pass through 
the microporous membranes. Control of viruses in water is crucial for public health and 
we have designed an affinity based membrane filter to capture virus. Nanofibers have a 
high surface to volume ratio providing a highly accessible surface area for virus 
adsorption. Chitosan an insoluble, biocompatible and biodegradable polymer was used 
for adsorbing trimer peptide WRW. About 0.2 μmoles of cysteine terminal WRW peptide 
was conjugated to amine terminal chitosan using maleimide conjugation chemistry. We 
achieved 90-99% virus removal from water adjusted to a neutral pH. The virus removal 
  16 
from affinity based chitosan was attributed to electrostatic and hydrophobic driven 
binding effect.  
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Chapter 1 
 
 
Introduction and overview 
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1.1  Introduction 
Viruses can either cause disease and death, or they can be manipulated into 
lifesaving vaccines and gene therapy vectors. This dissertation focuses on methods 
to purify and remove viruses for vaccines or water purification, respectively. The 
overarching theme is that the study of virus surface chemistry allows us to create 
operations that will improve a host of applications, including clean water, 
biotherapeutics, disease detection, and reduce disease transmission.  
1.2  Overview 
The dissertation starts with exploring different chromatography modes to achieve 
PPV purification from cell or media protein contaminants. Conventional downstream 
processing faces a challenge to effectively purify virus particles for vaccine 
therapeutics due to issues pertaining to purity, potency and quality. To overcome this 
issue we have investigated and designed an optimal aqueous two-phase system 
achieving a high virus recovery compared to industry standards. The dissertation 
also involves work on virus removal studies. Millions of people die every year due to 
bacterial and viral diseases from contaminated water especially in developing 
countries. In a quest to create economical point-of-care water filtration devices we 
have designed peptide-functionalized chitosan membranes for virus removal. Apart 
from virus purification and removal we also attempt to physically characterize the 
virus. Virus structural properties can help aid the design of virus surface adsorption 
and virus-cell interactions which would be useful for the development of separation 
strategies and antiviral drugs.  
  19 
In this dissertation, Chapter 2 is the literature review of the downstream 
processes available for purifying virus particles. We discuss the challenges and 
drawbacks encountered for each unit operation and propose ideas on improving 
virus recovery. In the second half of literature review chapter we discuss current 
water purification strategies used for human water consumption. Viruses can be 
extremely small, highly resistant to chemicals and cause illness even if consumed in 
a parts per million dose. Keeping this in perspective, we have identified many 
purification methods lack of ability to remove all of viruses. Towards the end of the 
chapter, we discuss techniques and instrumentation available to characterize viruses 
by their surface properties and size.  
In chapter 3 we explore different methods to purify and characterize virus 
particles.  We describe chromatography techniques for purifying virus based on 
charge and size. We used ion exchange chromatography to detect and purify virus 
from protein impurities. Next, we used size exclusion chromatography for different 
virus concentrations samples to examine if the technique can be an effective virus 
quantification tool. The predominantly used virus quantification method in our lab is 
the MTT cytotoxicity assay. The MTT assay can be a laborious and time consuming 
technique, requiring abundant consumables. Later in the chapter, we investigated 
the experimental hydrophobicity of virus. The surface hydrophobic residues of virus 
was examined using reverse phase chromatography and ANS fluorescent probe.  
Our pursuit on identifying a tool for virus quantification also featured observing 
individual virus particle trafficking through cells. In chapter 4 we developed a protocol 
to tag the virus with a dye label and observe it under fluorescent microscope as it 
  20 
makes its way through the cellular machinery. In the second half of the chapter, the 
protocol was used towards studying osmolytes behavior in the presence of virus 
using immunohistochemistry. The protecting nature of osmolytes was determined to 
reduce the virus infection by 4 LRV by my colleague Ms. Maria Tafur.  IHC 
determined that the capsid proteins were still produced, even in the presence of 
protecting osmolytes.  We hypothesize that the osmolytes reduce the ability of 
capsid proteins to assemble. The immunohistochemistry work has been published in 
Antiviral Research.  
Chapter 5 is dedicated to virus recovery work for vaccine therapeutic production. 
Aqueous two-phase system (ATPS), a polymer-salt precipitation technique, is often 
evaded for biomanufacturing process due to co-precipitation of impurities and low 
yield. In the chapter we design a robust ATPS by manipulating the biomolecular 
charge, virus surface hydrophobicity, and surface tension of the system to achieve a 
high recovery in the polymer phase. The work has been published in the Journal of 
Chromatography B.  
Chapter 6 deals with the creation of microfiltration membrane for virus removal 
from potable water. Microfiltration membranes have a low back pressure, which 
prevents fouling and allows for a high water flux. To adsorb virus, we have 
synthesized cysteine regulated trimer WRW peptide ligands on the electrospun 
chitosan nanofibers. We discuss the conjugation chemistry to attach peptide on the 
fibers and report results of filtration from virus contaminated water.  
Chapter 7 reviews the results from all the previous chapters and provides ideas 
for future work.  
  21 
 
 
 
 
 
Chapter 2 
 
  
Virus characterization and its separation from aqueous 
medium 
  
  22 
2.1  Introduction  
Viruses are known to cause diseases and many times even leading to death. On 
the contrary viruses can also be purified and used for creating therapeutic vaccines. 
The goal of this dissertation is to study virus surface characteristics and manipulate 
their mechanism to a) improve virus recovery for vaccine production and b) remove 
virus from solution for creating potable drinking water.  
Vaccines are biological components which provide immunity from infectious 
diseases. Vaccines are administered by introducing foreign antigens or a weakened 
virus strain that is incapable of triggering disease but induces the production of 
antibodies. The antibodies are capable of remembering the antigen as a foreign 
material and destroy the invader when it is later encountered. Vaccines continue to 
save millions of lives. The current global decade vaccine action plan is to avert an 
additional 24-26 million deaths and a hundred million illnesses using a total of 10 
vaccines [1]. Five strategic objectives have been proposed by the WHO to 
accomplish the vaccine action plan. A crucial strategic objective among the five is to 
improve research and development in low and middle income countries and to 
enable multidisciplinary technology for reducing the financial burden on vaccine 
production [1]. For several decades, the egg-based technique has been the 
predominant technique for the production of vaccines [2]. However the pandemic 
over the lack of preparedness for the Influenza vaccine in the recent years, frequent 
bottlenecks in production and financial burden has highlighted the fragile nature of 
egg-based system [3]. The main drawbacks include a six to nine month 
production lead time and requirement of a pre-planned choice of the virus strain. 
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These shortcomings has demanded an innovative modern technology alongside the 
traditional egg-based vaccine [4]. Cell-based vaccines have become an alternative 
to the embryonated eggs but the downstream operations or purification steps remain 
unchanged. Research on the purification mechanisms for cell-based techniques is 
required to decrease the large financial burden that is placed on the downstream 
operations of vaccine manufacturing [5].  
In addition to vaccine purification, many of the techniques we study can be 
applied to the removal of viruses from drinking water. Clean drinking water is a basic 
human right. Lack of access to safe potable water jeopardizes the social and 
physical well-being of an individual and his or her human dignity [6]. In spite of the 
importance of water, 884 million people lack access to safe clean water and 2.6 
billion people are denied proper sanitation and toilets [7]. In 2001 it was estimated 
that 26% of deaths worldwide were caused by pathogen containing water supplies, 
and the pathogens included virus, bacteria and protozoans [7]. Even today the 
burden of infectious diseases due to the microbial organisms remains quite high. 
Although several thousand species of pathogens have been recorded in the past, 
new species seems to be continuously emerging causing infectious diseases such 
as middle east respiratory syndrome (MERS) and severe acute respiratory 
syndrome (SARS). Among the main classification of pathogens into bacteria, 
protozoa, fungi and viruses, it is the viruses which are responsible for 44% of the 
emerging diseases [6]. A traditional technique for providing safe drinking water from 
virus has been to use a multiple barrier system. The multiple barrier system has 
included pretreatment systems, chemical treatment, membrane filtration and 
inactivation using disinfectants [8, 9]. Despite these measures, it has been difficult to 
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adopt these techniques universally for all virus families, especially in the developing 
and underdeveloped countries. Our effort is focused on providing a working solution 
to reject virus from water using a specialized functional filtration mechanism with a 
model virus.   
2.2  Improving virus recovery for cell-based vaccines 
Cell culture based vaccines are produced by introducing a virus strain into 
susceptible cells in a bioreactor, followed by cell lysis and finally the removal of virus 
from the aqueous medium by a series of unit operations. Vaccines created in cell 
culture are reliable and robust due to faster production, shorter lead times, higher 
purity, reduced contamination and ability to combine upstream and downstream 
processes [10, 11]. With the current advances in upstream operations, which have 
increased yields, it is the downstream processing that requires innovative and 
optimized controls to reduce the 70% financial burden on the manufacturing process 
[5]. In vaccine manufacturing, the cell culture is commonly accompanied with cellular 
debris, unwanted media proteins, adventitious agents, residual DNA, nucleic acid 
and many process related leachable contaminants. As per the FDA vaccine approval 
requires the freedom from extraneous material whether or not harmful to the 
recipient [12]. Viruses have a unique size, shape and surface chemistry, i.e. 
hydrophobicity and charge. Most often a series of unit operations are required to 
increase the yield of virus particles. The currently used operations involve a 
combination of precipitation, centrifugation, filtration and chromatography [13, 14]. 
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2.2.1  Precipitation 
Precipitation of virus is generally achieved using polyethylene glycol (PEG), 
ammonium sulfate, or calcium phosphate [15-17]. Among all precipitation techniques 
PEG has been most frequently used. PEG has shown an enhanced virus yield up to 
64% in the case of bovine rotavirus compared to 7% from the ultracentrifugation 
process [18]. Some other examples include 8% PEG 8000 has been used as a 
preliminary step to improve the transduction efficiency and optimize the sequential 
CsCl gradient ultrafiltration [19]. PEG and salts can purify virus by altering its 
solubility causing precipitation or salting out effect [16, 17]. An alternate concept has 
been to precipitate the impurities from the virus while leaving the virus in solution. A 
750 kDa polyethyleneimine (PEI) of 0.0045 w/v% solution was able to precipitate 
85% of the DNA after centrifugation [20]. Polysorbate 80 or sodium chloride has also 
been useful during precipitation protocol by breaking up the aggregates between 
DNA and viruses which are held together by hydrophobic and electrostatic charge 
interactions [21]. Dissolution of aggregates is followed up with chromatography to 
achieve a final DNA concentration of 5 pg/dose [21]. The residual DNA is well below 
the expected standards of EP (European Pharmacopoeia) or FDA (Food Drug and 
Administration) of 10 ng/dose [12, 22]. There is tremendous potential for PEG or 
precipitation in general, however a high recovery yield and reduced immunogenicity 
needs to be addressed for improved application of this downstream operation in 
large scale manufacturing. 
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2.2.2  Centrifugation and density gradient 
Centrifugation is an easy to use, large scale separation method based on density 
differences. Biotherapeutic manufacturing uses centrifugation often in monoclonal 
antibody production; however, when it comes to virus particles, the high speed and 
strong centrifugal force can render the particles non-infectious [23]. An alternate 
mechanism is a density gradient using sucrose, cesium chloride (CsCl) or iodixanol. 
In the case of sucrose, the solution is highly viscous and hyper osmotic, reducing the 
overall yield of the virus stock [24]. CsCl gradient has known to increase the virus 
particle to infectious virus ratio up to 1600:1, whereas the requirement is in a much 
lower range around 20:1 [25]. This shows the reduced efficiency of CsCl in terms of 
maintaining liability of virus particle. Iodixanol density gradient is a low viscous 
system which can form an iso-osmotic solution and maintain the functionality of the 
virus structure [26]. Retrovirus recovery of 37% and a promising 95% purity has 
been reported using Iodixanol gradient [24]. Gradient centrifugation has yielded 
satisfactory result in laboratory scale, but it continues to remain a time consuming 
and laborious process which is impractical in large scale manufacturing. 
2.2.3  Tangential flow filtration 
Tangential flow filtration (TFF) is the commonly used size based filtration 
technique for virus purification from cell culture medium. A two stop process was 
created to purify influenza virus particles. A large pore size (0.45 μm) was used to 
allow the passage of virus while holding cell debris. This was followed by a 100 kDa 
filter that retained the virus and allow host cell proteins to pass through the filter [27]. 
For smaller viruses, such as the minute virus of mice (MVM) which range in the 20 
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nm size, a smaller filter pore size is required to retain viruses [28]. Such a small pore 
size often leads to membrane fouling and pore plugging from the virus particles, 
protein aggregates and the media contaminants such as bovine serum albumin 
(BSA) [29]. Another disadvantage encountered to small pore size membranes is the 
osmotic pressure gradient that can lead to concentration polarization. It causes 
unwanted protein contaminant retention on the feed side, therefore reducing virus 
yield [30]. All of the discussed factors also lead to a major issue of high 
transmembrane pressure (TMP) and low permeate flux causing reduced filter 
throughput and poor membrane performance. To try and reduce the concentration 
polarization that occurs with small pore sized membranes, research has been 
conducted with the polymeric skin, or the functional part of the nanofiltration 
membrane, is placed away from the feed (i.e. loading the filter backwards from 
manufacturers recommended configuration). Viresolve 180 filter (membrane nominal 
pore size ~ 18 nm) using cysteinylated BSA as a model protein with skin-surface 
away from the feed showed a higher flux at 240 L/m2 compared to skin-surface 
facing the feed at 13 L/m2 [31]. A higher virus removal can be expected with skin-
side away due to reduced osmotic effects from the better control over the membrane 
supporting structure leading to the skin. In summary of TFF, researchers have 
recommended a narrow pore size distribution to retain maximum virus and a good 
pore interconnectivity allowing the liquid media to flow through easily. Such 
measures will control the TMP and increase the permeate flux with no fouling. TFF 
continues to be used frequently for large scale manufacturing but many 
troubleshooting issues due to the cell media proteins, pore size distribution, 
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permeate flux continue to be experienced especially for the small pore size filters 
less than 100 nm.   
2.2.4  Chromatography 
Chromatography is a separation technique based on the interaction between a 
target virus and a stationery column matrix. The separation functionality can be 
broadly categorized into (1) charge, (2) size, (3) hydrophobic and (4) affinity. 
Conventional chromatography is comprised of porous resin beads that have a high 
internal surface area (Figure 2.1 (A)). Large virus particles have diffusion limitations 
that often preclude penetration into the pores and low dynamic binding capacity due 
to small pore sizes as compared to virus diameters. A kinetic and convective mass 
transfer limitation was desired to overcome this drawback and this led the way for 
membrane chromatography. A stacked membrane is used instead of packed resin 
beads. The virus is forced through the pores, reducing the process time and 
pressure drop, as shown in the Figure 2.1 (B). 
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 Figure 2.1 Chromatography column matrix. (A) conventional porous bead where 
large virus diameter is diffusion limited and restricted from entering internal pore 
surface area necessary for adsorption. (B) membrane adsorbers where diffusion 
limitation in conventional resin beads is overcome by convection based interaction 
allowing larger biomolecules. 
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B
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2.2.4.1  Ion exchange chromatography 
Ion exchange is a widely used mechanism for separation of biomolecules, where 
the opposing charge of the matrix and the virus particle dictates the adsorption 
effect, as shown in the Figure 2.2 with regard to a particular section of resin surface.   
 
Figure 2.2 Ion exchange chromatography. Oppositely charged resins and target 
biomolecule causes adsorption of molecule which can be eluted upon subjecting the 
column matrix to strong salt ions which replace the biomolecule. The figure above is 
a representation of anion exchange chromatography. 
  
 
All charge based virus interactions are dependent on the difference between the 
isoelectric point (pI) of the virus and the charge on the surface matrix. The pH of the 
solution is chosen such that the viruses are negatively charged and the base matrix 
is positively charged or vice versa creating electrostatic difference. Aedes 
densonucleosis virus (AeDNV) purification was conducted on Sartobind strong 
quaternary amine (Q) and Sartobind weak secondary amine (D) anion exchange 
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membranes (see Figure 2.3) [32] to study the virus concentration based on the 
strength of electrostatic interaction. The neutral pH of the buffer solution with respect 
to the virus pI of 3.5 was crucial to capture virus on the membranes effectively. 
However for the same neutral pH the weak D anion exchange membrane 
experienced a lack of pH buffering capacity due to the hydroxyl ions (OH-) that are 
released during the virus capture step on the membrane surface.  This causes pH 
fluctuations and hence a lower dynamic binding capacity [32]. In addition to 
hydroxyls, the limited capacity on weak anion exchange was also noticed due to the 
competition from amino acids, host cell DNA (same size of virus) and extraneous 
proteins (similar pI of virus) causing a significant reduction in binding capacity by 
several orders [32, 33].  
 
Figure 2.3 Anion exchange chromatography. Strong (Q) and weak (D) amine 
resins. 
 
Limitations due to weak anion exchange chromatography (AEC) has also been 
reported for the purification of influenza virus on monolithic chromatographic support. 
Monolithic chromatography is a convection controlled separation process on 
membrane monoliths, similar to membrane chromatography. The recovery yield of 
influenza virus (pI 4-4.5) for a strong anion exchange monolith with a Q functionality 
was 70-90% and was reduced to 30-50% when using the weak D ligand [34]. In this 
case, the reason for low yield was again due to the lack of pH buffering capacity. 
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The pH rise up to 9.5 during NaCl elution caused loss of immunogenicity where 
influenza is susceptible to inactivation [34]. The authors hypothesize that strong ion 
exchange ligands can adsorb virus effectively, however they too have had issues of 
maintaining virus surface conformation during elution [33]. Protein conformation on 
the virus surface is very crucial since the proteins attach to cell receptors during 
vaccine therapy. Some other drawbacks that have been reported for ion exchange 
membranes is the steric hindrance effects [35]. In pretext to design strong 
electrostatic attraction between the stationery phase and virus, the first inlet of virus 
can display excessive covalent binding. This excessive binding sterically hinders 
other virus particles from binding to the membrane and reduces the virus particle 
recovery. The steric hindrance issues can prevent the continuous flow use and can 
reduce the working life of the ion exchange membranes [35].  
2.2.4.2  Size exclusion chromatography 
Size exclusion chromatography (SEC) is a separation technique using tightly 
packed stationery matrix of silica or agarose gel beads [36]. In SEC, the large 
molecules elute first because they only pass through the interparticle void volume. 
The small molecules elute with longer residence time after passing through the pore 
volume and the void volume as shown in the Figure 2.4. SEC can be used for virus 
concentration by collecting virus in the void volume and separating it from the small 
protein contaminants. Studies reported on recombinant baculovirus and the turkey 
coronavirus have shown a high purity but very moderate recovery in the range of 30-
40% [14, 37]. The main advantages of SEC are the low cost of resins and ease in 
operation due to isocratic mode. However the technique severely lacks selectivity, 
  33 
needs low flow rate operation and also suffers from low productivity. A scale up 
operation using SEC is restricted because the column can easily get saturated with 
host cell proteins, preventing the separation of host cell proteins and large viruses. 
These drawbacks question the application of SEC as a key process in vaccine 
manufacturing.          
           
Figure 2.4 Size exclusion chromatography. Large biomolecules elute earlier in the 
void volume compared to the small molecules which use a longer path between resin 
pores and narrow spaces in the column. 
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2.2.4.3  Hydrophobic interaction chromatography 
Hydrophobic interaction chromatography (HIC) is governed by the interaction 
of hydrophobic patches on the target molecule with hydrophobic ligands on the 
stationary matrix. At high salt concentration the kosmotropic salt structures the water 
around itself and strips the hydrophobic biomolecule of their solvation water as 
shown in Figure 2.5 [38]. This phenomena exposes the hydrophobic patches on the 
molecule and causing it to nucleate on the surface of ligand. The recovery and 
purification of target molecule is acquired by reducing the salt conditions and 
annulling the hydrophobic interaction mechanism on ligand surface.      
                             
Figure 2.5. Hydrophobic interaction chromatography. At high salt conditions, the 
water structuring salt reduces the solvation of protein facilitating the hydrophobic 
interaction between the biomolecule and ligand. At low salt, the molecule-ligand 
hydrophobic interaction is minimized eluting the molecule by restructuring of water 
and restoration of protein solvation phenomena.  
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HIC is used frequently in biotherapeutics for purifying proteins or impurity 
removal but seldom for virus purification [39, 40]. For producing high virus purities, 
large amounts of DNA removal has been achieved using the various HIC resins with 
butyl, phenyl and hexyl ligands [41]. The hydrocarbon side chains, as shown in the 
Figure 2.6, form hydrophobic interactions with the non-polar amino acids on proteins 
and virus surfaces [42]. Purification of cell culture derived vaccinia ankara virus 
using the three mentioned HIC resins removed DNA easily between 48-64% from 
the flow through peak while the virus eluted using a gradient elution from 1.7 M to 0 
M ammonium salt (NH4)2SO4 [41]. Although successful results were noticed for DNA 
removal, the virus recovery was reduced to 34-37% mainly due to the high salt 
conditions of 1.7M (NH4)2SO4 [41] caused by reduced immunogenicity. In another 
study related to immunogenicity, Adeno associated virus (AAV) was subjected to the 
first capture step using IEC accompanied by HIC with a butyl resin. The AAV was 
eluted by a step gradient from 1.5 M to 0.6 M (NH4)2SO4. An overall recovery of 75% 
was obtained however the virus particle to infectious virus ratio was an average 
17500:1 making it a less than optimal system [43]. Canine adenovirus was 
recovered up to a high 88% on Fractogel propyl resin with a step gradient from 0.85 
M to 0 M (NH4)2SO4, followed by a diafiltration and ultrafiltration step. The virus 
recovery was measured with real time-polymerase chain reaction (RT-PCR) which 
fails to provide adequate information on immunogenicity of the virus [44]. Not only 
can the high salt reduce the immunogenicity of the virus, but the high salt 
concentration can also aggregate the virus particles [45].  
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 Figure 2.6 Hydrophobic resins. 
2.2.4.5  Affinity chromatography 
Affinity chromatography or pseudo affinity chromatography is based on creating 
reversible interaction sites between an immobilized ligand and a biomolecule as 
shown in Figure 2.7. The technique can offer high selectivity, resolution and 
capacity for adsorbing the molecule of interest. Affinity chromatography interactions 
often resemble the interaction of a molecule with its natural substrates. For 
recovering the biomolecule the ligand matrix can be treated with a competing 
molecule or by changing the ionic strength or pH. A few of the important ligand types 
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that have been applied for virus purification are metal affinity, heparin sulfate and a 
lectin ligand.  
 
Figure 2.7 Affinity chromatography. The target biomolecule is adsorbed on the 
specifically designed ligand using a unique interaction mechanism and desorbed by 
treating the ligand with competitive molecule, change in pH or ionic strength.  
 
Immobilized metal affinity chromatography (IMAC) consists of a matrix containing 
a chelating agent and a metal ion. The chelating agent (electron donor) is covalently 
bound to the metal ion (electron acceptor) on the matrix [46]. The virus particles are 
purified on the IMAC setup due to histidine, cysteine or tryptophan affinity to the 
available metal ion active residues. Metal ion sites for virus affinity have also been 
coupled with electrostatic and hydrophobic interactions in affinity systems requiring a 
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thorough investigation of ion strength and pH to optimize the purification. Influenza 
virus purification on a zinc-modified Sartobind iminodiacetic acid membrane at 1M 
NaCl and pH between 7-8 showed 93% recovery [47]. The process achieved 
removal of 93% DNA and 74% protein contaminant in the final sample [47]. Some 
other studies performed using IMAC have shown the use of cobalt for 78% recovery 
of herpes simplex virus and removal of 96% of the contaminant proteins [48]. 
Although IMAC is able to achieve good virus recovery, it must be noted that the 
binding is often obtained from multiple covalent sites. The elution of viruses require 
strong ionic strength or pH conditions, or by addition of imidazole or glycine, which 
compete for active sites [23]. Harsh desorption conditions for viruses from ionic 
strength or pH can change the virus conformation, reducing its transfection 
properties or even causing virus degradation [23]. Imidazole and glycine, if used, 
would need to be removed from the final product with additional removal steps. 
IMAC is also known for leaching of the metal ions as in the case of nickel ions for 
retroviruses [49]. This would again require additional steps to remove ions which can 
increase the operating procedures and reduction in virus yield.  
Lectin affinity chromatography (LAC) is based on lectin ligands on porous beads 
or membrane adsorbers. The ligands have an affinity towards glycan proteins or 
carbohydrate residues on the virus surfaces. For example, the Euonymus 
Europaeus lectin (EEL) and Erythrina Christagalli lectin (ECL) were used for the 
purification of influenza A/B virus from Vero and MDCK cell line. For the MDCK cell 
line, the EEL recovered 80-??????????????????????????????????????????????????????????
DNA removal of 64-84% and the final cell protein content removal of 98% [50]. For 
Vero cells, the difference in glycosylation patterns from MDCK yielded poor binding 
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affinity for both ECL and EEL [50]. Where EEL on MDCK yielded >80% recovery, 
ECL on MDCK did not yield good recovery due to slow and weak binding which 
would require low flow rates or buffer recirculation for efficient recovery, and these 
conditions are not practical for scale up operations [50]. LAC are often designed for 
specific virus progenies. LAC severely lacks process robustness and hence it cannot 
be used as a universal platform approach for a range of viruses.   
Heparin sulfate, another type of pseudo-affinity chromatography, uses heparin, a 
heavily sulfated glycosaminoglycan consisting of hexuronic acid and D-glucosamine 
residues, which act as receptors for virus attachment [51]. Downstream operation of 
Moloney Murine leukemia virus (MoMLV), porcine reproductive respiratory syndrome 
(PRRS) and influenza virus have been studied using heparin ligands. The recoveries 
achieved were 43% for MoMLV [52], 53% for PRRS [53] and 82% for influenza [54]. 
The operation also achieved >90% removal of cellular proteins but the DNA was 
between 75-1725 ng/dose [54] which is much higher than 10 ng/dose standard set 
forth by the EU . Heparin sulfate, similar to LAC, is specific to virus epitopes that can 
cause lower yield and restrict its use as a platform technology. Additionally, the 
branched structure of the heparin ligand and the hydrogen bond between a virus and 
heparin make it difficult to elute the virus without effecting its immunogenicity [55]. 
In summary affinity chromatography is a highly selective process with a high 
dynamic binding capacity due to the multivalent interactions (charge, hydrophobic 
and hydrogen) between the ligand and the virus. It has immense potential to be 
incorporated after a clarification step, achieving high recoveries and contaminant 
removal. However, for large scale vaccine applications, a more detailed analysis is 
still required as the performance remains to be unpredictable due to the virus 
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subtypes, post translational modification and glycosylation changes. In addition there 
remains a limited knowledge on the cell receptor binding capacity for vaccine 
products due to the expected conformational changes on the virus surface after the 
salt elution process on affinity systems. Affinity chromatography is specific to each 
virus subtype, making it a specialized process per vaccine product.  A more 
universal approach to vaccine purification would lead to lower costs and faster time 
to market for desperately needed vaccine products. 
2.2.5  Aqueous two-phase extraction 
Currently, the downstream processing of viral products combines several of the 
previously mentioned unit operations. The biopharmaceutical industry currently 
considers 30% an acceptable virus recovery for vaccine products [56]. Our goal is to 
produce a high infectious yield with an alternate robust technique that has the 
potential to be applied as a platform technology. To fulfill this goal, we have been 
exploring aqueous two-phase systems (ATPS) as an optional mechanism to purify 
virus. ATPS combines clarification, concentration and purification into a single, 
integrated step to obtain a high yield with a low financial burden [57, 58]. ATPS is 
formed by mixing water soluble polymers, or a water soluble polymer and a salt, 
above a critical concentration that results in two immiscible aqueous phases [58]. It 
is a versatile method used for the separation and purification of biological molecule 
[59, 60]. For virus-like particle separation, a 54% recovery was noted for human 
papillomavirus [61] and 37% for a DNA plasmid vaccine [62] in a PEG-phosphate 
system. A high recovery for infectious virus is more difficult and sought after since 
the ratio of infectious particles to non-infectious particles can be as high as 1:1000. A 
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30-38% recovery was obtained for infectious bacteriophage T4 using a PEG-
phosphate system [63]. A recovery yield of < 55% demonstrates the need to improve 
the virus purification using ATPS. Other shortcomings with ATPS include reduced 
transduction from chemicals, co-purification of proteins, and difficulty of polymer 
recycling. We have successfully tackled a majority of the concerns and this will be 
discussed in detail in Chapter 5.  
In the last few years, there has been extensive research on the development of 
cell-based vaccines alongside egg-based vaccines. Egg-based vaccines face 
several drawbacks, including lengthy process time, requirement of a large inventory, 
frequent bottlenecks etc. Cell-based vaccines are a faster way of producing 
vaccines, however it too can be burdened with financial constraints. The majority of 
the financial burden is experienced by downstream processes and creating an easily 
scaled and uniform platform approach for virus purification could greatly improve 
vaccine production systems.  
2.3  Virus removal for water purification 
Modern methods of virus removal for the purification of drinking water focus on 
sized-based removal with membranes, disinfection with UV or ozone treatment and 
affinity adsorption to surfaces. While many of these methods have been shown to 
successfully remove viruses from drinking water, a widely accepted technology to 
curb worldwide deaths from lack of purified water has yet to emerge. While many of 
these methods have been shown to successfully remove viruses from drinking 
water, a widely accepted technology to curb worldwide deaths from lack of purified 
water has yet to emerge.  Here I will discuss many of the many drinking water 
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purification methods, as related to viruses.  Many methods are similar to those used 
in virus purification, but cost and lack of other proteins in the system make some of 
the methods distinct for water purification. 
2.3.1  Size based  
Membrane filtration is a separation process using semipermeable membrane. It 
works on the principle of differential hydraulic pressure by passing water from one 
side of the membrane to another. Methods used for the membrane filtration include 
microfiltration (MF), ultrafiltration (UF), nanofiltration (NF), and reverse osmosis 
(RO). Figure 2.8 represents the size range for each of the filtration type and Table 
2.1 provides the operating pressure of the filters.  
 
Figure 2.8 Size range of different filtration methods 
 
 
 
 
10001001010.10.010.0010.0001
PARTICLE FILTRATION
MICROFILTRATION
NANOFILTRATION
REVERSE OSMOSIS
SANDYEASTBACTERIAVIRUSIONS
Micrometer 
(log scale)
ATOMIC 
RADIUS
Approx. molecular wt.5000 kD100 kD3 kD
ULTRAFILTRATION
Granular filtration
Filter screens
Membrane filtration
  43 
Table 2.1 Membrane pore size and applied pressure 
Filter type Size (μm) Operating Pressure 
(kPa) 
Microfiltration 0.1 – 1 30-50 
Ultrafiltration 0.1 - 0.01 30-50 
Nanofiltration 0.001 - 0.001 500-1000 
Reverse Osmosis 0.001- 0.0001 1000-5000 
 
The virus removal mechanism is analyzed and quantified using the log reduction 
value (LRV). LRV is a mathematical term used to show the relative number of virus 
particles eliminated after treatment as highlighted in Equation 2.1. The 
Environmental Protection Agency (EPA) demands greater than 99.99% removal or 4 
LRV as a drinking water standard and to make it available for safe consumption [64].   
??? =  ??????  
???????? ????? ?????????????
???? ????? ?????????????                                   (2.1) 
2.3.1.1  Ultrafiltration 
In 2006, it was reported that globally about 3 billion gallons of water per day was 
processed through low pressure filters, of which 60% catered to drinking water 
needs and 22% for wastewater facilities [65]. The low pressure filters were MF and 
UF. UF has a pore size of 0.1 - 0.01 μm and it can remove some but not all viruses. 
In the United States 43 out of 50 states have not credited UF to achieve satisfactory 
log removal of viruses [66]. Regardless, the UF mechanism has often been stated to 
achieve moderate removal between 1 to 6 LRV for MS-2 and GA bacteriophage (a 
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virus that infects bacteria) [67] and 3 to 4 LRV for influenza viruses [68]. The reason 
for the moderate removal in the majority of reports was not only attributed to the size 
exclusion effect, but other interactions, such as hydrophobicity, electrostatic charge 
and presence of colloids, contributed towards the virus removal. A virus removal 
study for drinking water using MS2 bacteriophage, which is 27 nm in diameter, and 
??????????????????????ich is 33 nm in diameter, has shown that MS2 produces 
higher removal. Although MS2 is smaller in size, the electrostatic repulsion effect 
increases its removal [69]. At pH 7.4, the differences in the pI of the viruses (MS2 - 
??????????- 6.6) causes changes in the electrostatic charge, playing a key role in the 
high LRV for MS2. In a study involving organic matter, MS2 was studied at neutral 
pH conditions with a 0.1 μm nominal pore size filter. Five different factors of virus 
removal were identified, namely adsorption, sieving, charge, small organic matter 
concentration and large organic matter concentration [70]. The sorption and sieving 
could only achieve 1 LRV [70]. The maximum recovery of 3.4 LRV was witnessed in 
the presence of the organic matter due to the ability of colloids to cause pore 
constriction and cake formation [70]. A cartoon of each removal mechanism is 
shown in Figure 2.9.The other factor which can influence the virus concentration in 
UF is the transmembrane pressure (TMP). Increasing TMP has caused a decrease 
in virus retention due to abnormal enlargement of pores under pressurized 
??????????????????????????????????????????????????????????????????????????????????
from 100 kPa to 500kPa ?????????????????????????????????????????????????????????on 
commerical Ultipour DV20 membrane filter has shown that pressure release from 
210 to 100 kPa can cause a virus to penetatrate the membrane for a loss of 1 LRV 
[72]. Ultrafiltration has been shown to achieve good virus removal but a lack of 
  45 
consistent separation makes this form of filtration very susceptible to virus 
breakthrough.  
 
Figure 2.9 Five potential mechanisms for virus removal. (i) Sorption to the 
membrane, (ii) physical sieving, (iii) electrostatic repulsion, (iv) large organic matter 
induced removal, v small organic matter induced removal. Reprint permission 
granted from [70].  
 
2.3.1.2  Nanofiltration and reverse osmosis 
NF is a pressure driven process and has a smaller pore size than MF and UF. 
The MWCO of 200 to 1000 Da is likely to remove the majority of viruses. In a 
Minnesota field study, a cellulose acetate membrane CA2PF (MWCO 2000 Da) and 
polyamide membrane AFC30 (MWCO 350 Da) achieved 4.1 - 4.2 LRV for MS2 
bacteriophage [73]. A study involving NF membranes showed 4.3 – 6.7 LRV of MS2 
[74]. However imperfection in the membranes, such as the presence of an abnormal 
pinhole, faulty barrier coating and glue line discontinuity have been witnessed [75] to 
reduce the performance drastically to a low 1 LRV of MS2 [74]. NF membrane are 
also highly prone to boundary layer fouling from multivalent ions and organics, 
reducing the permeate flux [76]. 
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RO works on the principle of diffusion unlike MF, UF and NF which operate 
based on sieving. RO works on the principle opposite to osmosis where high 
pressure is exerted for water movement from low concentration (high salt) to high 
concentration (low salt). Studies have shown varying viral removal efficacy from 2 
LRV to 5.9 LRV for the MS2 virus [77, 78]. This inconsistency is believed to be due 
to the imperfections in the membranes that are correlated with a loss of salt rejection 
[79]. RO membranes are also known to undergo membrane compaction resulting in 
reduced permeability [80].  
In summary NF and RO are seldom used for virus removal in water purification 
due to their high cost compared to previous filtration steps [81]. NF techniques are 
frequently used in biotherapeutics industry to achieve virus removal as the costs of 
NF is small in comparison to the higher prices of therapeutic drugs. One of the major 
disadvantages with NF is also its membrane fouling due to the increased pressure 
and the small pore size.  
2.3.1.3  Flocculation  
Membrane filters are commonly prone to fouling due to blockage of membrane 
pores by adsorption of the particulate compounds. In the case of virus in water 
containing natural organic matter (NOM), precoagulation or flocculation is necessary 
to prevent blockage and to remove viruses. Coagulation is a hybrid system followed 
by microfiltration to remove the flocs. MS2 bacteriophage removal in water 
containing NOM was able to achieve a 6 LRV by addition of ferric chloride (FeCl) 
and polyaluminium chloride (PACl) followed by hybrid ceramic microfiltration [82]. 
Without the FeCl or PACl only 1 LRV of MS2 (pI 3.5) was achieved. To accomplish a 
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high 6 LRV, a pH 5.0 for FeCl and 5.5-6.5 for PACl was required to maintain the 
negative charge on the virus particles. A high dose of 8 mg Fe/L and 4 mg Al/L was 
used to enable efficient charge neutralization since NOM are anionic competitors to 
the virus [82]????????????????????????????????????????????????????? ????????????.8 
for negative charge was able to achieve > 6 LRV [83]. The addition of coagulants for 
flocculation shows that a highly regulated coagulant dose and pH were important to 
achieve a high removal of pathogens. The major drawback of flocculation is the 
presence of residual metal ion content in the potable water may be higher than the 
legal regulation limit [82].  
2.3.2  Inactivation process using UV and ozone treatment 
Filtration may leave traces of microbial pathogen, which can be removed by the 
follow up technique of inactivation. Inactivation is a process of using disinfectants 
such as chlorine and ozone which bring about chemical oxidation of organic 
microbial species. The factors involved in this process are disinfectant concentration, 
contact time, temperature and pH. Chlorine is theorized to destroy microorganisms 
by combining with proteins to form N-chloro compounds and by interacting with 
sulfhydryl compounds of proteins [84]. Chlorine causes physiological damage to the 
cellular membrane along with causing decreased glucose, nutrient transport and 
energy level of cells [85]. Primary sewage effluents were treated with 8, 6 and 30 
mg/L of chlorine to remove poliovirus by 2.8 LRV and MS2 for significantly lower 
value of 0.1-0.2 LRV [86]. Murine norovirus and poliovirus have also shown > 4 LRV 
at 0.1 mg/L for contact time of 120 minutes and 0.5 mg/L for 0.5 minutes [87]. 
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However the major drawback of using chlorine is the formation of halogenated 
compounds with NOM which may be carcinogenic in nature [88]. 
Ozone is known to inactivate resistant microorganisms more effectively than free 
chlorine. It requires reduced concentration and shorter contact time than free 
chlorine to achieve similar inactivation [89]. Ozone inactivates virus by attacking 
protein capsid, liberating the nucleic acid and attacking them [89]. Adenovirus type 
40 AD40 was inactivated > 3 logs with ozone concentration between 0.30-0.49 mg/L 
with a contact time of 2 minutes or more [90]. Murine norovirus was ozone 
disinfected at 0.3 mg/L and 1.2 mg/L to achieve 2 and 3 LRV respectively [91]. 
Ozone is also known to be carcinogenic in nature when treated with bromide ions in 
water [92].  
2.3.3  Adsorptive virus removal from water 
Virus removal by size is the most common in water purification applications.  
Membranes that are tuned to have a specific charge and hydrophobicity have shown 
promise for the purification of water and hence continue to be developed. A growing 
area of research is exploring the adsorption of viruses to functionalized surfaces 
using affinity interactions and multimodal binding for water purification applications.  
Carbon nanotubes, incorporated as the pores of a PTFE membrane, are capable 
of removing pathogens from water [93]. The charge of the virus and the matrix can 
be manipulated with the knowledge of the pI for each and strict control over the pH 
of the solution. At a pH of 3, 8.13 LRV was achieved since the pI of MS2 is 3.5 
where MS2 had a slight positive charge and MWCNT was negative. As the pH 
increased, making both the bacteriophage and the surface negatively charged, the 
  49 
LRV dropped to 5.38 at pH 5.5 and a lower 4 LRV at pH of 9 [93]. Anodic multiwalled 
carbon nanotubes (MWCNT) act as electrochemical filters have also been used for 
MS2 removal. The positively charged anodic filter and negative virus particles can 
facilitate pathogen attachment, following which the virus undergoes inactivation by 
oxidation [94]. The electrical conductivity of the carbon nanotube was able to 
showcase 5.2 to 7.9 LRV or inactivation of MS2 bacteriophage under the application 
of a small DC potential between 2- 3 V [94]. Charge based filtration was also 
investigated using magnesium oxyhydroxides on ceramic depth filters. When the 
diatomaceous silica sand was coated with magnesium oxide (MgO), the outer 
surface gained Mg(OH)2 ?????????????????????????????????????????????????????? 
particles [95]. The pI of MgO of 12 exhibited increased virus removal compared to 
Fe, Al, Zr and Y which had lower pI between 8-10 [95]. These studies clearly 
demonstrate the importance of pH for virus removal studies that focus on ionic 
interactions.  
Virus particles tend to aggregate when the pH is equal to the pI of the virus, 
reducing the electronic repulsion amidst the virus particles. Studies involving bivalent 
cations such as Ca+2 and Mg+2 have shown that apart from the electrostatic 
interactions, steric interactions and specific binding between the cation charge and 
carboxylate moieties on the virus capsids also play a role in determining virus 
adsorption on membrane surfaces [96, 97]. Virus removal studies from water for 
????????????????????????????????????????????????????????????????????????????????????
with amino (-NH2), carboxyl (-COOH), phosphate (PO4), chloropropyl (-PO3H2-) and 
sulfonate groups further emphasized that virus particle interactions cannot be 
determined by simple charge repulsions and attractions. The acidic groups COOH 
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and H2PO3 showed 1-2 LRV and HSO3 demonstrated 4 LRV despite the negative 
zeta potential on all of the mentioned functionalized substrates. The molecular 
composition and the localized virus surface characteristics can be vital and in fact 
are likely more important than the net zeta potential or hydrophobicity [98].  
Addition of salt at high pH and minimal electrostatic charge difference has shown 
increased LRV due to secondary interactions, such as hydrogen bonding and 
hydrophobic interactions. The ability to improve adsorption has been feasible due to 
the use of kosomotropes. Kosmotropes such as citrate anion are water structuring 
agent capable of inducing secondary interactions [99]. The water structuring 
phenomena  and hydrophobic associations was confirmed by exhibiting high LRV of 
poliovirus in microfilters with an pI of 7 at pH conditions on both sides of the pI of 3.5 
and 9.5 [100]. Hydrophobic and hydrophilic MF membrane with pore size of 0.22 μm 
were used to test the hydrophobic interaction pattern on the MS2 removal from 
water. The hydrophobic MF showed a 5.9 LRV at pH 3.9, close to pI of MS2, and a 
4.3 LRV at pH 7 [101]. The hydrophilic MF showed 0.3 LRV at pH 3.9 and 0.04 LRV 
at pH 7 [101].  
Many size, charge and hydrophobic-based filtration and removal mechanisms 
have been studied on an individual basis. However, there is still a need to improve 
current water purification methods. We plan to combine multiple binding modes into 
a single system, known as multimodal binding for virus capture.  Multimodal binding 
should provide a high LRV with flexible operating conditions. In our investigation, we 
propose to remove porcine parvovirus (PPV), one of the smallest known mammalian 
viruses, using multimodal binding of charge and hydrophobicity from water by using 
peptides on nanofiber membrane filters. For porcine parvovirus (PPV) removal, it 
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was noted that trimeric peptide WRW and hexameric peptide YKLKYY achieved 4.5-
5.5 LRV in human blood plasma [102] on a resin chromatographic column. The 
trimer WRW exhibited binding affinity to the virus due to the charge and hydrophobic 
interaction and in case of hexamer YKLKYY it is believed to be due to the secondary 
structure of the peptide [102, 103]. Our current research study will add to the current 
knowledge of creating superior water filtration systems using affinity and multimodal-
based adsorption.  
2.4  Virus characterization 
2.4.1  Virus and protein structure 
Viruses are macromolecular biological entities that cannot replicate by 
themselves and undergo assisted multiplication within its host cell organism [104]. 
Commonly, virus particles introduce a genome into the cell which is capable of 
producing infectious virions that can rupture the cell [104]. The virus is made of 
nucleic acid and a protective coating of proteins called a capsid. Many viruses also 
have a lipid bilayer envelope composed of receptor binding glycoproteins and are 
known as enveloped viruses. Viruses that do not contain a lipid bilayer are called 
naked or non-enveloped viruses (see Figure 2.10). The two types of nucleic acid 
which form the genetic material are RNA and DNA.  
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 Figure 2.10 Virus structure (A) enveloped. Reprint permission granted from [105] 
and, (B) non-enveloped virus. 
A thorough understanding of the viral surface can be useful for managing the 
purification of vaccine biopharmaceuticals or enabling the virus removal from water. 
A viral surface is made up of a variety of functional groups. Figure 2.11 (A) shows a 
slightly negative charge due to the carboxyl groups whereas Figure 2.11 (B) shows 
a neutral charge since the carboxyl groups are replaced by amine groups [106]. Due 
to the multiple functional groups on viral coat proteins, differences in strains and lack 
of purification processes to obtain an absolute pure sample make it difficult to 
quantify the virus pI and other surface properties [106].  
The hydrophobic interaction of virus is another relevant property which can be 
used for designing virus separation strategies. In a study involving removal of GA, 
?????????????????????????????????????????????????????????????????????????????????
to 2.2 LRV compared to > 4 LRV for MS2. It was hypothesized that this was due to 
the hydrophobic difference of the phages, which was dete???????????????????????
MS2 by testing the binding of the phages to the hydrophobic substrate 1-
dodecanethiol gold-coated surface and polypropylene. For viruses, the non-
enveloped PPV was removed using hydrophobic peptides attached to a 
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chromatography resin [102, 103]. Influenza virus affinity to gold surface again 
highlighted hydrophobic effects of virus since gold is hydrophobic in nature [107].    
 
Figure 2.11 Coat proteins of virus strains. The strand (A) is negatively charged 
due to excessive carboxyl groups and strand (B) is positive due to excess amine 
groups. Reprint permission granted from [106] 
 
 
The study on the morphology and functionality of viruses has grown substantially 
over the last few years. Information on surface characterization is still lacking and an 
improvement here will help the bioprocessing and water purification industries 
improve their pathogen removal systems.  
2.4.2  Surface antigen characterization 
Physical characterization of viruses is severely limited in the literature. It can be 
vital for recognizing the specific molecular recognition sites on the surface of the 
virus which help to purify large titer virus and achieve efficient separations. Analytical 
tools that quantify the size and adsorption characteristic of viruses will be discussed 
in detail in the following sections. 
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2.4.2.1  Size characterization 
Knowledge of the size of virus particles can enhance our design of virus 
purification or removal processes. The particle size will then dictate the pore size 
needed in chromatography or membrane removal process. For aqueous two-phase 
system (ATPS), an increase in virus particle size can be used to determine if PEG is 
interacting with the virus particle and interfering with the purification. Understanding 
the size of virus particles can also provide in depth knowledge on the aggregation or 
flocculation of virus. Similar to purification studies, virus removal systems can be 
improved with the knowledge of virus morphology so that the permeate flux can be 
maintained and the available surface area for virus adsorption can be optimized.  
2.4.2.1.1  Dynamic light scattering 
Dynamic light scattering (DLS) or photon correlation spectroscopy is an optical 
analytical method used to measure the hydrodynamic size and its accompanying 
size distribution of particles [108]. It works on the principle of the Brownian motion of 
the particles and their ability to scatter a laser light at different fluctuations or 
intensities [109]. Analysis of these fluctuations yields the size distribution of particles.  
During the purification process, virus particles are subjected to elevated 
pressure, change in pH and ionic salt strength. In addition they are burdened by the 
presence of cell protein contaminants, which may cause the virus to lose 
conformational stability and form aggregates, therefore reducing the immunogenic 
properties of the virus. The human influenza virus [110], parvovirus [111], adenovirus 
[112], baculovirus [113] after either a TFF or IEC were investigated for particle 
volume distribution, monodispersivity, aggregation or conformational changes of the 
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virus for sample characterization using DLS. Determination of virus structure with 
DLS from biomolecular separation involving ATPS is limited in literature but the 
technique has been applied for immunoglobulins which are in the size range of 10 
nm, close to the virus size [114]. Virus structural validation after purification has also 
been performed using an antigen-antibody system as in the case of separation of 
VLP’s from the yeast cell homogenate after each step of cell lysis, fermentation and 
chromatography [108].  
For virus removal systems, virus or proteins aggregation can cause membrane 
fouling, flux decay and permeability effects in filters [115]. The hydrodynamic 
diameter of virus acquired using DLS is useful in process validation to improve filter 
performance and govern the virus filter spacing. Filter performance using DLS have 
been assessed for parvoviruses [111] ?????????????????????????[116], pp7 [116], 
PR772 [117]?????????????[118] on commercial virus filters. The bacteriophages are 
most often considered as surrogates for mammalian viruses especially the 
parvovirus in the range of 20 nm. In these studies the virus sample to be passed 
through filter systems are analyzed for non-aggregated particles and a low 
polydispersity index. The biggest challenge in DLS technique for viruses is the 
heterogeneous sample especially if contaminants are in similar sized components as 
virus themselves.  
2.4.2.1.2  Electron microscopy 
An image or picture of a biomolecular structure can speak a thousand words and 
capturing ultrastructure dimensions and conformations using electron microscopy 
remains an important technique for virus detection. The electron microscopy is an 
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acceleration of monochromatic beam of electrons from gun source on a thin 
specimen under high vacuum and voltage [119]. The scattered electrons are imaged 
using optical microscopy. Transmission electron microscopy (TEM) visualizes the 
internal and external virus structure in 2D and scanning electron microscopy (SEM) 
visualizes the 3D surface topology [120]. However among the two techniques the 
TEM has been used more predominantly for determining the morphology of virus 
capsids.  
As discussed in the DLS section the virus purification procedures often run the 
risk of debilitating or aggregating the virus particles during to operating parameters. 
TEM is a significant tool to identify intact viruses or report structural changes 
encountered during downstream steps. Virus size and shape for a variety of the 
purification strategies namely the Tick bone encephilatis virus from SEC [121], 
Nervous necrosis viruses from heparin chromatography [122], herpesvirus from TFF 
and centrifugation [123] and White spot syndrome virus from differential 
centrifugation [124] have been shown using the TEM. An example of virus structure 
acquired on TEM is shown in Figure 2.12. For the investigation of purification of 
PPV from ATPS, TEM can be used after removal of virus from the PEG phase. For 
virus removal, the TEM is a potential tool to assess the virus morphology before the 
filtration and after it is washed and collected post filtration. The framework of the 
pathogen will be valuable to evaluate the filter performance and in accordance with 
assay and chromatography studies it can be crucial to investigate mechanism of 
adsorption. The sample preparation for TEM will importantly involve the staining 
procedure using uranyl acetate or phosphotungstic acid. The stain scatters the 
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electrons better, creating a well-defined image but also needs careful administration 
from virus aggregation or drying.  
Figure 2.12 TEM image of virus. A negative stained vaccine virus providing size ~ 
200 nm and spherical shape features. Reprint permission granted from [125]. 
2.4.2.1.3  Atomic force microscopy 
Atomic force microscopy (AFM) is a versatile technique for obtaining three 
dimensional topographical images of a sample in the order of nanometers [126]. To 
form a well-defined image, AFM uses a cantilever with a sharp tip that measures the 
interfacial atomic forces when in close proximity to a sample. These forces can be 
interpreted as a distance (Hooke’s law of elasticity) and the data are communicated 
to the user as an image [127] The apparatus and working principle has been shown 
in Figure 2.13 (A). The greatest advantage of AFM over other methods is it can be 
performed in aqueous medium without disturbing its natural state. Although liquid 
state AFM is available, many virus studies have been performed in the dry state, 
thus negating one of the most powerful aspects of AFM. Other advantages of AFM 
200 nm 
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include a reduced sample preparation time and that there is no need for staining, 
fixing or synthetic preparation [126].  
 
 
Figure 2.13 AFM apparatus (A) A microscope stage with x,y,z scanner is attached 
to a cantilever with a probe tip. The tip moves over the biomolecule providing 
deflections that are traced by laser and converted into a digital image for the 
observer [128] (B) An icosahedral symmetry of protoretrovirus that infects yeast 
showing capsid structure and capsomeres. Reprint permission granted from [129].  
 
AFM can image fine details of virus capsid architecture as well as protein 
subunit, capsomeres on the virus as seen in Figure 2.13 (B) [129]. Topographical 
images in a lateral and vertical resolution at a nanometer range have been procured 
for Tick bone encephilatis virus after SEC purification [121], hepatitis B after salt 
precipitation [130], hepatitis B after ultracentrifugation and SEC [131], and 
orthopoxvirus after sucrose gradient [126]. For virus purification and removal 
systems, the AFM is a useful method to obtain molecular structural definition similar 
to TEM. It is suitable to assess the shape and size framework along with its 
aggregation behavior. The information helps evaluate the purification performance 
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from the perspective of contaminant proteins and virus denaturation. The virus 
morphology can help evaluate and improve filter performance.  
2.4.2.2  Adsorption mechanism 
Virus adsorption to a functionalized substrate surface can provide knowledge on 
molecular binding interactions and bonding mechanisms (covalent or secondary 
interactions) which can be key to designing effective virus removal systems. Based 
on the adsorption mechanism used, one can also obtain kinetic and thermodynamic 
variables which can provide details for identifying adsorption isotherms as a function 
of concentration and temperature.  
Surface plasma resonance (SPR) is a label-free, real-time detection of 
biomolecular interactions between a receptor and target analyte. Bioreceptors in 
SPR for virus are usually an antibody, but investigations have also been conducted 
on peptides [132], and nucleic acids [133]. In SPR, a polarized light is incident upon 
an electrically conducting thin film on a sensor chip, creating total internal reflection 
of the incident light which is detected by a photodetector as shown in Figure 2.14 A 
[134]. In the presence of an antibody-analyte interaction on the sensor chip, a 
reduced intensity of reflected light is observed from the propagation of a plasmon 
wave at a resonance angle. The change in SPR angle and band shift can be then 
used to determine the mass of the antibody-analyte on the film interface [134, 135].  
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Figure 2.14 SPR working principle. (A) A shift in SPR band from red to black 
position is noted when antigen (green circles) is bound to antibody (blue Y-shaped 
objects) on sensor chips. (B) Response curve showing association of antigen-
antibody after injection and dissociation after injection completion. Reprint 
permission granted from [134].  
 
 
Biospecific response from feline calcine virus [134], baculovirus [136], influenza 
virus [137, 138], hepatitis B [139] and tobacco mosaic virus [136] were obtained 
against specific antibodies. The above examples used SPR for virus detection [134], 
epitope mapping [137], infection cycle [137] and interaction mechanism for 
therapeutic drugs [137, 138]. In these studies the change in response due to 
antigen-antibody was noted and plotted as resonance units vs. angle or time (see 
Figure 2.14 (B)). Kinetic association and dissociation can be obtained from the 
response units, which can help deduce binding interaction useful for virus structural 
conformation. Additionally, if the binding interactions are measured over a 
temperature range they can determine thermodynamic variables of change in 
??????????????????????????[140, 141]. SPR can be a valuable tool for examining the 
hydrophobic surface residues and charge species using PPV antibodies. The 
binding response can be useful to make valid conclusions on results procured from 
A B
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ATPS and water purification project. Peptides synthesized on SPR surface can help 
understand the binding kinetics of PPV to the ligand.  
2.5  Conclusions  
Vaccine production in therapeutic industry is currently performed on a case-by-
case basis for each virus and a single platform system to purify viruses is still 
lacking. A traditional ATPS system was used for virus precipitation but lack of 
selectivity for virus against protein contaminants and difficulty in separation from 
polymer phase inhibited ATPS progress towards vaccine development systems. In 
our study we have borrowed the traditional ATPS and customized it with new 
considerations that can help improve the infectious virus yield and help prevent co-
precipitation of host cell contaminant proteins. The second goal of my Ph.D work is 
on designing membrane filters for removal of pathogen from water. Water is an 
important source for maintaining public health. Current filter systems for removing 
viruses use small pore size by size exclusion but this reduces permeate flux and 
cause membrane fouling. Our study uses peptides adsorbed on woven chitosan 
polymer with large micropores to remove viruses by chemical adsorption interactions 
and not size. Virus characterization by size and adsorption mechanism as discussed 
in the later section are some of the many ways that will help fulfill our objectives of 
better inexpensive vaccines and easy-to-use point of care water filters devices.  
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3.1  Introduction 
Animal cell cultures are grown in sterile conditions with specialized media and 
cellular nutrients for proliferation. Viruses are grown in vitro by inoculating cells with 
virus. The cells are lysed to produce a virus solution which contains media 
components, host cell DNA, endotoxins and cellular components. In this chapter we 
will focus on porcine parvovirus (PPV) purification using downstream processing 
techniques such as ion exchange chromatography (IEC) and size exclusion 
chromatography (SEC). The chapter will also describe the characterization of the 
virus, with a focus on hydrophobicity. Understanding virus surfaces can be important 
to the development of therapeutic vaccine and designing viral vector for gene 
therapy. Our work here will also explore the surface hydrophobicity characteristic of 
PPV and compare it to a range of different proteins using C18 reverse phase 
chromatography (RP-HPLC) and a fluorescent probe assay.  
3.1.1  Model viruses 
PPV is a non-enveloped virus of the parvoviridae family and known to cause 
reproductive failure in swine. PPV is a small, icosahedral, single-stranded DNA virus 
around 16-28 nm in diameter [1]. It is a model for the B19 human parvovirus [2, 3]. 
B19 parvovirus is pathogenic, causing a common childhood rash and in adults it has 
known to cause chronic anemia or mimic rheumatoid arthritis [3]. In addition to B19’s 
hazardous nature, it is also difficult to propagate in cell culture. Hence we use PPV 
for laboratory experimentation. PPV is negatively charged at neutral pH and has a pI 
of 5 [4]. PPV has a high resistance to inactivation from heat, pH and chemical 
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treatment [5]. The robustness provides a broad scope for experimental working 
conditions.  
Sindbis virus is an enveloped virus from the Togaviridae family and a member of 
alphavirus subfamily [6].  It is known to cause flu-like symptoms in humans. Sindbis 
virus is 40-70 nm in diameter with icosahedral symmetry.  It is a single stranded 
positive-sense RNA virus [6, 7]. Sindbis virus is negatively charged at neutral pH and 
has a pI of 6 [8]. The heat resistant strain of the virus has a healthy virus particle to 
infectious virus ratio of close to unity, which makes it an excellent model for 
infectious virus studies [9]. 
3.1.2  Chromatographic purification of PPV  
Traditionally, virus is purified by ultracentrifugation on cesium chloride (CsCl) or 
sucrose gradients [10, 11]. However, the shear force has been known to reduce 
virus infectivity and moreover, it is time consuming, labor intensive and difficult to 
scale up [12]. Virus precipitation with modest results have been obtained using salts 
ammonium sulfate [13] or calcium phosphate [14].  Polyethylene glycol 
(PEG)/aqueous two-phase system has also been studied for virus purification [15], 
but the technique lacks the ability to purify virus from many cell culture contaminants. 
Chromatography a popular technique for biomolecular purification has been seldom 
used for virus recovery due to diffusional limitations and large virus size, restricting 
access to internal surface area of beads. The technique has not provided high virus 
yield but it is known to work well for protein biomolecules < 5 nm in size [16]. 
Chromatography has gained wide spread attention due to its ability to create 
specificity for a biomolecule based on several variables as charge, size and 
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hydrophobicity [17-19]. The virus produced in the lab is heavily contaminated with 
cell media proteins and our goal is to consider each variable individually (charge, 
size and hydrophobic) for maximum protein removal with best possible recoverable 
virus. The purified virus can be very useful to analyze cell protein and contaminant 
interference during lab scale experimentation.  
In this chapter we will show the results found from accomplishing the following 
objectives: 
Objective 1: Develop a chromatography method to purify virus 
Objective 2: Develop a chromatography method to quantify virus 
Objective 3: Characterize the hydrophobicity of virus with chromatography 
and ANS dye fluorescence. 
3.2  Materials and Method 
3.2.1  Materials 
For the phosphate buffer solution, sodium hypophosphite (NaH2PO4.H2O) was 
purchased from VWR (Radnor, PA) and sodium triphosphate (Na3PO4) was 
purchased from Fisher Scientific (Pittsburgh, PA). Sodium chloride was purchased 
from Macron Chemicals (Center Valley, PA). Guanidine hydrochloride was 
purchased from Sigma (St. Louis, MO). Sodium hydroxide was purchased from 
Acros Organics (New Jersey, NY). Hydrochloric acid was purchased from EMD 
Chemicals (Billerica, MA). Solutions were made with water that was purified with a 
NanoPure water system (Thermo Scientific, Waltham, MA) to a resistance of >18 
????????????????????????????????????????????????????????????????????????????????????????
syringe filter (Nalgene, Rochester, NY) prior to use.   
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Phosphate-buffered saline (PBS) pH 7.2, 0.25% trypsin/EDTA, 
penicillin/streptomycin (pen/strep) and minimum essential medium (MEM) for cell 
propagation were purchased from Life Technologies (Grand Island, NY). For virus 
titration, 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) and 
sodium dodecyl sulfate (SDS) were purchased from Sigma-Aldrich (St. Louis, MO).   
The proteins in this study, bovine serum albumin, BSA, (Sigma, St. Louis, MO), 
chicken egg white lysozyme, LYS (CalBioChem, Billerica, MA), bovine fibrinogen, 
FIB (Sigma, St. Louis, MO), bovine hemoglobin, HEM (Sigma, St. Louis, MO), and 
human insulin, INS (a generous gift from Novo Nordisk A/S, Denmark) were used as 
received.  8-Anilino-1-naphthalenesulfonic acid (ANS) was purchased from Sigma 
(St. Louis, MO). HPLC grade acetonitrile and trifluoroacetic acid (TFA) were 
purchased from Sigma-Aldrich (St. Louis, MO) and Alfa Aesar (Ward Hill, MA), 
respectively.  
3.2.2  Cells, virus and titer assay 
Porcine kidney cells (PK-13) were a gift from Dr. Ruben Carbonell at North 
Carolina State University. PK-13 cells were grown in MEM supplemented with 10% 
fetal bovine serum (FBS) (Atlanta Biologicals, Oakwood, GA) and 1% pen/strep at 
37°C, 5% CO2 and 100% humidity. The cells were propagated every 3-4 days at a 
split ratio of 1:5. Conditioned media was withdrawn from the cells and centrifuged 
prior to use.  
Baby hamster kidney cells (BHK-21) cells were grown in EMEM supplement 
(Hyclone, Logan, UT) with 10% FBS (Atlanta Biologicals, Oakwood, GA), 10 μg/ml 
gentamicin (Gibco,Frederick, MD), and 5% tryptose phosphate broth (TPB) (Gibco, 
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Frederick, MD) at 37°C, 5% CO2 and 100% humidity. The cells were propagated 
every 1-2 days at a split ratio of 1:3. Conditioned media was withdrawn from the cells 
and centrifuged prior to use. 
PPV strain NADL-2 and Sindbis virus heat resistant strain (SVHR) were also gifts 
from Dr.Ruben Carbonell and Dr. Raquel Hernandez, respectively, at North Carolina 
State University. PPV and SVHR were propagated in PK-13 cells and BHK-21 cells 
respectively, as described previously [20] and clarified with centrifugation prior to 
use. 
PPV and SRHV were titrated with a cell viability assay, the colorimetric MTT 
assay, as described previously [20, 21]. Briefly the PK-13 and BHK-21 cells were 
seeded in 96-well plates. Plates were infected with 25 μl of the virus and serially 
diluted across the 96-well plate. After five days of incubation for PPV and two days 
incubation for SRHV, the MTT salt solution was added. Four hours later, solubilizing 
agent was added. Plates were read on a Synergy Mx microplate reader (BioTek, 
Winoski, VT) at 550 nm between 4-24 hours after addition of the solubilizing agent. 
The 50% infectious dose (MTT50) value was determined to be the virus dilution that 
corresponded to an absorbance of 50% of the uninfected cell absorbance. The value 
was converted to a per millimeter basis and stated as the MTT50/ml titer [20]. 
3.2.3  Ion exchange chromatography 
Ion exchange chromatography was performed using the quaternary amine Q 
Sepharose XL virus (GE healthcare, Pittsburgh, PA) on a Waters Alliance HPLC 
equipped with a photo diode UV-Vis detector. The resins had an average particle 
size of 90 nm and mean pore size of 20 nm [22]. They were manually packed into an 
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Omega 2 mm * 5 cm (small scale size) and an Omega 4.6 mm * 25 cm (large scale 
size) chromatography column, purchased from Idex Health Science (Oak Harbor, 
WA). Buffer A was 10 mM phosphate in water and Buffer B was 10 mM phosphate, 
150 mM NaCl in water and both at pH 7.2. 6M guanidine hydrochloride was used for 
cleaning after each run. A linear gradient of increasing Buffer B was performed and 
the % of NaCl needed to elute the protein was taken as the %B elution on IEC. PPV 
NADL-2 strain was filtered through a 0.2 μm syringe filter and injected at a volume of 
?????????????????????????????? ?? ?????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????? ?? ?????The 
optimized method was a gradient of 5 to 55% Buffer B accomplished from 2.1 min to 
24.35 min. The method and the column were validated for a cleaning procedure after 
every single run with 6M guanidine hydrochloride to maintain the accuracy in peak 
area and height.  
Samples were collected for all the chromatogram peaks at different retention 
times and the virus recovery using IEC was calculated by conducting the MTT 
assay. The cumulative virus titer for all samples against the starting stock value 
provided the % recovery value for the process. Equation 3.1 provides the 
mathematical term to calculate the recovery. The term Vf and Vi represents the 
volume of each fraction and the injection volumes respectively. For a small scale 
column Vf  was 0.25 ml and for a large scale column it was 1.0 ml.  
% ????? ???????? 
=  ? (??
??? ???????? ??? .???????? ?
??????? ??? .?????????? ?
??????? ??????? .??)
???????? ???????? (????? ?
??????? ??? .??)
 ? 100………. (3.1) 
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3.2.4  Size exclusion chromatography 
Size exclusion chromatography was performed on a Waters Alliance HPLC 
equipped with a photo diode UV-Vis detector using Sephacryl S-300 HR purchased 
from GE healthcare (Pittsburgh, PA). Sephacryl was manually packed into an 
Omega 4.6 mm * 25 cm column. Buffer was 50 mM phosphate and 150 mM NaCl in 
?????????????????????????????????????????????????????????????????????????????????
rate of 1.0 ml/min.  
3.2.5  Reverse phase chromatography 
Reverse phase chromatography (RP-HPLC) was performed with a Waters 
XBridge BEH 130 C18 column on a Waters Alliance HPLC equipped with a photo 
diode UV-Vis detector. Buffer A was 0.1% TFA in water and Buffer B was 0.1% TFA 
??????????????????????????????? ?? ?????????????????????????????????????????????????????
of 1.0 ml/min. The co?????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????
column. A linear gradient of increasing Buffer B was performed and the % of 
acetonitrile needed to elute the protein was used to estimate the experimental 
hydrophobicity values.  
3.2.6  SDS-PAGE 
SDS-PAGE was run using a 4-12% Bis-Tris NuPage gel (Life Technologies, 
Grand Island, NY) in NuPage MES running buffer (Life Technologies, Grand Island, 
NY). Samples were reduced in DTT (Life Technologies, Grand Island, NY) and 
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heated to 90°C for 10 min prior to loading onto the gel. SDS-PAGE was stained with 
the SilverXpress kit (Life Technologies, Grand Island, NY). 
3.2.7  ANS Fluorescence  
ANS was dissolved to a concentration ??????????????? ???2PO4 (Sigma, St. 
????????????????????????????????????? ???????????????????????????????????????????????
and read on a Synergy Mx microplate reader (BioTek, Winooski, VT) at an excitation 
of 350 nm and an emission of 482 nm. A plot was made of ANS fluorescence versus 
protein concentration and the slope of the line was expressed as the ANS 
fluorescence/???????????????????????????????????????????????????????????????????????
a 5 ml Zebra spin desalting column from Thermo scientific (Waltham, MA). The 
column eluent was collected by spinning the contents at 1000 xg for 2 minutes in a 
Sorvall ST16R Centrifuge (Thermo Scientific, Waltham, MA). 
3.3  Results and Discussion 
3.3.1  Virus purification using IEX chromatography 
In biomolecular separation, the ability of a technique to distinguish between a 
target analyte and protein contaminants and to increase the specificity of the target 
molecule requires an understanding of the properties of all the components present 
in a given sample. Among the properties of size, polarity and charge, which can be 
used to distinguish the virus from cell media contaminants, this section will address 
the charge specificity. Charge-based separations can be performed using 
electrophoresis, isoelectric focusing and ion exchange chromatography. 
Electrophoresis and isoelectric focusing can be used for purification but they are 
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primarily used for confirming the purity qualitatively. IEC is a highly robust and 
accurate technique which is more commonly used for obtaining purified samples.  
The miniaturized scale of anion exchange chromatography Q-sepharose column 
was initially used to establish the capacity to purify the PPV. The IEC on Q-
sepharose yielded sharp peaks which were recognized using the UV absorbance at 
280 nm as shown in the Figure 3.1. The first peak at 0-2 mins was the flow through 
peak. The flow through represents the PPV and protein contaminants which were 
unable to adsorb to the column resin beads based on charge or due to overloading 
of the column. The remaining well-defined peaks eluted at 11 min and 14 min.  The 
likely proteins were the cell media protein contaminant of bovine serum albumin 
(BSA) and PPV respectively. The proteins were present in bulk in the stock and 
close proximity in peaks bodes well with the close range in pI 4.7 for BSA and pI ~ 5 
for PPV. The peak at 11 min and 14 min were analyzed for virus concentration using 
the MTT assay and analyzed for proteins using the silica matrix SEC and SDS-
PAGE.  
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 Figure 3.1 Ion exchange chromatography for PPV purification on a small IEC 
column packed with Q-sepharose resin (the figure is a representation and not an 
actual chromatogram). 10 μl PPV was injected through on small column manually 
packed with Q-sepharose beads. The Buffer A was 10 mm phosphate at pH 7.2 and 
elution Buffer B was 10 mM phosphate and 150 mM NaCl at pH 7.2. The gradient 
used was 5% to 55% of Buffer B from 2.1 min to 24.35 min. 
 
MTT assay results for the samples collected in the interval of 10 min to 16 min 
are displayed in Figure 3.2. The fractions at 10 and 11 min show a limit of detection 
of 1.6 log10 MTT50/ml and 12, 13, 14, 15 min exhibit the 3-4 log10 MTT50/ml infectivity. 
The data supports the virus elution between 12 and 15 min. The overall recovery 
was calculated at an average low of 0.2 %. The recovery was calculated by the 
Equation 3.1.  
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 Figure 3.2 PPV concentration of samples from a small IEC column. Titer results 
of 0.25 ml fractions collected at different time points from the small column after 10 
μl PPV injection. The limit of detection is 1.6 log10 MTT50/ml. All data points are the 
average of two separate tests and error bars represent the standard deviation. 
 
SDS-PAGE was performed on the fractions as it is considered the gold standard 
for protein validation. All the fraction samples shown in Figure 3.3, including controls 
of media, BSA and PPV, show bands in the range of 66 kDa. The main protein in the 
PPV capsid is VP2, and it has a molecular weight (MW) of 64 kDa [23] and the MW 
of BSA is 66 kDa. Over 80% of the PPV capsid is VP2 and hence the PPV and BSA 
are seen to run closely together in SDS-PAGE. The fractions at 11, 12 and 13 min 
show a thick protein band. The PPV recovery and concentration as obtained from 
the MTT assay is low to obtain thick protein bands hence the bands are likely BSA. 
The fraction at 15 min appears to have removed the majority of the contaminants, 
but the data presented so far is not substantial enough to prove an increase in purity.  
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The experimental investigation using MTT titer was often very close to the limit of 
detection, which prevents virus quantification and possibly causing a low recovery. 
To circumvent the low recoveries and the overlapping bands on SDS, the process 
was scaled up to the large-scale IEC.  
 
 
Figure 3.3 SDS-PAGE of PPV samples from a small IEC. Proteins bands of 0.25 
ml sample fractions collected at different time points from the 10 μl PPV injection on 
small column.  
 
A large IEC column of 4.6 mm x 25 cm was manually packed with the Q-
sepharose resin. The larger column was scaled-up to maintain the linear flow rate 
(cm/min) of the smaller column, a common practice in chromatography scale-up. 
This residence time was same for both small and large column. The injection 
capacity of the instrument could not be increased past 264 μl, so the inject volume 
per volume of packing was reduced. The gradient elution pattern was maintained the 
same as the small scale column. The chromatogram for the large column is shown in 
BS
A
8 
m
in
6 
m
in
5 
m
in
4 
m
in
PP
V
M
ED
IA
M
AR
KE
R
66 kDa
  84 
Figure 3.4. Samples were collected with intervals of 1 min and the fractions were 
validated using the MTT assay.  
 
 
Figure 3.4 Ion exchange chromatography for PPV purification on large IEC 
column packed with Q-sepharose resin. 264 μl PPV was injected through a large 
column manually packed with Q-sepharose beads. The Buffer A was 10 mm 
phosphate at pH 7.2 and elution Buffer B 10 mM phosphate and 150 mM NaCl at pH 
7.2. The gradient used was 5% to 55% of Buffer B from 2.1 min to 24.35 min.   
 
The MTT assay results showed an increase in log values for all fractions (see 
Figure 3.5), overcoming the issue of being near the limit of detection. All the 
fractions from 10 min to 16 min had PPV at a titer of 5-6 Log10 MTT 50/ml. The PPV 
in the large column started eluting out earlier as compared to the small column. 
Scale up of a column can have issues as lower bead stability due to lack of wall 
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support and increase in bed pressure due to a larger amount of resin [24]. These 
variables can influence operating conditions and sample loading causing change in 
peak width and shape [25]. Nonetheless an improvement with the virus recovery at 
0.8% was noted compared to 0.2% of small scale IEC. The protein bands on the 
SDS-PAGE (not shown) had similar inferences as observed on the small scale due 
to the close MW of PPV and BSA. Without further confirmation that BSA was being 
removed from the virus preparation, we did not continue to pursue purification of 
PPV with IEC.  
 
Figure 3.5 PPV concentration of samples from a large IEC column. Titer results 
of 1 ml fractions collected at different time points from the large column after 264 μl 
PPV injection. The data points are plotted using results from a single test.  
 
Virus purification and recovery analysis was also performed on Sindbis virus. A 
264 μl Sindbis virus injection into the large IEC column was performed with the same 
gradient protocol as PPV. The elution pattern for Sindbis virus was similar to the 
PPV as shown in the Figure 3.6.  
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 Figure 3.6 Ion exchange chromatography for Sindbis purification on a large 
IEC column packed with Q-sepharose resin. 264 μl Sindbis was injected through 
a large column manually packed with Q-sepharose beads. The Buffer A was 10 mm 
phosphate at pH 7.2 and elution Buffer B 10 mM phosphate and 150 mM NaCl at pH 
7.2. The gradient pattern used was 5% to 55% of Buffer B from 2.1 min to 24.35 min.   
 
The samples collected from the fraction collector were analyzed with the MTT 
assay and SDS-PAGE as shown in Figure 3.7 and 3.8. A higher recovery of 2.2% 
on the MTT assay was obtained. For the SDS-PAGE, the BSA (66 kDa) presence 
was seen from the media contents but low concentration of Sindbis virus showed no 
trace of protein bands preventing us from making valid conclusions. 
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Figure 3.7 Sindbis virus concentration of samples from a large IEC column. 
Titer results of 1 ml fractions collected at different time points from the large column 
after 264 μl Sindbis injection. The data points are plotted using results from a single 
test. 
 
 
 
 
Figure 3.8 SDS-PAGE of Sindbis virus samples from a large IEC. Proteins bands 
of 1 ml sample fractions collected at different time points from the 264 μl Sindbis 
injection on a large column.  
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3.3.2  Size exclusion chromatography 
Measurement of infectious virus is an expensive and time consuming process. 
Techniques commonly employed for measuring viruses from mammalian cells are 
reverse transcriptase polymerase chain reaction (RT-PCR), plaque assay or TCID50. 
PCR can measure the DNA/RNA of the virus but lacks the ability to distinguish 
between infectious and non-infectious particles. Plaque assay is a gold standard 
approach but the number of samples to be processed in a given time is limited 
because it is a labor intensive and time consuming process. TCID50 is also a time 
consuming process and requires an experienced operator to obtain values 
consistently. The MTT assay, a cell viability assay, was used in our lab for PPV and 
Sindbis quantification. The tetrazolium salt has the ability to cleave to the 
mitochondria of live cells changing the yellow salt into purple formazan crystals [26]. 
The crystals are solubilized and the absorbance was measured. MTT assay for 
parvovirus takes 5 days for a full cycle of infection in addition to a lot of supplies [20]. 
To try and reduce the time needed for virus quantification, we considered developing 
a virus quantification procedure with chromatography. Successful results with 
chromatography can be very productive and efficient since it is a rapid method for 
the detection of proteins. In this section we will be discussing the work on applying 
SEC for purifying and quantifying virus from cell culture media.  
Sephacryl S-300 high resolution resin with a fractionation capacity for globular 
proteins between 1x104 – 5 x 106 Da was packed in a 4.6 mm x 25 cm column. PPV 
stock from virus production was repeatedly shown to be 8 log10 MTT50/ml in our lab. 
The stock was diluted to prepare samples from 8 log10 MTT50/ml to 3 log10 MTT50/ml. 
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The values were confirmed using the MTT assay. Samples ranging from 8 to 6 log10 
MTT50/ml are superimposed and shown in Figure 3.9. For a 50 μl injection a limit of 
detection was noted at 6 log10 MTT50/ml and hence the chromatograms from 5 log10 
MTT50/ml to 3 log10 MTT50/ml have not been shown in the figure. The peak area for 
the retention time of 2 min on all samples was plotted against the MTT assay values 
to obtain a linear plot (see Figure 3.10).  
 
Figure 3.9 SEC for PPV purification on large IEC column packed with sephacryl 
resin. 50 μl PPV samples of 8 log10 MTT50/ml to 6 log10 MTT50/ml was injected 
through a large column manually packed with sephacryl beads. The Buffer was 10 
mm phosphate and 150 mM NaCl at pH 7.2 at rate of 1 ml/min. 
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 Figure 3.10 SEC vs. MTT assay. The chromatogram peak obtained from injection 
of 50 μl PPV samples 8 log10 MTT50/ml to 6 log10 MTT50/ml on a SEC sephacryl 
column was measured for peak area and compared against corresponding MTT 
assay values. 
 
Injection volumes were steadily increased from 50 μl to 200 μl for each of the six 
samples of 8 log10 MTT50/ml to 3 log10 MTT50/ml to improve the detection limit. A limit 
of detection 5 log10 MTT50/ml was noted for 200 μl injection close to injection 
capacity and any more improvement in terms of detection was not expected.   
In summary, the SEC experiment has the potential to be used for samples 
greater than 5 log10 MTT50/ml. However the detection limit is inconvenient for 
investigations involving virus in our lab and hence the idea of using SEC was 
withdrawn. If the technique is used for virus quantification in the future, then 
additional experimentation towards detecting any protein contaminants in the peak 
should be conducted. BSA is a major contaminant in the cell media during virus 
6
7
8
10000
100000
1000000
10000000
100000000
1 10
Pe
ak
 A
re
a
Log10 (MTT50/ml)
Peak Area
  91 
production and it is likely present along with the PPV in the chromatogram peak 
discussed above. 
3.3.3  Validating the hydrophobicity on viruses 
Virus surface characteristics information can be important in virus purification 
during attachment to a chromatographic matrix, membrane operations and in 
developing gene vectors for specific cell receptor attachment. The knowledge on the 
surface hydrophobicity of viruses is limited. Phages (viruses that infect bacteria) 
were shown to have a varying degree of hydrophobicity, as demonstrated by carbon 
adsorption [27]. B19 human parvovirus [28] and our work of PPV [29] being 
precipitated with glycine concluded that the action was likely due to the highly 
hydrophobic surface of the virus. A considerable scope is available to improve the 
literature on the nature of the hydrophobic residues on viruses. The work in this 
section highlights the hydrophobicity measurement using reverse phase 
chromatography and ANS (1-anilino-8-naphthalene sulfonate), a fluorescent dye that 
attaches to hydrophobic patches on proteins [30]. The investigation of virus surface 
hydrophobicity can be used to better understand virus-cell interactions, as well as 
create improved methods to detect, remove, and purify viruses.  
3.3.3.1  Reverse-phase chromatography 
The virus hydrophobicity was measured and compared against the 
hydrophobicity of a panel of proteins. The proteins used for the experiment are 
shown in the Table 3.1. The RP-HPLC hydrophobicity was measured by determining 
the percentage of acetonitrile required to elute the sample from a C18 column. 
Higher acetonitrile and protein residence time meant a higher hydrophobicity. The 
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investigation of the elution of proteins on RP-HPLC was performed by an 
undergraduate colleague in our lab group, Amna Zahid. It was simple to determine 
the location of the protein peak for pure proteins since they only had one major peak. 
The peaks obtained for proteins were sharp and well defined peaks. The order of 
hydrophobicity based on the residence time was INS< LYS< BSA< FIB< HEM as 
seen in the Figure 3.11.   
Table 3.1 Panel of proteins 
Protein/Virus Abbreviation Molecular weight (MW) 
Bovine Hemoglobin HEM 67 
Bovine Serum Albumin BSA 66 
Fibrinogen FIB 340 
Insulin INS 6 
Lysozyme LYS 14.3 
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 Figure 3.11 Reverse-phase chromatogram of pure proteins. 20 μl of 5 mg/ml of 
each protein was injected into a C18 RP-HPLC with a buffer flow rate of 1 ml/min. 
Buffer A was 0.1% TFA in water and Buffer B was 0.1% TFA in acetonitrile. The 
percentage of acetonitrile needed to remove the protein from the column was used 
as the experimental hydrophobicity. 
 
It was more challenging to identify the virus peaks.  Virus is produced by the 
process of cell lysis and hence it is accompanied with cell media and additional 
proteins formed during the cell growth together known as conditioned media. It is 
also at a low molar concentrations ~ 4 μM. Hence we first compared crude virus 
solutions to conditioned media as shown in Figure 3.12. The large peak at 21 min 
was BSA from the fetal calf serum in the crude PPV and conditioned media, as 
confirmed by the pure BSA peak in Figure 3.11.  To confirm that the earlier peaks 
that had different absorbance values were associated with the conditioned media, 
we desalted the PPV and the conditioned media with a spin column.  Most of the 
peaks prior to 20 min in the conditioned media were reduced or eliminated as shown 
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in Figure 3.13. The concentration of PPV was the same before and after desalting, 
as measured by the MTT assay (data not shown).   
 
Figure 3.12 Reverse-phase chromatography of PPV and conditioned media.  
PPV (solid line) was compared to conditioned media (dotted line) to determine the 
acetonitrile needed to elute PPV.  Buffer A was 0.1% TFA in water and Buffer B was 
0.1% TFA in acetonitrile. The insert shows the range of 50 – 70% acetonitrile.  The 
SDS-PAGE has lane 1 – marker, lane 2 – stock PPV, lane 3 – 27.5-28.5 min, lane 4 
– 28.5-29.5 min, and lane 5 – 29.5-30.5 min. 
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 Figure 3.13 Reverse-phase chromatography of PPV and conditioned media: 
stock and desalted. PPV and the conditioned media (solid line) was compared to 
desalted PPV and desalted conditioned media ( dotted line) to determine the 
contaminants 0 to 20 min belong to conditioned media. Buffer A was 0.1% TFA in 
water and Buffer B was 0.1% TFA in acetonitrile. 
    
Now in order to identify the PPV peak in the Figure 3.12 the PPV trace was 
compared with conditioned media for different times and the unique peaks were 
subjected to SDS-PAGE for PPV validation. Three peaks were found in the PPV 
sample that were not in the conditioned media. These peaks eluted at 23, 28.5 and 
29.5 min. The peak at 23 min was disregarded as being too large for the 
concentration of PPV that was in the sample.  The SDS-PAGE shown in Figure 3.12 
was run for fractions collected at 27.5, 28.5 and 29.5 min and labelled as lane 2, 3 
and 4. The peak 29.5 min had the highest amount of PPV, even showed a protein 
band at MW range of PPV at 66 kDa. We therefore labeled the 29.5 min as the PPV 
peak.   
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The retention time of PPV on RP-HPLC confirmed the hydrophobicity of PPV 
was stronger than the panel of proteins. A schematic for retention time of proteins is 
shown in Figure 3.14. Hence the hydrophobicity evaluation and the hypothesis of 
viruses having a strong hydrophobic surface using RP-HPLC was successful but 
another study comparison of PPV against panel of proteins would improve this 
investigation.  
 
 
Figure 3.14 Order of protein hydrophobicity using reverse phase 
chromatography. The hydrophobicity sequence based on protein retention time 
was experimentally determined using the C18 column and the % acetonitrile for 
elution.  
 
3.3.3.2  Surface hydrophobicity using ANS 
ANS fluorescent probe is an organic compound with a high affinity for the 
hydrophobic patches on a protein surface. ANS is a non-florescent probe in water, 
but in the presence of non-polar surfaces, ANS undergoes a blue shift and high 
florescence emission. ANS measurements have been used to determine the 
hydrophobicity of serum albumins [30]. 
Graphs were created for the ANS fluorescence vs. protein concentration as 
shown in Figure 3.15. The slope determined from the plots was used for calculating 
the average surface hydrophobicity values for the proteins tested [30]. All proteins, 
except for insulin and lysozyme, produced a good linear correlation fit. The slope 
INSULIN <           LYSOSYME <           BSA <             FIBRINOGEN < HEMOGLOBIN <         PPV
19 20 21 22 26 30
Retention Time (minutes)
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equations are presented in the graphs. The insulin and lysozyme gave inconsistent 
data including large error bars (not shown). Insulin has given us inconclusive results 
in other studies performed in our lab on hydrophobicity. Insulin is known to have 
many different conformations with minor changes in pH [31].  It is likely that the 
different pHs of our experiments (low pH for RP-HPLC and neutral pH for ANS) 
changed the conformation of insulin. 
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 Figure 3.15 Average surface hydrophobicity measurement using ANS 
fluorescence. Proteins A) Insulin B) Lysozyme C) BSA D) Fibrinogen E) HEM F) 
PPV of volume 5 μl at different concentrations (μM) and ANS of volume 95 μl at 
20μM concentration were mixed to measure fluorescence at Ex/Em 350/482 nm. 
Slopes were measured by plotting fluorescence against protein concentration (μM) 
to determine average surface hydrophobicity. All data points are the average of three 
separate tests and error bars represent the standard deviation.  
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From the average measured values of fluorescence/μM, the order of 
hydrophobicity strength was gauged as shown in the Figure 3.16. The sequence 
was not as observed as per the C18 RP-HPLC and this comparison between the two 
techniques is shown in Figure 3.17.  
 
Figure 3.16 Order of protein surface hydrophobicity using ANS fluorescence. 
The decreasing sequence of hydrophobic protein affinity to fluorescent probe was 
experimentally determined using the ANS assay and fluorescence measurement. All 
data points are the average of three separate tests and error bars represent the 
standard deviation. 
 
 
Figure 3.17 ANS surface hydrophobicity vs. % elution buffer from C18 RP-
HPLC.  
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The PPV fluorescence was extremely high and this may be due to the media and 
conditioned cell proteins procured during the virus preparation. Virus production in 
the lab is performed by inoculating the virus in mammalian cells. Hence the 
conditioned media comes along with the PPV stock. The presence of conditioned 
media causing ANS fluorescence in PPV sample was proven by measuring ANS for 
desalted conditioned cell media which is shown in Figure 3.18. The PPV curve in 
the figure is similar to the conditioned media especially considering the error bars. 
The decrease in PPV fluorescence units can be due to additional clarification step 
involved during virus production. However it is clear that PPV may be obtaining a 
large ANS value due to conditioned media.  
Removal of the extraneous proteins was attempted for bettering the surface 
hydrophobicity measurement from the virus itself. The ANS fluorescence was 
measured for desalted PPV that gave a slope of 3800 ANS / μM protein and a 30% 
reduction in slope value from PPV. The value of 3800 ANS / μM protein is extremely 
high compared to second highest BSA at 1242 ANS / μM protein. It is likely from the 
evidence that the ANS is from media proteins rather than a measurement of virus 
hydrophobicity.  
The hydrophobic evaluation from ANS was not successful as the evaluation of 
the hydrophobicity by C18 RP-HPLC. However the foundation for the technique has 
been laid out with ANS values for a panel of proteins. When a highly pure strain of 
PPV has been obtained from contaminant media proteins the ANS for PPV 
determination is likely to fit the trend of surface hydrophobicity as noted for RP-
HPLC.  
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 Figure 3.18 ANS fluorescence measurement for virus and conditioned media. 
The comparison of slopes of ANS fluorescence vs. concentration for stock sample 
(dotted line) and desalted samples (solid lines). All data points are the average of 
three separate tests and error bars represent the standard deviation. 
 
3.4  Conclusions 
Purification of virus is usually performed from density gradient centrifugation or 
salt or polymer precipitation techniques. The methods are difficult to scale up or lack 
specificity from co-precipitating impurities. Filtration is another technique for virus 
purification but this may cause virus degradation from shear stress, especially in 
tangential flow filtration conditions. An efficient and fast paced system to achieve 
high purity virus is required.  Chromatography is the preferred method of purification 
due to its easy scale up, robust and repeatability. We studied virus purification on 
IEC and SEC for PPV without successful conclusions.  
The IEC was performed on a small scale column, which identified multiple peaks. 
Virus peaks were selected by virus infectious titer however, the overall yield was 
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only a low 0.2%. To improve the yield we scaled up the column and increased the 
virus input. The large scale column provided a similar chromatogram, which was 
encouraging, since scale up operations are often hindered by a change in resin bead 
pressure and wall stress conditions. The overall yield for PPV in the large column 
was 0.8%. Gel electrophoresis was used to visualize the purity of the virus 
preparations.  However the result from the gel was inconclusive since the MW of the 
VP2 protein in PPV is 66 kDa and for BSA it is 65 kDa.  These run very closely in the 
gel and cannot be separately identified.  
Our learning on virus purification for PPV using IEC was worthwhile since our 
preliminary results identified simple well-defined peaks. The MTT assay was a good 
virus quantification tool for eluted virus from the IEC columns. The study lacks the 
validation of media proteins since the MTT assay only measures virus concentration. 
In the future, a Western blot technique where an affinity bind capture step can help 
distinguish the PPV from BSA on the gel would be helpful.  However, antibodies with 
enough specificity to PPV are not currently available.  
Surface hydrophobicity of viruses is an important feature that can help build viral 
vectors or develop therapeutic vaccines or drugs. The knowledge of surface 
hydrophobicity of viruses is limited and hence we were interested in comparing the 
virus hydrophobic strength to other proteins. We used C18 RP-HPLC for calculating 
the acetonitrile elution strength of proteins, which is one method to determine the 
hydrophobicity of a protein. The result obtained was promising and the PPV eluted at 
a higher acetonitrile concentration as compared to the proteins tested. In a quest to 
strengthen the hypothesis, we used ANS fluorescence as a hydrophobic 
measurement. Our results indicated the PPV to have a higher surface hydrophobic 
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value compared to standard proteins. However further examination revealed to us 
the high ANS value for PPV could have been due to cell media proteins, including 
BSA. We proved the exaggerated fluorescent values were coming from the cell 
proteins when we read ANS values for conditioned media obtained during cell 
culture.  
The surface hydrophobicity investigation was useful to prove the higher 
hydrophobic values for PPV compared to standard proteins. The ANS was useful to 
validate surface residues for all proteins however the analysis on pure virus strain is 
pending. When the PPV is available in its pure form without media proteins the ANS 
study should be repeated to make a strong case for virus hydrophobicity.   
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4.1  Introduction 
Virus and cellular structures and their interactions are highly dynamic in nature. 
Virus infection is an intriguing process and a thorough understanding of the infection 
pathway of a virus particle through a cellular organism has tremendous potential for 
the development of antiviral drugs and gene therapy vectors. Every virus follows a 
unique mechanism of cell recognition, internalization, cellular transport, genome 
release, replication, and new virus particle release [1]. The subject is extremely vast 
and hence we will be limiting our discussion to porcine parvovirus (PPV) that will be 
used for trafficking investigation in this chapter.  
PPV belongs to the family Parvoviridae. PPV is known to cause reproductive 
failure in swine [2, 3].  Parvoviruses are small non-enveloped virus that are ~26 nm 
in diameter.  The genome is negative single-stranded DNA of about 5 kb in length 
[4]. The PPV capsid is made up of three proteins VP1, VP2 and VP3, of which 90% 
can comprise of the VP2 protein [5].  
The PPV infection process starts with the virus binding to the surface cell 
receptors. Entry into the cell happens through receptor-mediated endocytosis. 
During endocytosis, viruses uses glycan, glycolipid, glycoproteins to attach on the 
cell surface followed by rapid uptake into endosomes [6, 7]. Entry of PPV is typically 
found to be through clathrin-mediated endocytosis [5, 7, 8]. Once the viruses are 
within the endosome, they undergo acidification, which creates conformational 
changes that release VP1 capsids into the cytoplasm [5-7]. The endosomal 
acidification is also responsible for the release of phospholipase A2 domain, which 
creates early steps of gene expression [7, 9]. PPV have been known to reside within 
the endosome for several hours and release into cytoplasm appears to be a very 
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slow process [10]. PPV in the cytoplasm conjugates to ubiquitin which causes capsid 
transformation allowing the virus to transition into nucleus [8, 11]. The virus pathway 
from the cytoplasm to the nucleus itself is poorly understood. The minute virus of 
mice (MVM) parvovirus has been known to infect a cell by degrading the nuclear 
membrane [12]. Once the virus is in the nucleus transcription is initiated when the 
cell enters the S-phase. Here the single strand DNA is replicated along with 
synthesis of mRNA. The mRNA are transported into cytoplasm where the ribosome 
translates the mRNA into capsid proteins. Mature viruses formed here cause cell 
apoptosis and infection of remaining cells.     
4.1.1 Single virus tracking using fluorescence microscopy 
Virus quantification for PPV has been performed by reverse transcriptase 
polymerase chain reaction (RT-PCR) [13], plaque assay [14], MTT assay [15] and 
TCID50 [15, 16]. However each of these techniques have their shortcomings. RT-
PCR can quantify nucleic acids but they cannot distinguish infectious from non-
infectious particles. For PPV this can be a major disadvantage since the particle to 
infectious ratio can be as large as 1000:1 [7, 8]. Methods such as plaque assay, 
MTT assay and TCID50 are more accurate for infectious virus but they are time 
consuming, laborious and have high errors. Our goal is to establish a fast-paced 
effective technique for quantification for infectious PPV. Here we are proposing to 
fluorescently tag virus particles and observe particles trafficking through the cellular 
machinery under the microscope. The technique has immense potential to quantify 
virus immediately upon its intrusion into cellular compartments.    
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One of the widely used technique to unravel the infection cycle of a single virus 
particle is real time imaging using fluorescence microscopy [17]. The common 
microscopes used for tracking fluorescently-labeled virus particles are confocal 
microscopy, total internal reflection microscopy (TIRM) and fluorescence imaging 
microscopy [18]. The confocal microscope gives a 3D imaging but the large focal 
area can cause signal loss. TIRM has minimal signal loss but the lack of imaging 
depth restricts the tracking study to only the cell surface. The fluorescence 
microscope has the largest imaging depth and is often preferred when a long-range 
and detailed study of the virus-cell interaction is desired [18].  
The virus and cell must be sufficiently labelled with dye molecules and analyzed 
by procuring high temporal and spatial resolution images. The most common ye 
label is fluorescent labels. Commonly used chemical fluorophores for attachment to 
proteins are fluorescein, rhodamine and Alexa fluor dyes [19]. Of the three dyes, 
Alexa fluor is known to have good photostability and less pH sensitive than the other 
proteins based dyes and this can be useful for visualizing virus particles during the 
acidification process of the infection cycle. In virus labeling, it is important that the 
fluorophore does not hinder virus activity [20]. Zhang et al. studied the labelling and 
internalization of Dengue virus with Alexa Fluor 597, maintaining a balance between 
the dye brightness and pathogen function [21].  
In our investigation we will be tracking the PPV capsid through a mammalian cell 
line using an Alexa fluor dye. We optimized the labelling efficiency from reducing 
virus immunogenicity, prevented impurity labeling and obtained a time study of virus 
trafficking through the cellular machinery.  
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4.1.2  Immunohistochemistry 
Immunohistochemistry (IHC) is an integral research tool to diagnose infectious 
disease in tissue culture systems by creating an antigen-antibody interaction and 
then identifying the antibody (or immunoglobulins) via direct or indirect labeling [22, 
23]. For direct labeling, an antigen is detected by binding with a labeled antibody [22, 
24] as shown in Figure 4.1 (A). The method is quick, but lacks the sensitivity to 
detect many antigens due to the lack of obtaining pure, conjugated antibodies. In 
indirect labeling, the antigen is detected by using two antibodies. The primary 
antibody is bound to the antigen and then the secondary labeled (or second layer) 
antibody is bound to the primary antibody [22, 24] as shown in Figure 4.1 (B).  
Antibodies are of two kinds monoclonal and polyclonal. Monoclonal antibodies 
are highly specific to an epitope on an antigen [25] and polyclonal antibodies can 
bind to multiple epitopes on an antigen. Polyclonal antibodies generate an effective 
antigen signal but this can be disadvantageous since there is a high likihood of non-
specific binding that would produce false positive signals [25]. Indirect labeling often 
uses a monoclonal antibody (unlabeled) as the first antibody and a polyclonal 
antibody as the second antibody (labeled). By doing this, the specificity for an 
antigen target is increased and then the label is amplified by binding the secondary 
antibody to more than one site on the primary antibody. IHC has often been 
accompanied with the use of chemical inhibitors to block the specific pathways 
giving valuable information on the virus dissemination through a living cell [26]. 
Specific chemical antivirals against porcine reproductive respiratory syndrome virus 
(PRRV) replication was identified by IHC [26]. For our investigation we will be using 
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the IHC technique to study the action and effect of antiviral compounds during the 
PPV infectivity of PK-13 cells.  
 
Figure 4.1 Immunohistochemistry techniques (A) direct labeling and (B) indirect 
labeling. 
 
In this chapter we will show the results found from accomplishing the following 
objectives: 
Objective 1: Explore the PPV infection by tracking the movement of 
fluorescently labeled viral particles 
Objective 2: Determine if PPV capsids are formed when cells are in contact 
with antiviral osmolytes. 
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4.2  Materials and methods 
4.2.1  Materials 
Sodium bicarbonate (NaHCO3) for buffer was purchased from Sigma–Aldrich (St. 
Louis, MO). For pH control the 12.1 M hydrochloric acid (HCl) was purchased from 
VWR (Radnor, PA). The osmolytes trimethylamine N-oxide (TMAO) dehydrate and 
glycine were purchased from Sigma–Aldrich (St. Louis, MO). The bovine serum 
albumin (BSA) was purchased from Sigma (St. Louis, MO). 3-(4, 5-dimethyl-2-
thiazolyl)-2, 5-diphenyl-2H-tetrazolium bromide (MTT) and sodium dodecyl sulfate 
(SDS) were purchased from Sigma–Aldrich (St. Louis, MO). Phosphate-buffered 
saline (PBS, pH 7.2) and 0.25% trypsin/EDTA for cell propagation were purchased 
from Life Technologies (Grand Island, NY). Poly-L-lysine for cell attachment on glass 
slide and 4, 6-diamidino-2-phenylindole dihydrochloride (DAPI) for nuclei staining 
were purchased from Sigma–Aldrich (St. Louis, MO). 3.7% formaldehyde for cell 
permeabilization and fixation was purchased from VWR (Radnor, PA). The Alexa 
fluor 488 NHS ester (succinimidyl ester) for antigen tag was purchased from Life 
Technologies (Grand Island, NY). The monoclonal mouse anti-PPV primary antibody 
was purchased from VMRD (Cat no. 3C9D11H11, Pullman, WA) and the polyclonal 
Alexa fluor 546-conjugated rabbit anti-mouse secondary antibody was purchased 
from Life Technologies (Cat no. A11060, Grand Island, NY). All solutions were made 
with Nano-??????????????????????????????? ???????????????????????????????????
filtered with either a 0.2 μm syringe filter (Nalgene, Rochester, NY) or a Millipore 0.2 
μm bottle top filter (Billerica, MA) prior to use.  
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4.2.2  Cells, titer and assay 
Porcine kidney cells (PK-13) were a gift from Dr. Ruben Carbonell at North 
Carolina State University. PK-13 cells were grown in MEM supplemented with 10% 
fetal bovine serum (FBS) (Atlanta Biologicals, Oakwood, GA) and 1% pen/strep at 
37°C, 5% CO2 and 100% humidity. The cells were propagated every 3-4 days at a 
split ratio of 1:5. PPV strain NADL-2, also a gift from Dr.Ruben Carbonell at North 
Carolina State University, was propagated in PK-13 cells, as described previously 
[15]. PPV was clarified with centrifugation prior to use. 
PPV was titrated with a cell viability assay, the colorimetric MTT assay, as 
described previously. Briefly, PK-13 cells were seeded in 96-well plates. Plates were 
infected with 25μl of PPV and serially diluted across the 96-well plate. After five days 
of incubation, the MTT salt solution was added. Four hours later, solubilizing agent 
was added. Plates were read on a Synergy Mx microplate reader (BioTek, Winoski, 
VT) at 550 nm between 18-24 hours after addition of the solubilizing agent. The 50% 
infectious dose (MTT50) value was determined to be the virus dilution that 
corresponded to an absorbance of 50% of the uninfected cell absorbance. The value 
was converted to a per millimeter basis and stated as the MTT50/ml titer [15]. 
4.2.3  Virus trafficking in cells 
The Pierce bicinchoninic acid (BCA) protein assay kit, from Thermo scientific 
(Waltham, MA), was used for determining the protein content of PPV solutions. For 
cellular trafficking 500 μl PPV (2 mg/ml) was mixed with 50 μl of 1M NaHCO3 and 
different volumes of Alexa flour dye in a Rotoshake Genie for 2.5 hours. The tagged 
PPV sample was added to a 5 ml Zebra spin desalting column from Thermo 
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scientific (Waltham, MA). The column eluent was collected by spinning the contents 
at 1000 xg for 2 minutes in a Sorvall ST16R Centrifuge (Thermo Scientific, Waltham, 
MA). 1 ml PBS was added to the column followed by centrifuging to collect additional 
factions. A UV lamp was used to observe sample fluorescence after each collection. 
All samples were stored at -20°C in micro centrifuge tube wrapped in foil to prevent 
fluorescence loss.  Size exclusion chromatography (SEC) was performed on a 
Waters Alliance HPLC equipped with a fluorescent detector using Sephacryl S-300 
HR purchased from GE healthcare (Pittsburgh, PA). Sephacryl was manually packed 
into an Omega 4.6 mm * 25 cm column. The elution buffer was 50 mM phosphate 
?????????????????????????????????????????????????????????????????????????????????
a flow rate of 1.0 ml/min.  
To prepare glass slides for cellular attachment, the slides were soaked in 2 M 
HCl for 1 hour to etch and remove any grease. Then, 200 μl of poly-L-lysine was 
added to the area of cell growth. After five minutes, the slides were washed with 
water and dried for 2 hours under UV light. Cells were seeded on the slides at a 
density of 5 x 104 cells/slide with a total volume of 50 μl/slide. Cells were incubated 
for 6 mins at 37 °C, and 5% CO2, then 10 ml of fresh media was added to the petri 
dish that contained the slides. After 24 hours of incubation, the media was removed 
and cells were washed with PBS. Each slide was infected with 15 μl/slide of Alexa 
fluor 488 tagged PPV (108 MTT50/ml) for 30 minutes. The slide was then washed 
twice with PBS to remove any unattached PPV and stored in media. At different time 
intervals post-infection, the media was removed, washed with PBS and the infected 
cells were fixed with 200 μl of 3.7% formaldehyde for 20 min at room temperature. 
The slide was washed twice with PBS and the cells were blocked with 200 μl of 5 
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mg/ml BSA for 10 minutes. The slide was washed with PBS twice. Finally, 50 μl of 
150 μM DAPI was added for 5 min at room temperature and washed with PBS. 
Images of the cells were taken with an Olympus IX51 microscope with a DP72 
camera (Olympus, Center Valley, PA).  
4.2.4  Immunohistochemistry 
Glass slides were prepared as described in Section 4.2.3. Cells were seeded on 
the slides at a density of 5 x104 cells/slide with a total volume of 50 μl/slide. Cells 
were incubated for 6 mins at 37 °C, and 5% CO2. Ten ml of fresh media was added 
to the petri dish that contained the slides. After 48 hours of incubation, the media 
was removed and cells were washed with PBS. Each slide was infected with 50 
μl/slide of either PPV (108 MTT50/ml), PPV containing either 0.20 M TMAO or glycine 
(108 MTT50/ml), PBS, or media containing 0.20 M TMAO or glycine. After 30 min, the 
cells were washed twice with PBS to remove any unattached PPV, and 10 ml of 
fresh media with or without osmolytes were added. The cells were placed at 37 °C, 
100% humidity, and 5% CO2 for different times. The media was removed and the 
cells were washed once with PBS. At different time intervals post-infection, the 
infected cells were fixed with 200 μl of 3.7% formaldehyde for 20 min at room 
temperature, and then washed twice with PBS. The cells were blocked with 200 μl of 
0.3% low-fat milk in PBS. After 1 hour, 50 μl of 1:100 v/v anti-PPV antibody were 
added and incubated for 1 hour at 37 °C followed by two PBS washes. Then, 50 μl of 
Alexa fluor 546-conjugated rabbit anti-mouse IgG (1:500 v/v) were added and 
incubated for 1 hour at 37 °C followed by two PBS washes. Slides were washed 
again with PBS. To fix the antibodies, 200 μl of 3.7% formaldehyde were added for 
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20 mins at room temperature, and then the cells were washed twice with PBS. 
Finally, 50 μl of 150 μM of dye was added for cell nuclei staining for 5 mins followed 
by a PBS wash and cell mounting procedure. Images of the cells were taken with an 
Olympus IX51 microscope with a DP72 camera.  
For virus quantification we convert the procured image into binary image using 
imageJ software. ImageJ analysis was performed by gray scaling 100 ms exposure 
PPV images and 5 ms exposure DAPI images. The obtained multi-color images 
were converted to single color images by converting to 16 bit or a gray scale image. 
The threshold was adjusted and consistent values were maintained to analyze the 
entire set of images. A binary version of the image was created with pixel intensity of 
0 (white) and 255 (black). Any noise levels less or equal to 2 pixel density was 
removed and each image was analyzed for particle count and area.  
4.3  Results and Discussion 
4.3.1  Cellular trafficking of virus 
When a virus infects a cell, it goes through a range of processes, including 
endocytosis, internalization through organelles, nucleus entry, genome replication, 
assembly and finally cellular release. Understanding the disease pathogenies and 
virus mechanism can be very useful for antiviral drug and therapeutic vaccine 
development. We have considered a non-enveloped virus, tagged it with a 
fluorescent label and investigated to breakdown the various stages of infection cycle 
by using single particle time study.  
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4.3.1.1  Optimization of fluorescence label 
Prior to Alexa fluor label of virus particles, it was first important to determine the 
concentration of the virus and the total protein concentration. The protein 
concentration was determined with a microBCA kit. A calibration curve with BSA was 
created as shown in Figure 4.2 and then used to determine the protein 
concentration of the PPV solutions. The final PPV concentration was 2.4 mg/ml. The 
total protein concentration in the PPV solution was diluted to 2 mg/ml for the 
following Alexa fluor tagging experiments.  
 
 
Figure 4.2 BSA Calibration curve. A standard curve was plotted by measuring 
absorbance at 562 nm for different known BSA concentrations. The data points 
shown are results from a single test only.   
 
We used a conjugated succinimide ester dye in order to label the proteins in the 
PPV solution. Experiments were conducted for 1 μl, 3 μl, 5 μl and 9 μl of dye with a 
consistent virus concentration.  It was not known what dye concentration would give 
a high fluorescence signal without lowering the virus infectivity. After tagging, 1 ml 
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samples were collected from the desalting column until all the fluorescent dye was 
eluted by visible observation. A total of 7-8 samples were collected and each of the 
samples were subjected to the MTT assay. An example of samples collected and 
titer for the 5 μl dye on PPV and buffer is shown in the Figure 4.3.  
 
 
Figure 4.3 MTT assay of Alexa tagged PPV. A 500 μl of PPV (8 log10 MTT50/ml), 
0.1% NaHCO3 was tagged with 5 μl Alexa fluor dye and eluted from a desalting 
column. By passing PBS elution buffer 7 samples were collected of 1 ml each and 
subjected to MTT assay for infectivity determination. The data points shown are 
results from a single test only.   
 
The PPV titer was high for the initial samples and then reduced for the later 
samples. The result was expected since the desalting column had a molecular 
weight cut off of 7000 Daltons, which is approximately a 0.7 nm nominal pore size 
allowing the large 18-26 nm virus to elute early in the void fraction. The figure in 
comparison to log 8 stock control did not lose infectivity and hence confirmed that 
the dye does not prevent infection on the cells.  
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After confirming the titer had not altered with the tagging protocol, it was 
necessary to identify the impurities that had been tagged in the sample along with 
the virus and remove them. The virus production in the lab comes with media and 
cellular proteins including BSA. The presence of any tagged impurity in the sample 
would stray us from our observation in virus infection imaging process. To 
circumvent this issue, we injected 10 μl of tagged virus into a sephacryl size 
exclusion column and measured the fluorescence. The size exclusion column was 
designed to identify and discriminate the virus from smaller impurities. Experiments 
were again performed for 1 μl, 3 μl, 5 μl and 9 μl dye on the virus. An example of the 
5 μl Alexa fluor tagged PPV sample is shown in Figure 4.4. Samples from the 
desalting column were combined into 2 ml fractions, so sample 1 corresponds to 
fractions 1 and 2 in Figure 4.3. For the desalted sample 1, we were interested in the 
peak at 2 minutes. We proposed that this peak belonged to the virus as the sample 
provided the highest titer on the MTT assay, and the virus should elute in the void 
fraction of an SEC column. We hypothesized the peak at 4 minutes belonged to the 
tagged BSA and extraneous proteins based on the results of Chapter 3 (section 
3.3.2). In this section, the PPV stock, which included BSA-containing media proteins, 
obtained a broad peak ranging from 2 min to 6 min due to the PPV and the protein 
contaminants from the cell media. By desalting the sample in the current 
investigation we are able to remove majority of the proteins in the sample 1 that has 
created distinct peaks at 2 and 4 min.  We also used fluorescence detection, which 
is more sensitive than the UV detection used earlier. The hypothesis that the initial 2 
min peak belongs to PPV and 4 min to contaminants bodes well with the results from 
remaining desalt samples as well. For remaining samples the 2 min peak is 
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negligible and the 4 min peak has a high fluorescence reading. The high 
fluorescence is owing to smaller and more abundantly present proteins which elute 
out behind the PPV due to size exclusion. An alternate theory may also be possible 
that the unincorporated dye is the eluting at the 4 min peak range. Even if this is the 
case the unincorporated dye is an unwanted impurity as it may hinder the epitope 
selection in the infection process. With a goal of having purified virus for imaging 
trafficking study, the sample 1 seemed to be the best sample. However even sample 
1 had a significant impurity peak with larger fluorescence units than virus peak. We 
were interested to decrease the impurity significantly and hence tagging the PPV 
after its purification using the ion exchange chromatography (IEC) was planned. As 
discussed in Chapter 3, the IEC had removed BSA and media proteins from the PPV 
stock and additionally if we happen to note a reduction in the 4 minute peak we can 
be sure the peak belonged to protein impurities and not unincorporated dye.  
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Figure 4.4 Fluorescence measurement of desalted and Alexa fluor tagged PPV 
using SEC. A 500 μl PPV (2mg/ml), 0.1% NaHCO3 was tagged with 5 μl Alexa fluor 
and desalted through a desalting column. Four 1 ml samples were collected and 
subjected to SEC and fluorescence measurement in a 2475 Water fluorescence 
detector.  
 
Several samples of 500 μl of purified PPV (from IEC, as described in section 
3.3.1) were tagged with Alexa fluor dye. First it was necessary to show the tagged 
virus was not preventing infection steps. This was proven by MTT assay which 
showed the virus titer of the samples with different dye concentrations was 
comparable to the control (see Figure 4.5).  
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Figure 4.5 MTT assay of IEC purified PPV with different dye volume. A 500 μl of 
PPV (purification of PPV stock using IEC), 0.1% NaHCO3 was tagged with different 
volumes of Alexa fluor for immunogenic testing or transfection efficiency. The data 
points shown are results from a single test only.   
 
The labeled PPV samples were injected on to the SEC column for detecting virus 
and impurity peaks (see Figure 4.6 A). The injection run for the initial sample 1 
shows the PPV and protein impurity dye peaks at 2 and 4 minutes, similarly as seen 
in the Figure 4.4. A PPV peak with higher fluorescence at 2 minutes compared to 
the 4 minute impurity peak unlike the Figure 4.4 was noted. The result was 
encouraging confirming the 4 min peak belonged to impurity that was reduced 
sufficiently. To satisfy the unincorporated dye theory we analyzed dye concentration 
using a fluorescent plate reader (see Figure 4.6 B) for the desalted samples 1-4. If 
unincorporated dye impurity is available in the samples we wanted it to be at a 
minimum to prevent the dye from blocking active sites for virus transfection. From 
the IEC purified tagged virus investigation, we inferred the 3 μl of dye provided the 
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best virus: impurity peak height ratio (Figure 4.5 A) and a minimum unincorporated 
dye if any (Figure 4.5 B).  
 
 
Figure 4.6 Fluorescence emission for samples (A) SEC (B) Fluorescence plate 
reader. A 500 μl of IEC purified PPV, 0.1% NaHCO3 was tagged with different 
volumes of Alexa fluor and measured for fluorescence to determine the optimum 
dye: virus ratio. 
 
4.3.1.2  Cellular trafficking of PPV in live cells 
We then proceeded to observe the cellular trafficking of PPV through cells with 
the tagged PPV samples. Images were procured at 1, 8 and 20 hour post infection of 
cells with Alexa fluor tagged PPV, as shown in the Figure 4.7 (A), (B) and (C) 
respectively. The virus in (A) was seen in the cell vesicle, in (B) at the perinuclear 
region and in (C) it was mainly observed in the cell organelle with a few particles in 
the nucleus as well. The virus, as per the figures, appears to be trafficking in a non-
linear, multiple pathway system, as also noted by other research groups [8]. Studies 
involving parvoviridae family have shown multiple cell entry mechanism or receptor 
mediated endocytosis as sialic acid [27], macropinocytosis [8], clathrin [28] which 
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occurs within the initial 0 – 2 hours [8]. It is the process of endosomal trafficking and 
the compartments which virus chooses before entering the cytoplasm and nucleus 
that gets more complicated and unclear [29]. Particles can reside in different 
organelle at different time periods [7] and this seems likely from the Figure 4.7 
where the virus is present within an organelle at 1 hour and also again at 20 hours. It 
is not well documented but the stock virus particle: infectivity ratio can be as large as 
1000: 1 that can reduce the ability to distinguish between an infectious and non-
infectious particle. IEC cannot differentiate between infectious and non-infectious 
particle. Another phenomenon that is difficult to account for is the presence of 
individual and aggregated virus particles. Infection pathways can be different for 
aggregated and individual particle. Isolated and purified PPV has been found to 
follow clathrin mediated endocytosis whereas aggregates follow the 
macropinocytosis pathway [8]. Due to these concerns the multiple pathway system 
required a more dynamic and informative live cell imaging for tracking a single virus 
particle in real time, which we did not have access to obtain. The time analysis to 
study virus trafficking with tagged PPV could not be successfully implemented. 
However this investigation helped us to establish and implement the virus time study 
using IHC, which was successfully implemented to understand the effects of antiviral 
compounds on the PPV infection cycle.  
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 Figure 4.7 Alexa tagged PPV trafficking in PK-13 cells. Fixed cell images of 
Alexa fluor (3 μl) in IEC purified PPV (500 μl) on infected cells at (A) 1 hour, (B) 8 
hour, (C) 20 hours.     
4.3.2  Determining the action of virus on cells with and without the 
presence of osmolytes 
Osmolytes are natural organic compounds found in water-stressed organisms to 
maintain cell volume by stabilizing intracellular proteins. Protecting osmolytes fold 
proteins by structuring water around themselves and changing the interaction 
between water and the protein backbone [30]. In work mainly done by my fellow 
graduate student, Maria Tafur, several protecting osmolytes were found to have 
antiviral activity against PPV. For antiviral activity, TMAO and glycine at a 
concentration of 0.20 M were observed to reduce the infectivity of PPV by a 
A B
C
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promising 4 LRV, as defined in Eq. 4.1.  It was noted that the treatment of virus with 
osmolytes prior to the PPV infection showed no reduction in PPV infectivity. It shows 
that the osmolytes played no role in hindering the virus-host cell attachment process. 
However, the compounds worked even when added to the cells up to 20 hours post-
infection.  Antiviral activity past 20 hours of infection is quite a long time post-
infection process. Upon examination of the PPV infection cycle (see Figure 4.8), we 
decided to explore the mechanism of the antiviral activity by starting at the end of the 
infection cycle and proceeding backwards. To determine the mechanism of action of 
the osmolytes, we examined mechanisms from the end of the virus infection cycle 
because we believed that the mechanism of action was late in the infection cycle.  
To study if virus capsid proteins were created, we used IHC. [31].  
Log Reduction =  ? log (????? ????? ???? ????????)(????? ????? ?? ???????)       ……………..   (4.1) 
 
Figure 4.8 The PPV infection cycle 
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To examine the function of osmolytes on the PPV infection cycle, we employed 
IHC for a detailed time study from 0 -20 hours post-PPV infection to determine the 
amount of PPV capsid found in infected cells. The samples under investigation were 
PPV+0.2 M TMAO, PPV + 0.2 M glycine, media containing TMAO and glycine only 
(no PPV) and the positive control of only PPV and the negative control of PBS. 
Figure 4.9 is a representation of virus at 16 hours post infection. PPV capsid 
proteins were found in all samples infected with PPV, including those containing 0.20 
M TMAO and 0.20 M glycine. PBS without virus was used as a negative control, and 
did not show any virus capsid protein formation. TMAO and glycine were also tested 
without virus present and no virus capsid protein formation was detected (not 
shown).  
 128 
 Figure 4.9 Impact of osmolytes on virus capsid protein formation (A) Images of 
PPV, 0.20 M glycine + PPV, 0.20 M TMAO + PPV and PBS mock infected cells at 16 
hours. TMAO and glycine were tested in order to determine osmolytes cross-
reactivity with antibodies and no virus capsids were found (data not shown). Reprint 
permission granted from [34].  
To quantify PPV capsid proteins per cell, we converted multi-color images into 
16-bit binary images using ImageJ and selected thresholds such that noise 
disturbances were removed, leaving only virus or nuclei in each image (see Figure 
4.10). The PPV per cell could be analyzed by using either PPV capsid (by count) or 
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PPV capsid (area) for each DAPI nuclei (count). For PPV capsid (count) to DAPI 
(count) we do a summation of all the assembled virus capsid particles shown as 
orange-fluorescent dye particles in Figure 4.9 and divide against the number of 
nuclei represented in DAPI blue stain. For PPV area to DAPI count we do a 
summation of cross-sectional area covered by PPV fluorescence and divide against 
the available DAPI nuclei count. For PPV, our initial proposition was to analyze on a 
count basis but this changed after beginning our hands-on microscope operation. 
While analyzing PPV by count we noticed that minor disturbances that were difficult 
to control created many noise specs. The noise specs could not be removed 
completely by the pixel threshold and they accounted for large unreasonable value 
and errors during particle count. On the other hand, analyzing the PPV by area 
accounted the noise specs as tiny surfaces in terms of area, giving us smaller errors. 
Also, it allowed for the possibility that one large PPV fluorescent spot could be 
multiple capsids.  Hence we chose PPV capsid analysis by area and for nuclei we 
chose the DAPI count since it did not have noise reduction issues as PPV. 
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Figure 4.10 Binary images for virus per cell quantification. ImageJ software was 
used to create binary Images of PPV, 0.20 M glycine + PPV, 0.20 M TMAO + PPV 
and PBS mock infected cells at 16 hours to quantify virus/cell. Reprint permission 
granted from [34].  
The graph of PPV area/DAPI count (Figure 4.11) shows for the sample involving 
PPV with osmolytes, the fluorescence per cell started to increase after 8 h. Similar 
trends were observed with the positive control PPV. These results show that viral 
capsid proteins are produced under these conditions. Since the osmolytes were 
shown to reduce infectivity by 4 LRV, we infer that although capsid proteins are 
produced they are not viable particles.  
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Figure 4.11 Impact of osmolytes on virus capsid protein formation by 
determining the ratio of the fluorescence of PPV capsid proteins to the count 
of DAPI. All data points are the average of three independent slides with 10 images 
per slide and the error bars represent the standard deviation. TMAO and glycine 
were tested in order to determine osmolytes cross-reactivity with antibodies and no 
virus capsids were found (data not shown). Student’s t-test was used to evaluate the 
statistical significance between cells infected with PPV (with or without osmolyte) 
and the PBS negative control *p value of <0.05. Reprint permission granted from 
[34].  
The fact that capsids are produced but not viable proves that the osmolytes are 
working post-virus infection process as shown in the Figure 4.12. We hypothesize 
that protecting osmolytes are disrupting capsid assembly by stabilizing viral capsid 
proteins and preventing the assembly process. Osmolytes are known to stabilize 
proteins by preferential hydration [32]. This can cause the proteins to adjust to a 
more compact configuration [30]. It is likely the compact structure of VP2 proteins, 
which constitute 90% of the PPV is not able to assemble into viable infectious 
capsid. The other alternate hypothesis is the presence of osmolytes is preventing the 
assembly mechanism from guiding the DNA into the capsid. However since 
enzymes have to been known to be stable under the presence of osmolytes 
conditions [33] we would suppose the osmolytes are disrupting the self-assembly of 
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virus capsid proteins.  A third option that we never tested was the DNA was not 
being created due to the presence of the osmolytes. 
 
Figure 4.12 PPV infection cycle and the osmolytes action on virus infectivity 
4.4  Conclusions 
Virus infection and trafficking through cells is a very challenging and complicated 
process. Understanding the virus pathway through cells can greatly benefit gene 
vector therapy and antiviral drug design. We were interested in understanding the 
PPV trafficking through PK-13 cells. Research groups studying PPV pathway had 
found that PPV entered through receptor mediated endocytosis, internalized through 
endosomes, entered the cytoplasm and then nucleus. The DNA replication step is 
poorly understood and following the genome synthesis cells are lysed releasing virus 
for further replication. Our objective was to tag the virus with a fluorescent dye and 
observe its trafficking under fluorescence microscope.  
PPV
Receptor
Nucleus
Attachment
Susceptible 
host cells
Endocytosis
Endosome
Nuclear 
Trafficking
Virus
release
DNA 
Synthesis
Protein 
Synthesis
Capsid 
assembly
DNA
Likely 
action of 
osmolytes
133 
The virus was tagged with Alexa fluor 488 and desalted using a column. We 
analyzed the desalted samples using MTT assay to make sure the virus had not lost 
its immunogenic properties upon tagging. The protein impurities present along with 
the virus from virus production protocol were identified using fluorescent signal from 
the SEC. Any impurities, especially if tagged, could change our virus trafficking 
observation under the microscope. Hence it was important to remove as many 
impurities as possible. In order to remove the impurities we made use of IEC with Q-
sepharose beads in an omega 4.6 mm x 25 cm column. After the purification, we 
tagged the virus and used for trafficking purpose. Tagged virus was observed at 
vesicle in the first hour, at the perinuclear region after 8 hours and at 20 hours it was 
observed in nucleus, vesicle and perinuclear region. In our observation the virus 
seemed to be trafficking in multiple ways through the cellular machinery. The low 
infective particle ratio 1:1000 along with PPV multiple pathways made it difficult to 
make a valid conclusion for single virus trafficking project. Our learning and 
experimental working here was used to study the infectivity mechanism of PPV in 
the presence of antiviral drugs. 
  Osmolytes are natural compounds that are found in stressed animal to maintain 
cell volume by stabilizing intracellular proteins. Protecting osmolytes are a special 
type of osmolytes which structure water around themselves causing protein folding. 
Several osmolytes were screened for observing antiviral activity. Among them TMAO 
and glycine at 0.20 M concentration were found to inhibit PPV infection by a 
promising 4 LRV measured using the MTT assay. In order to further understand the 
mechanism of osmolytes on the infection process, we made used of IHC. We 
performed a 0-20 hour timed study post PPV virus infection in the presence of 
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osmolytes. The fact that the PPV capsids are seen using IHC but inhibited by 4 LRV 
using cell viability assay shows that osmolytes are preventing the formation of viable 
virus particles. We hypothesize the protecting osmolytes TMAO and glycine are 
disrupting virus capsid assembly process by stabilizing and preferentially hydrating 
the VP2 capsid proteins.   
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5.1  Introduction  
The goal of public sector immunization programs is to ensure high quality 
vaccines are produced in adequate quantity and at affordable prices. With 
industrialized countries producing original, higher profitable vaccines in lieu of 
traditional vaccines, vaccine manufacturing of older vaccines is steadily being 
outsourced to developing and emerging economy countries. This poses an 
overwhelming challenge of meeting the demand of vaccines for public sector 
immunization programs while re-engineering the manufacturing steps to reduce the 
financial burdens [1]. With 70% of the overall vaccine production costs being spent 
on downstream processing, improving vaccine purification is an appropriate target to 
reduce manufacturing costs [2].  
The purification strategies for the downstream processing of viral vaccines have 
included a variety of methods. Some of the typical unit operations are precipitation, 
centrifugation, ultrafiltration and chromatography. Precipitation using ammonium 
sulfate and polyethylene glycol (PEG) has been used for virus precipitation based on 
particle-particle interaction and hydrophobicity [3]. However, the lack of process 
robustness and co-precipitation of impurities has limited the application of this 
method. Centrifugation has been predominantly used in lab-scale production of large 
biomolecules based on density gradients of cesium chloride or sucrose. Particle 
degradation from pressure and osmotic shock and lengthy processing times plague 
density gradient centrifugation, along with scale-up difficulties [4]. Tangential flow 
filtration (TFF) has been used to purify viruses. However, the high transmembrane 
pressures in TFF can reduce virus infectivity and membrane fouling can reduce 
permeate flux [5, 6].  
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Column chromatography using porous beads is the most routine method used for 
virus purification. Chromatography is designed for biomolecules and 
nanoparticulates < 5 nm in diameter and virus particle diameters typically range 
between 20-200 nm. This creates issues pertaining to pore diffusion and pore 
plugging, which severely restricts virus adsorption within the inner surface area of 
the solid matrix [7, 8]. Due to the reduced adsorption surface accessibility, monolith 
and membrane chromatography have gained considerable attention as adsorption 
matrices. However, membrane absorbers face a similar drawback as TFF, which is 
the degradation of liable virus particles due to shearing effects [8, 9]. For each 
physically different stationary phase configuration, chromatography still requires a 
change in mobile phase. The change in salt concentration, pH, or addition of a 
solvent equally run the risk of inactivating virus particles [10]. In vaccine 
manufacturing, chromatography also has a tendency to fail to discriminate between 
virus and protein contaminants [11], likely due to the different amount of surface area 
available to the proteins and virus particles that can alter the balance of the 
equilibrium. 
Currently, the downstream processing of viral products combines several of the 
previously mentioned unit operations. The purification of viruses using clarification or 
filtration along with a chromatographic step have demonstrated recoveries of 32% 
for adenovirus [12], 25% for baculovirus [13], and 30-50% for adeno-associated virus 
[14]. Overall, virus recoveries of 30% are considered an acceptable standard  
for the entire vaccine purification train [15]. Our goal is to design an alternative unit 
operation that is capable of creating a high infectious yield. In a quest to fulfill this 
goal, we have been exploring aqueous two-phase systems (ATPSs) as an optional 
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mechanism to purify virus. ATPS has been unable to gain widespread 
implementation mainly due to loss of virus infectivity, co-purification of proteins, and 
difficulty of polymer recycling [16]. Enveloped viruses have a sensitive lipid bilayer 
that makes them susceptible to inactivation in high ionic strength environments. The 
majority of non-enveloped virus families, reovirus, picornavirus, polyomavirus [17] 
and parvovirus [18], are known to withstand contact with high concentrations of 
polyethylene glycol (PEG).  
ATPS is formed by mixing water soluble polymers, or a water soluble polymer 
and a salt, above a critical concentration that results in two immiscible aqueous 
phases [19, 20]. It is a versatile method used for the separation and purification of 
biological molecules such as proteins [21], enzymes [22], nucleic acids [23] , virus 
[24], antibodies [25] and cell organelles [20]. The partitioning is governed by many 
physicochemical properties, such as surface hydrophobicity, electrostatic 
interactions, van der Waal’s forces and hydrogen bonding [26]. ATPS combines 
clarification, concentration and purification into a single, integrated step to obtain a 
high yield with a low financial burden. A monoclonal antibody was purified with ATPS 
and obtained a similar yield as protein A chromatography at 39% reduced operating 
costs [27]. In the recovery of penicillin acylase from recombinant E.Coli, ATPS was 
able to reduce the number of unit operations from 7 to 4 and achieve a 97% yield 
with a gross cost reduction of 37% compared to ion exchange chromatography [28].  
ATPS also boasts other advantages: easy scale-up, environmentally-friendly, low 
cost and high mass transfer [20]. Some of the disadvantages of ATPS include the 
removal of the PEG from the final biological product, dilution of the product, and 
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large buffer volumes that would need to be recycled. As we pursue the purification of 
virus with this method, we will tackle many of these disadvantages. 
Chemical cost is always a dominant factor in any biochemical process. Due to 
this, the inexpensive PEG-salt ATPS has been widely favored for commercial use 
instead of the PEG-dextran system.  The drive to eliminate PEG is not so great as it 
is inexpensive when purchased in a large MW range and forms two phases with 
most natural polymers and salts [29]. In order to achieve an extraction with high 
recovery of virus and purity from cell contaminants, the composition of ATPS needs 
to be carefully chosen. ATPS has been frequently used in the past for recovery of 
virus-like particles (VLPs). VLPs are multiprotein structures that contain the same or 
similar immunogenic features of infectious viruses, but lack the viral genome the is 
required for virus replication [30]. A VLP vaccine against the human papillomavirus 
was obtained with a 54% recovery in a PEG 1000-phosphate system [31]. A DNA 
plasmid vaccine was recovered from a PEG 400-phosphate system with a 37% yield 
[32]. However, appropriate technologies to obtain high yields for infectious virus 
particles are still being sought. Infectious bacteriophage T4 in a PEG 8000-
phosphate system obtained a recovery of 30-38% [33]. The yields of < 55% 
demonstrate a need to find an alternative purification method for large biomolecular 
vaccines. 
The aim of this study is to recover infectious porcine parvovirus (PPV) using a  
PEG-salt system. PPV was chosen due to its small size, simplicity and its structural 
similarity to adeno-associated virus (AAV), a commonly studied gene therapy vector. 
It is also used as a surrogate for Hepatitis A and poliovirus, both of which have 
vaccines. PPV is also a model non-enveloped virus for the human B19 parvovirus, a 
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known blood-borne pathogen in humans. We successfully achieved 64% virus 
recovery in a PEG-citrate ATPS and eliminated the major contaminant protein, 
bovine serum albumin (BSA), which comes from the addition of serum to the media. 
Although many vaccines are now produced in serum-free media, we used this as a 
proof-of-concept study that a major protein contaminate could be separated from the 
virus with ATPS. The partition behavior of virus has been explained primarily on the 
basis of electrostatic interactions, surface hydrophobicity and ATPS surface tension. 
5.2  Materials and Methods 
5.2.1  Materials 
PEG samples with molecular weights (MW) of 3K, 8K and 12 KDa were 
purchased from Sigma-Aldrich (St. Louis, MO). Sodium phosphate and sodium 
sulfate were purchased from VWR (Radnor, PA). For the phosphate buffer solution, 
sodium hypophosphite (NaH2PO4.H2O) was purchased from VWR (Radnor, PA) and 
sodium triphosphate (Na3PO4) was purchased from Fisher Scientific (Pittsburgh, 
PA). Sodium hydroxide was purchased from Acros Organics (New Jersey, NY). 
Sodium chloride was purchased from Macron Chemicals (Center Valley, PA). 
Sodium citrate dihydrate and hydrochloric acid were purchased from EMD 
Chemicals (Billerica, MA).  
Phosphate-buffered saline (PBS) pH 7.2, 0.25% trypsin/EDTA, 
penicillin/streptomycin (pen/strep) and minimum essential medium (MEM) for cell 
propagation were purchased from Life Technologies (Grand Island, NY). For virus 
titration, 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) and 
sodium dodecyl sulfate (SDS) were purchased from Sigma-Aldrich (St. Louis, MO).  
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High pressure liquid chromatography (HPLC) grade acetonitrile and trifluoroacetic 
acid (TFA) were purchased from Sigma-Aldrich (St. Louis, MO) and Alfa Aesar 
(Ward Hill, MA), respectively. BSA was purchased from Sigma-Aldrich (St. Louis, 
MO). All solutions were made with water from a NanoPure water system (Thermo 
Scientific, Waltham, MA) to a resistan?????????? ??? 
5.2.2. Cells, virus and titer assay 
Porcine kidney cells (PK-13) were a gift from Dr. Ruben Carbonell at North 
Carolina State University. PK-13 cells were grown in MEM supplemented with 10% 
fetal bovine serum (FBS) (Atlanta Biologicals, Oakwood, GA) and 1% pen/strep at 
37°C, 5% CO2 and 100% humidity. The cells were propagated every 3-4 days at a 
split ratio of 1:5. PPV strain NADL-2, also a gift from Dr.Ruben Carbonell at North 
Carolina State University, was propagated in PK-13 cells, as described previously 
[34]. PPV was clarified with centrifugation prior to use. 
PPV was titrated with a cell viability assay, the colorimetric MTT assay, as 
described previously [35]. Briefly, PK-13 cells were seeded in 96-well plates. Plates 
were infected with 25μl of PPV and serially diluted across the 96-well plate. After five 
days of incubation, the MTT salt solution was added. Four hours later, solubilizing 
agent was added. Plates were read on a Synergy Mx microplate reader (BioTek, 
Winoski, VT) at 550 nm between 18-24 hours after addition of the solubilizing agent. 
The 50% infectious dose (MTT50) value was determined to be the virus dilution that 
corresponded to an absorbance of 50% of the uninfected cell absorbance. The value 
was converted to a per millimeter basis and stated as the MTT50/ml titer [34]. The 
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MTT titer for PPV has been shown to be linearly correlated to the more common 
TCID50 [34]. 
5.2.3  Binodal Curve 
To study the experimental space of a PEG-salt system, we determined the 
binodal curves by the turbidmetric titration method [21]. Different bulk salt: bulk PEG 
ratios were made to obtain multiple phase transition lines transcending towards the 
origin. The unique aqueous combinations were initially stirred for 1 minute until the 
solution was turbid. Small volumes of water were then added using a burette until a 
clear solution was obtained. The composition of the mixture when the clear solution 
was obtained was determined to be the binodal point.  
5.2.4  ATPS 
All the experiments presented are mini ATPS performed using 1.7 ml 
microcentrifuge tubes for a total of a 0.9 g system. The scale-up and scale-down of 
ATPS have not been considered problematic [36]. PEG solutions with bulk 
concentration of 33 w/w% were prepared and mixed with salt solutions of varying 
concentrations for a total of 0.8 g [37]. The pH of the system was kept at 7 using HCl 
or NaOH, unless otherwise stated. To this system 0.1 g of 108 MTT50/ml of PPV was 
added and the mixture was vortexed for 30 seconds and centrifuged using a Sorvall 
ST16R Centrifuge (Thermo Scientific, Pittsburgh, PA) for 3 min at 19-22°C. Visual 
estimates were made on the graduated microcentrifuge tubes for determining 
volume ratios. The PEG-rich phase was extracted using a 10-100 μl pipette tip and 
the salt-rich phase using a rounded gel tip (USA Scientific, Oscala, FL) to minimize 
disturbances and sample withdrawal from the interface. The samples were tested for 
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infectious PPV with the MTT assay, as described in Section 5.2.2. The final virus 
concentration in each phase is reported in percent recovery (see Eq. 5.1), taking into 
consideration the volume of each phase for closing the mass balance of the system. 
We tested the infectivity of the unseparated PEG-salt systems and used this as the 
starting value for the mass balance. The mixed PEG-salt systems did not lose 
infectivity, as calculated from the known stock infectivity. The % recovery is defined 
as,  
 % ???????? =  
?????
?? ?,?× ??,?
?????
?? ?× ??
? 100% ...................................................... (5.1) 
where p, s, and i represent the virus concentration in the PEG-rich phase, salt-rich 
phase, or initial concentration, respectively.  
5.2.5  RP-HPLC and SDS-PAGE 
In order to validate the removal of the main contaminating protein BSA, we 
monitored the BSA separation in ATPS.  Reverse-phase high pressure liquid 
chromatography (RP-HPLC) was performed with a Waters XBridge BEH 130 C18 
column on a Waters Alliance HPLC equipped with a photo diode UV-Vis detector 
operating at 254 nm wavelength. Samples of 200 μl from the PEG-rich and salt-rich 
phases were withdrawn from multiple ATPS experiments until a final volume of 800 
μl was obtained. The samples were dialyzed using a 20 kDa MWCO cellulose 
membrane purchased from Spectrum Laboratories (Dominguez, CA) to remove the 
high concentration of salt or polymer in the system that would interfere with the RP-
HPLC analysis. The dialysis was conducted against 50 mM phosphate, 150mM NaCl 
at pH 7.2 for 48 hours at 20°C with two buffer exchanges. Dialyzed samples were 
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???????????????????????????????????????????????????????????????????????????????????????
RP-HPLC C18 column at a flow rate of 1.0 ml/min. Mobile phase A was 0.1% TFA in 
water and mobile phase B was 0.1% TFA in acetonitrile. A linear gradient of 
increasing mobile phase B was performed.  
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was run 
using 4-12% Bis-Tris NuPage gels in NuPage MOPS running buffer purchased from 
Life Technologies (Grand Island, NY). Samples were reduced in DTT and heated to 
70°C for 10 minutes prior to loading onto the gel. SDS-PAGE was stained with the 
SilverXpress kit (Life Technologies, Grand Island, NY). 
5.3  Results  
5.3.1  Model Virus 
The virus used in this study was porcine parvovirus (PPV). PPV is a pathogen 
causing reproductive failure in swine [38]. PPV is a non-enveloped, single-stranded 
DNA virus with a diameter of 18-26 nm [39] and a model for the human B19 
parvovirus [40].  B19 causes fifth disease, a mild rash illness that generally affects 
children. PPV and other parvoviruses are commonly used to test virus removal in 
biotherapeutic manufacturing [41, 42]. The PPV was produced in serum-containing 
media; therefore, bovine serum albumin (BSA) removal was studied as a model 
contaminating protein. Many vaccines are currently produced in serum-free media, 
and future work will be to study the removal of host cell proteins (HCPs) from the 
virus system.   
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5.3.2  Binodal Curve 
Binodal curves are needed to predict the two-phase region that can be utilized for 
ATPS extraction and partitioning of biomolecules. The binodal curve divides the 
region of component concentration into two phases; above the curve is the two-
phase region and below the curve is the miscible, one-phase region. From Figure 
5.1, it can be seen that there is an expanded two-phase zone with increasing 
polymer molecular weight for the PEG-salt system.  There was a similar trend to 
binodal curves found by others [21, 43]. Due to the high PEG MW that was used in 
this work, binodal curves from other studies could not be utilized.          
 
Figure 5.1 Binodal curves for (A) PEG-citrate, (B) PEG-phosphate and,  
(C) PEG-sulfate 
5.3.3  Effect of anion 
Before choosing the appropriate PEG-salt system, it was important to identify the 
anionic salt which was well-suited for PPV separation. Three different salts, citrate, 
phosphate and sulfate, were individually tested for ATPS separation containing PEG 
12K. After extraction and cytotoxicity analysis, the results are shown in Figure 5.2. 
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Citrate demonstrated the greatest recovery of PPV in the PEG-rich phase. All three 
salts had minimal PPV found in the salt-rich phase. We assumed that the remaining 
virus resided at the liquid-liquid interface between the PEG-rich and salt-rich phases, 
shown in Figure 5.2C. We also assumed no loss of infectivity. We tested the 
infectivity of many unseparated PEG-salt systems and used this as the starting value 
for the mass balance. The mixed PEG-salt systems did not lose infectivity, as 
calculated from the known stock infectivity. All further experiments were carried out 
in the PEG-citrate system. 
 
Figure 5.2 Effect of salt type on PPV separation. Partition behavior of PPV in 15 
w/w% PEG 12K and salts at 14 w/w%. Virus concentration in (A) PEG-rich phase, 
(B) salt-rich phase, and (C) interface. The interface is calculated from the mass 
balance of the recovery from the PEG-rich and salt-rich phases. All data points are 
the average of three separate tests and error bars represent the standard deviation. 
 
5.3.4  Effect of polymer size and salt concentration 
PPV partitioning was conducted on PEG 3K, 8K and 12K with a constant polymer 
concentration and various salt concentrations, as shown in Figure 5.3. The 
concentration of salt and the PEG MW affect the partitioning of infectious virus in 
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12K, a maximum recovery was reached at 14 w/w% citrate, and additional citrate 
decreased the recovery. At higher citrate concentration than 14 w/w%, the virus was 
pushed into the interface (Figure 5.3C). At lower citrate concentrations than 14 
w/w%, the virus was found both at the interface, but also in the salt-rich phase 
(Figure 5.3B). As the salt concentration encroached the binodal curve (Figure 5.1), 
more virus was found in the salt-rich phase. For the PEG 8K, there also appears to 
be an increase in recovery in the PEG-rich phase as the citrate concentration 
increases, but it occurred at the higher citrate concentrations tested (16-21 w/w%). 
The PEG 8K also had much more virus at the interface than the PEG 12K at the 
optimal citrate concentration for that particular PEG MW. There was an increase in 
recovery of the PPV in the PEG-rich phase for PEG 3K with increasing salt 
concentration, but it was just beginning at the highest citrate concentrations tested. 
The PEG 3K also had most of the virus residing at the interface. It is undesirable to 
have the virus reside at the interface because it is difficult to recover and is likely 
aggregated and not infectious. 
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 Figure 5.3 Effect of salt concentration on PPV separation. Partition behavior of 
PPV in 15 w/w% PEG and different citrate concentrations. Virus concentration in (A) 
PEG-rich phase, (B) salt-rich phase, and (C) interface. The interface is calculated 
from the mass balance of the recovery from the PEG-rich and salt-rich phases. All 
data points are the average of three separate tests and error bars represent the 
standard deviation. 
 
5.3.5  Effect of ionic strength and pH 
Addition of sodium chloride has been known to improve protein recovery in the 
PEG-rich phase [44]. It is hypothesized that the increased ionic strength in the salt-
rich phase increases the hydrophobic interactions between PEG and protein [45]. To 
determine the effect of sodium chloride on the partitioning behavior of PPV, the 
addition of NaCl to 15 w/w% PEG 12K and 14 w/w% citrate was studied. In Figure 
5.4A, we see that at all concentrations of NaCl tested, the virus partitioned less to 
the PEG-rich phase and more to the interface. The addition of NaCl may tell us more 
about the mechanism of virus separation, but it did not improve the virus recovery. 
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 Figure 5.4 Effect of addition of NaCl on PPV separation.  Partition behavior of 
PPV in 15 w/w% PEG 12K and 14 w/w% citrate with addition of NaCl. Virus 
concentration in (A) PEG-rich phase, (B) salt-rich phase, and (C) interface. The 
interface is calculated from the mass balance of the recovery from the PEG-rich and 
salt-rich phases. All data points are the average of three separate tests and error 
bars represent the standard deviation. 
 
The pH of the ATPS solution was varied by controlling the pH of the bulk PEG 
and salt solutions prior to ATPS separation.  The PPV partitioning is shown for 15 
w/w% PEG 12K and 14 w/w% citrate ATPS in Figure 5.5. PPV is stable in the pH 
range of 3-9 [46], but lower pH in the 3-4 range resulted in miscible solutions in the 
chosen ATPS. From Figure 5.5A we observe that between pH 5 to 8, the separation 
to the PEG-rich phase increases from 7% to 64% and drops to 58% at pH 9. Virus 
recovery shifts from the salt-rich phase near the virus pI (~5 [47]), as shown in 
Figure 5.5B, to the interface at pH 6 and then to the PEG-rich phase from pH 7-9. 
This demonstrates that a neutral virus prefers the salt-rich phase, whereas a 
negatively charged virus prefers the PEG-rich phase. A change in pH does not 
change the amount of virus at the interface except at pH 6 (Figure 5.5C). 
A B C
0
20
40
60
80
100
0 0.6 1.2 1.8 2.4
0
20
40
60
80
100
0 0.6 1.2 1.8 2.4
Vi
ru
s 
re
co
ve
ry
 (%
)
0
20
40
60
80
100
0 0.6 1.2 1.8 2.4
NaCl w/w%
 152 
 Figure 5.5 Effect of pH on PPV separation. Partition behavior of PPV in 15 w/w% 
PEG 12K and 14 w/w% citrate with pH controlled for the PEG-rich and salt-rich 
phases before ATPS was created. Virus concentration in (A) PEG-rich phase, (B) 
salt-rich phase, and (C) interface. The interface is calculated from the mass balance 
of the recovery from the PEG-rich and salt-rich phases. All data points are the 
average of three separate tests and error bars represent the standard deviation. 
 
5.3.6  Effect of polymer dehydration 
We also explored the possibility that dehydration of the polymer phase would 
affect the partitioning of the PPV. As shown in Figure 5.6A, the volume ratio of the 
PEG-rich and salt-rich phases change as the citrate concentration changes in the 
PEG 12K system. The highest recovery of the virus in the PEG-rich phase is at a 
citrate concentration of 13-14 w/w%, which corresponds to even volumes of each 
phase. At lower salt concentrations, the virus tends to partition more to the salt 
phase and the salt-phase volume decreases. At higher salt concentrations, the virus 
tends to partition to the interface and the PEG-phase volume decreases.  To test the 
hypothesis that the virus favors a system where the salt-rich and PEG-rich phases 
are close to equal, we explored the volume ratios of the different salts tested and the 
addition of NaCl, shown in Figure 5.6B and 5.6C. However, these systems did not 
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to the PEG-rich phase. All of the ATPSs with different NaCl concentration and 
different salt types had equal volume ratios; however the partitioning did not favor 
the PEG-rich phase (see Figure 5.4 and Figure 5.2, respectively). 
 
Figure 5.6 Effect of polymer dehydration on PPV separation. (A) Volume ratios 
of PEG-rich phase and salt-rich phase of ATPS for 15 w/w% PEG 12K and various 
citrate concentrations. (B) 15w/w% PEG 12K and 14 w/w% citrate with addition of 
NaCl. (C) 15w/w% PEG 12K and 14 w/w% salts. All data points are the average of 
three separate test and error bars represent the standard deviation 
 
5.3.7  Separation of PPV from contaminant proteins 
After partitioning PPV to the PEG-rich phase, we validated the purification and 
separation of virus particles from the most abundant contaminant, bovine serum 
albumin (BSA).  BSA comes from the fetal bovine serum (FBS) used in virus 
production. Previously, it has been shown by Lu et al. that BSA partitions to the 
PEG-rich phase in a PEG 1K-citrate system, but partitions to the salt-rich phase 
when the polymer MW is increased [21]. We therefore hypothesized that the BSA 
would partition to the salt-rich phase in our PEG-citrate system since we were using 
a high MW PEG. 
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SDS-PAGE is generally considered the first choice as an assay for protein purity, 
however, PPV and BSA run closely together in SDS-PAGE. The main protein in the 
PPV capsid is VP2, and it has a MW of 64 kDa [48] and the MW of BSA is 66 kDa. 
Over 80% of PPV capsid is VP2, making the capsid fairly homogeneous. Not being 
able to determine the separation of PPV and BSA with SDS-PAGE, we sought a 
different method to distinguish the two biomolecules. 
RP-HPLC was used to identify the presence of BSA in ATPS. We first used pure 
BSA to test our RP-HPLC method with high concentrations of BSA and without PPV 
present (Figure 5.7A). The BSA eluted at 21.5 minutes. Figure 5.7B shows 
chromatograms of BSA partitioning in the polymer and salt phases of ATPS, with an 
insert that focuses on the region of BSA elution. The concentration of BSA in Figure 
5.7B is about 10 times lower than in Figure 5.7A, therefore many of the baseline 
peaks from the water used to make the solutions can be seen. We show that the 
BSA partitions to the salt-rich phase and none is found in the PEG-rich phase. The 
reduction in the PEG-rich phase is not due to dilution because the control system is 
the unseparated ATPS system, which contains the PEG, salt and BSA.  For this 
reason, the salt-rich phase is able to have a higher peak, and therefore concentrates 
the BSA in a smaller volume than the total system control. The peak at 21.9 minutes 
is believed to be contamination from the water used, as it is also found in the PBS 
control. Using higher concentrations of BSA than found in the PPV extract, we 
confirmed the RP-HPLC method with SDS-PAGE. Figure 5.7C demonstrates that 
there is no BSA in the PEG-rich phase, whereas it can easily be found in the salt-rich 
phase, confirming the results of RP-HPLC in Figure 5.7B. 
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Figure 5.7 RP-HPLC of BSA in ATPS. (A) Chromatogram of 0.05 injected 
milligrams of pure BSA eluted with a linear acetonitrile gradient.  (B) RP-HPLC of 
0.005 injected milligrams of pure BSA within the control ATPS. The insert highlights 
the BSA peak at 21.5 minutes.  (C) SDS-PAGE of samples from B: M=marker, 
C=control, S=salt-rich phase, and P=PEG-rich phase. The control was the 
unseparated ATPS containing PEG, salt and BSA. 
Once we determined that the BSA partitions to the salt-rich phase, we used RP-
HPLC to investigate the actual ATPS separation with PPV containing FBS from the 
cell culture media used to produce the virus (Figure 5.8). Again, the results show 
that all of the BSA partitions to the salt-rich phase and none is found in the PEG-rich 
phase. This demonstrates that the 15 w/w% PEG 12K and 14 w/w% citrate system 
was able to remove all detectable BSA. 
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 Figure 5.8 RP-HPLC of BSA in ATPS containing PPV. RP-HPLC of BSA after 
ATPS containing 0.1 g of PPV (which contains FBS from the PPV preparation), 0.4 g 
of 15 w/w% PEG 12K and 0.4 g of 14 w/w% citrate. The insert highlights the BSA 
peak at 21.5 minutes.   
 
5.4  Discussion  
From this study of PPV separation on a PEG-citrate system, we hypothesize that 
the dominant forces that are dictating the separation are biomolecule charge, 
surface hydrophobicity and the ATPS surface tension. Although others have 
suggested that the excluded volume of high MW PEG also plays a dominant role in 
ATPS [49, 50], we did not observe this effect.  
0
20
40
60
0.000
0.005
0.010
0 5 10 15 20 25 30
Ab
so
rb
an
ce
 (2
54
nm
)
Retention time (min)
0.001
0.002
0.003
21 21.5 22 22.5 23
Salt-rich phase
Control
PBS
PEG-rich phase
BSA
 157 
High salt concentrations can drive biomolecules out of the salt-rich phase. When 
this occurs in ATPS, the biomolecule can either partition to the PEG-rich phase or 
occupy the interface. Virus separation has been plagued with partitioning of the virus 
to the interface. The majority of bacteriophage T4 particles in a PEG 0.6K-sulfate 
system [33], adenoviral vectors in a PEG 8K-phosphate system [51] and B19 VLPs 
in a PEG 1K-sulfate system [36] partitioned to the interface. However, we have 
found that the strongly hydrating citrate ion, as compared to the sulfate or phosphate 
ion, is able to drive PPV to the PEG-rich phase. This is advantageous because it 
allows easier recovery of infectious virus as compared to virus that occupies the 
interface. Citrate has only recently been used in ATPS and is gaining popularity due 
to its environmentally friendly nature as compared to phosphate [21].  
5.4.1  Biomolecule charge 
The molecular weight, surface net charge, size, shape, and specific binding sites 
of biomolecules play a crucial role in the molecular partitioning mechanism [20]. The 
electrical potential created due to distribution of salt ions between the aqueous 
phases causes negatively charged protein molecules to partition to the PEG-rich 
phase and positively-charged proteins to partition to the salt-rich phase [22]. This is 
observed as the pH is changed in the separation of PPV in Figure 5.5. As the pH is 
increased beyond the pI of PPV~ 5 [47], the virus surface becomes negatively 
charged and the recovery of the virus in the PEG-rich phase increases.  
Water plays a significant role in the partitioning of proteins between phases. 
ATPSs typically consist of 70-90 w/w% of water. In PEG–salt systems, the 
distribution of anions and cations between the phases is highly dependent on their 
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ability to structure water [52]. The efficiency in virus separation can also be 
compared to the lyotropic Hofmeister series (see Figure 5.2). The order of anions as 
per Hofmeister are citrate3- > SO42- > PO42-> acetate-> Cl->NO3-. The sequence is in 
line with higher surface tension, stronger hydration, better protein stability and 
greater destruction of bulk water structure [53]. Citrate, a strongly hydrating 
kosmotrope, creates a charge difference between the PEG-rich and salt-rich phases, 
drastically changing the order of water molecules in the system. Hence, as citrate 
concentration is increased to 14 w/w% for the PEG 12K system, we can see a clear 
trend with increasing partitioning of PPV to the PEG-rich phase.  
5.4.2  Excluded volume and hydrophobicity  
The molecular mass of PEG used in these experiments is much higher than most 
other ATPS investigations. Several researchers in ATPS studies have acknowledged 
a necessity to identify optimal PEG MW. Increased polymer MW has a tendency to 
cause polymer compaction due to the increased intermolecular hydrophobic bonds 
formed by the high MW PEG, therefore decreasing free volume [49]. This volume 
exclusion principle decreases the partition coefficient and increases the separation 
of the desired protein toward the salt-rich phase [21, 50, 54]. The data shown in 
Figure 5.3A does not support the volume exclusion theory. The higher PEG MW 
enhances PPV partitioning to the PEG-rich phase. This is likely due to the interaction 
between the hydrophobic residues on lengthy high MW PEG and hydrophobic sites 
on the viral surface. It has been shown that hydrophobic proteins predominantly 
partition to the PEG-rich phase [55]. 
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There is a growing body of evidence that virus surfaces are hydrophobic. Phages 
(viruses that infect bacteria) were shown to have a varying degree of hydrophobicity, 
as demonstrated by carbon adsorption [56]. B19 human parvovirus [57] and PPV 
[58] were precipitated with glycine and it was concluded that this was due to the 
highly hydrophobic surface of the virus. Our past work on virus binding peptides 
concluded that both hydrophobicity and charge play a major role in the binding of 
peptides to PPV [59-61]. The work presented here adds to the body of evidence that 
viruses have a strong surface hydrophobicity.  
In support of the theory that hydrophobicity plays a major role in the partitioning 
of PPV to the PEG-rich phase, it has been shown that BSA partitions to the salt-rich 
phase of a PEG-citrate system when the PEG MW is greater than 1K [21]. Two 
theories were presented to explain this result, the increased PEG MW caused an 
excluded volume effect in the PEG-rich phase and the increased PEG MW 
increased the hydrophobicity of the PEG-rich phase and therefore the BSA preferred 
the salt-rich phase.  Our results with PPV do not support the theory of excluded 
volume, but it does support the exclusion of the hydrophilic BSA from the 
hydrophobic PEG-phase. 
5.4.3 Surface tension 
When it comes to the partitioning of biomolecules in ATPS, the surface tension of 
the solution is an important parameter. Upon salt addition, the surface tension of 
water increases due to additional ionic charge that causes highly structured 
networks of hydrogen-bonded water. This increasing surface tension can cause an 
increase in protein surface free energy [62] which brings about protein-protein 
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interactions mainly due to hydrophobic bonding and weak van der Waals forces. 
However, as PEG MW decreases, the surface tension increases [63].  Therefore, it 
appears that if surface tension is an important parameter in the separation of PPV, 
then the balance of the higher surface tension citrate salt (Figure 5.2) and the lower 
surface tension 12K PEG (Figure 5.3) have the correct combination to effectively 
recovery the PPV in the PEG-rich phase. 
To further explore the effect of surface tension on the separation and recovery of 
PPV, we added NaCl to the PEG-citrate system (see Figure 5.4). The addition of 
NaCl increases the partitioning to the interface (Figure 5.4C). We postulate that the 
PPV is residing at the interface upon high NaCl concentrations due to the increased 
surface tension of the system. The Cl- ion is weakly hydrating in comparison to the 
citrate anion, which is likely why higher salt concentrations are needed to see an 
effect on PPV separation.  The increase in surface tension would also explain why 
the PPV begins to partition to the interface at high citrate concentrations (Figure 
5.3C). 
5.5  Conclusions 
A model system of infectious PPV in a serum-containing media was used to 
determine a virus purification system to model a non-enveloped vaccine production. 
A system containing 15 w/w% PEG 12K and 14 w/w% citrate at a pH of 8 was found 
to have a recovery of infectious PPV of 64% in the PEG-rich phase. This is a high 
recovery for an infectious virus that could possibly improve the 30% industry 
standard for a series of vaccine purification steps [15]. High PEG MW was needed 
for a high infectious recovery in the PEG-rich phase; however, it was not likely due to 
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volume exclusion. A more likely theory is that the high hydrophobicity of the PPV 
allowed for the virus to separate into the highly hydrophobic, high MW PEG-phase. 
The electrostatic potential between the PEG and citrate phases also likely assisted 
in the PPV partitioning at a high PEG MW. ATPS has to be balanced so that the 
hydrophobic driving force is greater than the surface tension, so that PPV can enter 
the hydrophobic PEG-rich phase and not be deterred at the interface. High citrate 
concentration or high NaCl concentration created a high enough surface tension to 
entrap the virus at the interface. This is undesirable since it is difficult to recover 
infectious virus from the interface. Now that a system that partitions the virus to the 
PEG-rich phase has been found, other disadvantages of ATPS for large-scale 
manufacturing, including virus dilution and removal of PEG, can be tackled in the 
future. This system needs to be tested with other hydrophobic, non-enveloped 
viruses to determine if ATPS has the potential to become a platform purification 
approach for vaccine production. 
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Chapter 6 
 
 
Virus removal using peptide functionalized chitosan 
nanofibers 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The material contained in this chapter is planned for submission in a research 
journal. 
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6.1  Introduction  
Water is the key to existence. Yet, in spite of the importance of water, 884 million 
people lack access to safe clean water [1]. Water appropriated for human 
consumption originates either from surface water bodies (lakes, rivers, streams etc.) 
or is pumped from ground water sources. Infection is a very common problem when 
there is a shortage of adequate sanitation, hygiene and clean water for drinking and 
household activities. A few of the common waterborne diseases are diarrhea, 
cholera and schistosomiasis. The major pathogenic organisms responsible for water 
borne diseases are bacteria (E. Coli and V. cholera), viruses (hepatitis A, and 
poliovirus) and parasites (E. histolytica, Giardia, Hookworm, Schistosoma). 
Treatment is therefore needed to produce clean drinking water. Municipal water 
treatment plants typically treat water with coagulation, sedimentation, filtration, 
disinfection and storage [2]. The physical filtration and disinfection steps play a key 
role in the removal of pathogenic organisms. Most countries use coliphages, phages 
that infect E. coli, to assess microbiological quantities in drinking water [3]. However, 
bacterial indicators do not reflect the risks of viral pathogens [4]. Pathogenic viruses 
are smaller than bacteria and therefore capable of escaping the filtration 
mechanisms. Some viruses are highly resistant to conventional treatment systems 
such as chlorination [5]. Chlorination and ultraviolet (UV) radiation are the 
conventional techniques in disinfection to achieve 4 LRV as required by the EPA for 
drinking water standards. Chlorination and UV inactivation studies have often 
demonstrated the susceptibilities of enteric viruses that have the potential to create 
waterborne outbreaks, such as poliovirus [6] and adenovirus [7]. In third world 
countries where municipal water treatment is unavailable, water supplies are 
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generally provided from unprotected dug wells, unprotected springs, small carts with 
water drums, tanker trucks, surface water and bottled water [8]. Even a small dose of 
virus is capable of causing severe damage to human health. This necessitates the 
development of sustainable pathogen removal systems that can be applied 
worldwide.  
Methods used for physical filtration include microfiltration (MF), ultrafiltration 
(UF), nanofiltration (NF), and reverse osmosis (RO). MF has a pore size (0.1 – 10 
μm) which will restrict bacteria but allow viruses to seep through the filter pores due 
to their small size [9]. UF has a pore size of 0.01 – 0.1 μm that prevents some but 
not all viruses [10-12]. Better results using UF is reported in literature due to the 
charge of the virus, secondary interactions of virus with membrane surface, pore 
block from organic matter, pore constriction, and sieving [13, 14]. The virus removal 
due to the featured characteristic of UF i.e. size exclusion is not a foolproof system. 
The evidence for this has been witnessed during an inconsistent 1 to 6 LRV for MS2 
and GA bacteriophage [15] and 3 to 4 LRV of influenza virus [16] when filtered with a 
UF membrane. Despite a lack of reliable system for virus removal from UF, up to 1.8 
billion gallons per day of drinking water worldwide is processed through UF or MF 
mechanism only [17]. The alternate techniques of nanofiltration and reverse-osmosis 
have been proposed. Nanofiltration is accompanied with membrane fouling and low 
permeability effects due to its small pores [18]. NF and RO experience membrane 
design imperfections which can cause large virus escape [19, 20] and both methods 
are expensive to produce and maintain on a consistent basis [21]. A more detailed 
description of the ability of filters for virus removal from water has been explained in 
the literature review section 2.3.                        
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To overcome the processing problems that occur with standard size-based 
filtration, we propose to use nanofibers adsorption, which is a novel method to 
remove viruses. Nanofiber filtration has low pressure drops, high water fluxes and 
decreased fouling. Our proposal is to make nanofibers from the biocompatible, 
inexpensive and environmentally-friendly natural polymer, chitosan. Nanofibers have 
an increased surface area to volume ratio, which increases their adsorption capacity 
closer to that of chromatography, as compared to standard membrane absorbers. 
Nanofibers are also on the same size scale as viruses, creating a curved surface to 
increase virus adsorption. Ultrafine cellulose nanofibers (UCCN) modified with 
polyethylenimine infused into electrospun polyacrylonitrile nanofibrous scaffolds 
have removed E.Coli and MS2 bacteriophage by a LRV of 6 and 4, respectively, for 
water purification [22]. Polyurethane-based N,N-dodecyl,methyl-polyurethane (Quat-
12-PU) electrospun nanofibers exhibited antimicrobial properties against gram-
positive Staphylococcus aureus and gram-negative E.coli bacteria close to 7.5 LRV 
[23]. Chitosan polycaprolactone (PCL) nanofibers were able to remove almost all of 
Staphylococcus aureus [24]. [(2-hydroxy-3-trimethylammonium) propyl] chitosan 
chloride (HTCC) and polyvinyl alcohol (PVA) in ratio 4:6 were electrospun into 
nanofibers crosslinked with 30% glutaraldehyde vapor for 4 hours. This system was 
filtered for viral clearance studies with water which was able to remove up to 3.6 
LRV for porcine parvovirus (PPV) and 4.1 LRV for Sindbis virus [25]. Here, we 
recognize the potential of virus removal using nanofibers and propose to remove a 
model non-enveloped virus with an electrospun chitosan membrane.  
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6.1.1  Electrospinning 
Electrospinning is a technique that allows the fabrication of continuous 
nanofibers with diameters of 100 nm or less under the application of external electric 
field [26]. Electrospun nanofibers has gained considerable importance and studies in 
the areas of tissue engineering [27], drug delivery [28], water filtration [25] and 
wound dressing [29]. Nanofibers are desired due to their high surface-to-volume 
ratio, large pore size and the ease of functionalization of fiber membranes [30, 31]. 
Electrospun nanofibers possess high porosity, consistently interconnected pores 
which improve flux performance [32]. The pore size of the range of MF 0.1 μm also 
causes low membrane fouling and low backpressures [9]. MF can remove bacteria 
by size-exclusion, but not viruses. However, the electrospun fibers can be 
functionalized which can result in adsorption of viral pathogens. Microcrystalline 
cellulose nanofibers infused with polyethylenimine gave promising results up to 4 log 
of MS2 bacteriophage [22]. Positively charged and functionalized 
polyacrylonitrile membrane demonstrated not only 2-3 times higher permeation flux 
and low pressure drop compared to commercial MF but yielded a high 4 log removal 
of MS2 bacteriophage [33] .  
A typical setup for electrospinning consists of three major components: a high-
voltage power supply, a syringe pump and an electrically conductive collector [34]. In 
electrospinning, a polymer solution is held by its surface tension at the end of a 
needle and subjected to an electric field. Once the electric field reaches a critical 
value, mutual charges on the liquid surface cause a repulsion stronger than the 
surface tension. It induces an ejection of liquid from the tip of the needle, which then 
elongates from a hemispherical droplet into a cone-like structure known as a Taylor 
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cone [35]. As the viscous polymer solution is pulled toward the rotating drum 
collector, the solvent evaporates leaving a charged polymer fiber on the collector, 
forming a random, non-woven nanofiber mat. A schematic diagram is as shown in 
Figure 6.1 [36].  
 
Figure 6.1 Schematic of electrospinning apparatus [36]. The polymer solution held 
on syringe is collected as dry polymer fibers on an electrically conductive collector 
after subjecting the syringe to an optimum electric field (copyright permission 
granted).    
 
6.1.2  Chitosan 
Chitin (poly ?-?????-N-acetyl-D-glucosamine) is the second most abundant 
natural polysaccharide, after cellulose, and it provides structural integrity to insect 
and crustacean shells. These polymers are biocompatible, biodegradable, non-toxic, 
antimicrobial and have low immunogenicity, attracting immense future potential [37]. 
Chitosan is synthesized by deacetylation of chitin, which then exposes amine groups 
on the carbohydrate surface. Chitosan has been preferred over chitin for research 
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and commercial applications as it is easily soluble in acidic, aqueous solutions. 
Chitosan is popularly known for its antimicrobial properties [38-40]. Although the 
complete mechanism is yet to be understood, several hypotheses attribute it to the 
presence of the NH3+ group on the glucosamine monomer at a pH below the pI of 
6.3 [41]. At low pH, chitosan amines are protonated, making them a water soluble 
cationic polyelectrolyte [37, 42]. At high pH, chitosan is deprotonated, and the 
neutral polymer is insoluble in water. Chitosan has shown antiviral activity in plant 
and animal biological system. A few proposed antiviral mechanisms include binding 
to the proteins in the viral capsid, causing structural damage, blocking viral 
replication, and inhibiting replication of bacteriophages [43]. However the 
mechanism is poorly understood and limited literature is available on the effect of 
chitosan on viruses. We hypothesis that chitosan is a polycationic polymer, which 
can adsorb negatively charged viruses by electrostatic forces. Implementation of this 
research technique focusing on water purification is supported by the application of 
chitosan for extraction and separation of aromatic compounds (phenolic and 
polycyclic) for water decontamination. It also has the capacity to remove metals, 
chemicals and bacteria. Chitosan has been identified in reducing infection of 
bacteriophage MS2 and feline calicivirus FCV-F9 (from initial ?5 log plaque-forming 
unit (PFU)/ml viral titers) by 1.70 and 4.21 log PFU/ml [44]. For non-enveloped PPV, 
functionalized electrospun chitosan nanofibers with a positively charged quaternized 
amine forming HTCC has 2.0 LRV with 12% w/v HTCC:graphene blend in water 
[45]. One of the potential ways of improving the virus adsorption to chitosan 
nanofibers is to attach small peptide ligands to the fibers. For PPV removal it was 
noted that trimeric peptide WRW and hexamer peptide YKLKYY achieved 4.5-5.5 
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LRV in human blood plasma [46] on a chromatographic system. We propose to 
conjugate the CWRW peptide to the chitosan fibers and design a point-of-care 
filtration system for potable water from viruses.  
In this chapter we will show the results found from accomplishing the following 
objectives: 
Objective 1: Explore linker chemistry (carbodiimide and maleimide) required to 
synthesize peptide affinity ligands on electrospun chitosan fibers 
Objective 2: Determine the virus removal capability of chitosan membrane matrix 
from virus contaminated water 
6.2  Materials and Methods 
6.2.1  Materials 
Chitosan of 310,000 molecular weight and 75-85% deacetylated, polyethylene 
oxide (PEO) (MW 90,000) and glacial acetic acid required for making electrospinning 
polymer solution was purchased from Sigma (St.Louis, MO). Whatman quantitative 
Filter Paper Circles (Clifton, NJ), Grade 1, 55 mm and 10 mm diameter were used as 
????????????????????????????????????????????????????????????? ?????N-(3-
Dimethylaminopropyl)-N?-????????????? ??????????????????????????????????????????
g/mol) for carbodiimide reactions was purchased from Sigma (St.Louis, MO). Sulfo-
SMCC (MW 436 g/mol) purchased from Pierce (Rockford, IL) was used for 
maleimide crosslinking reaction. Sulfo-N-hydroxysuccinimide (Sulfo-NHS) and 2-
Mercaptoethanol were purchased from Sigma (St.Louis, MO). MES sodi???????????
98.0%, MW 217 g/mol) for buffer and dimethyl sulfoxide (DMSO) were purchased 
from Fisher Scientific (Pittsburgh, PA). For the phosphate buffer saline (PBS) sodium 
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phosphate and sodium hypophosphite (NaH2PO4.H2O) were purchased from VWR 
(Radnor, PA) and sodium triphosphate (Na3PO4) was purchased from Fisher 
Scientific (Pittsburgh, PA). Hydrochloric acid was purchased from EMD Chemicals 
(Billerica, MA) and sodium hydroxide was purchased from Acros Organics (New 
Jersey, NY) for pH control. All aqueous solutions were prepared using purified water 
???????????????????????????????????????????????????????????????????????????????????????
Pittsburgh, PA). Peptide CWRW (MW 649.7 g/mol) was purchased from Biomatik 
LLC (Wilmington, DE).  
Minimum essential medium (MEM) for cell propagation was purchased from Life 
Technologies (Grand Island, NY). For virus titration, 3-(4,5-Dimethyl-2-thiazolyl)-2,5-
diphenyl-2H-tetrazolium bromide (MTT) and sodium dodecyl sulfate (SDS) were 
purchased from Sigma-Aldrich (St. Louis, MO). High pressure liquid chromatography 
(HPLC) grade acetonitrile and trifluoroacetic acid (TFA) were purchased from Sigma-
Aldrich (St. Louis, MO) and Alfa Aesar (Ward Hill, MA) respectively. 
6.2.2  Methods 
6.2.2.1  Electrospinning of chitosan nanofibers 
The electrospinning was done using an in-house facility setup. Contents 
including 0.4 g of chitosan and 0.04 g of PEO was mixed in a 50 ml tube (VWR, 
Radnor, PA) with 90% acetic acid solution. After contents were mixed using a vortex 
it was let to sit on a bench top for 3 hours.  Three ml of the contents was drawn into 
a syringe and then attached to a syringe pump (Braintree Scientific INC, Braintree, 
MA). The needle inserted into the syringe tip was connected to the high voltage 
supply (Glassman high voltage, INC, High Bridge, NJ), and the ground was attached 
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to the rotating drum collector that was run by a pump (ElectroCraft TorquePower™, 
Ipolis, OH). Whatman circle papers were taped to the drum covered with aluminum 
foil for collecting fibers. The needle syringe was placed 6 cm away from the drum 
which was rotated at a speed of 2000 rpm as the fibers spun at flow rate of 6 ml/hr 
and voltage of 20 kV.  
6.2.2.2  Attachment of peptides onto chitosan electrospun fibers 
In our investigation, we used reagents capable of linking the amine reactive 
chitosan polymer to the thiol cysteine on the peptide. We have explored the 
carbodiimide with iodoacetic acid and maleimide to achieve our objective.  
6.2.2.2.1  IAA-EDC crosslinker 
Method 1: The amount of chitosan on the 23 cm2  Whatman circle paper was 
determined by weighing the paper before and after electrospinning. The adsorbed 
chitosan on the paper was assumed to be uniform and 1 layer of 0.5024 cm2 of 
paper was punched containing approximately 0.6 μmoles of chitosan or its 
equivalent amines. 50 mM of iodoacetic acid (IAA) and 50 mM of N-(3-
Dimethylaminopropyl)-N?-ethylcarbodiimide hydrochloride (EDC) was dissolved in 
PBS in a micro-centrifuge tube. The contents of the tube were pH adjusted to 7, 
transferred to 20 ml glass containers and allowed to react with punched chitosan for 
2 hours. The punched paper was then removed and excess IAA-EDC from the 
matrix was rinsed off with 10 mM phosphate buffer by rocking in a micro-centrifuge 
tube for 10 min on a Roto-shake Genie rocker (Scientific Industries Inc., Bohemia, 
NY). The rinsing procedure was repeated 3 times. Two separate tests were then 
performed; one to validate the coupling of amines using ninhydrin test and the other 
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to visually check for dissolving fibers. Ninhydrin reagent in practice is used for 
determination of primary and secondary amines in a solution or on a substrate. A 
ninhydrin kit test (2% solution) from Sigma (St.Louis, MO) was used to verify if the 
amine has been coupled to iodo group. For the ninhydrin test, we immersed the 
reacted chitosan in a solution of 100 μl ninhydrin reagent and 200 μl 10 mM 
phosphate buffer. We heated the contents to 100 °C for 10 mins, allowed it to cool 
and diluted in 500 μl ethanol before reading the absorbance at 570 nm. The punched 
chitosan was examined for dissolving fibers using electron microscopy, detailed in 
section 6.2.2.3. 
Method 2: The procedure for obtaining punched chitosan after electrospinning was 
followed as per section 6.2.2.2.1. 25 mM of IAA and 25 mM EDC were dissolved in 
MES buffer using a micro-centrifuge tube. Immediately 50 mM NHS was added, pH 
adjusted to 4-5 and the reaction allowed to proceed for 15 minutes. 2 μl 
mercaptoethanol was added to quench the EDC reaction and contents in the tube 
were desalted for terminating the reaction using an Econo-Pac 10DG column 
purchased from Bio-Rad Laboratories (Hercules, CA). PBS was used to elute the 
different 1 ml samples from the column, which were collected in separate micro-
centrifuge tubes. The desired 1ml sample was identified by reading the absorbance 
on a Synergy Mx microplate reader (BioTek, Winoski, VT) at 280 nm, where NHS 
activated IAA can be measured [47]. The sample pH was adjusted to 7-8 and 
allowed to react in the presence of punched chitosan (0.5024 cm2) in a 20 ml glass 
container. The reaction to bind iodo group onto the amine reactive chitosan was 
allowed to proceed for 2 hours following which the unreacted IAA and EDC were 
rinsed off with 10 mM phosphate buffer (pH ~ 7) in a Roto-shake Genie. The 
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ninhydrin kit test on chitosan as a validation step was followed due to the 
explanation given in section 6.2.2.2.1. Continuing from the IAA-EDC rinsing 
procedure, 1.5 mM CWRW peptide was adsorbed to the chitosan by dissolving 
CWRW peptide in 1 ml of 10 mM phosphate buffer in a micro-centrifuge tube. The 
reaction was performed overnight with rocking at room temperature. Peptide 
adsorbed on chitosan was quantified by measuring the aqueous tube contents using 
C18 reverse phase chromatography (RP-HPLC), detailed in section 6.2.2.4. The 
chitosan was carefully removed and retained for virus removal studies using MTT 
assay, detailed in section 6.2.2.5. Fiber morphology was examined in intermittent 
steps using electron microscopy, detailed in section 6.2.2.3. 
6.2.2.2.2  Maleimide crosslinker 
Method 3: The procedure for obtaining punched chitosan after electrospinning was 
followed as per section 6.2.2.2.1. 4.6 mM of Sulfo-SMCC in 10 mM phosphate 
buffer was prepared in a micro-centrifuge tube and the pH was adjusted to 7. Sulfo-
SMCC was treated with punched chitosan for 2 hours at room temperature in a 20 
ml glass container. The punched chitosan was removed from the container and 
rinsed using 10 mM phosphate buffer in a micro centrifuge tube for 10 minutes. 
Ninhydrin test was performed as a validation step to confirm the reaction of amines 
on the chitosan. The punched chitosan was immersed in 1.5 mM CWRW peptide in 
10 mM phosphate buffer from anywhere between 1 hour to 24 hours. All 
quantification was conducted, as described in section 6.2.2.1. 
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6.2.2.3  Scanning electron microscope 
The morphology of the nanofibers was observed by a Hitachi S-4700 field 
emission scanning electron microscope (FE-SEM) (Tustin, CA) which is a cold field, 
emission high resolution scanning electron microscope. The electrospun fibers were 
coated with a 5 mm layer of platinum/ palladium (Pt/Pd) using a Hummer 6.2 Sputter 
Coater (Union City, CA) before being examined by FE-SEM. The accelerating 
voltage for the FE-SEM was 5 kV, and the magnification was from 1,000× to 
10,000×. All fibers were dried in a Gold series DP-32 vacuum drying oven (Ontario, 
Canada) at 80°C for 2 hours before Pt/Pd coating and imaging with FE-SEM.  
6.2.2.4  Reverse phase chromatography 
For quantification of the CWRW peptide adsorbed to the chitosan membrane, 
RP-HPLC was performed with a Waters XBridge BEH 130 C18 column on a Waters 
Alliance HPLC equipped with a photo diode UV-Vis detector operating at 220 nm 
wavelength. Aqueous contents of the tube during peptide-chitosan reaction were 
collected before and after the reaction separately. Samples were filtered through a 
?????????????????????????????????????????????onto the RP-HPLC C18 column at a flow 
rate of 1.0 ml/min Buffer A was 0.1% TFA in water and Buffer B was 0.1% TFA in 
acetonitrile. A linear gradient of decreasing Buffer B was performed.  
6.2.2.5  Virus removal assessment 
Log 6 PPV was prepared by diluting stock virus in PBS or water. Peptide was 
attached on one or three layers of punched chitosan which were immersed in 500 ?l 
virus in a micro-centrifuge tube. The contacted was performed for 1-3 hours with 
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rocking. Loose fibers were spun down using the Sorvall ST16R Centrifuge (Thermo 
Scientific, Pittsburgh, PA) at 5000 RPM for 3 mins. The chitosan was then discarded 
and a minimum of 100 ?l supernatant was extracted using a 10-100 μl pipette tip 
(USA Scientific, Oscala, FL). The extract was used for determining virus 
concentration using the MTT assay, described in section 6.2.2.6.  
6.2.2.6  Cells, virus and titer assay 
Porcine kidney cells (PK-13) were a gift from Dr. Ruben Carbonell at North 
Carolina State University. PK-13 cells were grown in MEM supplemented with 10% 
fetal bovine serum (FBS) (Atlanta Biologicals, Oakwood, GA) and 1% pen/strep at 
37°C, 5% CO2 and 100% humidity. The cells were propagated every 3-4 days at a 
split ratio of 1:5. PPV strain NADL-2, also a gift from Dr.Ruben Carbonell at North 
Carolina State University, was propagated in PK-13 cells, as described previously 
[48, 49]. PPV was clarified with centrifugation prior to use. 
PPV was titrated with a cell viability assay, the colorimetric MTT assay, as 
described previously [48]. Briefly, PK-13 cells were seeded in 96-well plates. Plates 
were infected with 25 μl of PPV and serially diluted across the 96-well plate. After 
five days of incubation, the MTT salt solution was added. Four hours later, 
solubilizing agent was added. Plates were read on a Synergy Mx microplate reader 
(BioTek, Winoski, VT) at 550 nm between 18-24 hours after addition of the 
solubilizing agent. The 50% infectious dose (MTT50) value was determined to be the 
virus dilution that corresponded to an absorbance of 50% of the uninfected cell 
absorbance. The value was converted to a per millimeter basis and stated as the 
MTT50/ml titer. 
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6.3  Results and Discussions  
6.3.1  Characterization of peptide functionalized chitosan 
We selected two different conjugation chemistries in order to attach the terminal 
cysteine residue on the CWRW peptide to chitosan electrospun fibers. This peptide 
was selected due to its previously found properties of removing PPV from solutions 
containing human blood plasma (citation needed).  Electrospun fibers have been 
shown to adsorb viruses (cite Michelle’s papers) and we therefore desire to improve 
the virus removal capabilities by combining these two powerful virus removal 
techniques. 
6.3.1.1  Method 1: IAA-EDC crosslinker 
The chitosan was electrospun on Whatman filter paper. The spun fibers were 
observed for fiber density and morphology using the FE-SEM and images are shown 
in Figure 6.2.  
    
 
Figure 6.2 FE-SEM micrographs of electrospun chitosan/PEO in 90% acetic acid. 
The feed concentration was 2.5 wt%, feed rate was 6 ml/h, distance between the 
needle and collector was 6 cm, collector was rotated at 2000 rpm, volume of 
electrospun solution was 3ml and applied voltage of 20 KV (A) 2,000× (B) 10,000×. 
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Linking agents were used to conjugate the peptides to the amine group on the 
chitosan. We used IAA (iodo and carboxyl group) and EDC conjugate reactants in 
water or PBS as a coupling agent to react with chitosan. The carbodiimide reaction 
using the IAA-EDC conjugate will form active O-acylisourea ester and the chemistry 
is shown in Figure 6.3. The most important feature and requisite of this reaction was 
the coupling of iodo group on the primary amine of the chitosan.  
 
Figure 6.3 O-acylisourea ester and IAA-chitosan intermediate. 50 mM of IAA 
and 50 mM of EDC in PBS (~ 7) were treated with 0.5024 cm2 chitosan for 2 hours. 
It was to create a functional iodo group coupled to the primary amines on the 
chitosan fibers.  
 
Before proceeding with the peptide synthesis it was necessary to confirm the 
stability of fibers after the ester reaction. The initial few experiments were performed 
in water which dissolved the fibers (see Figure 6.4 (A)). Chitosan is soluble at pH < 
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6.3 [37] and it was necessary to maintain the pH > 6.3 during the carbodiimide 
reaction which was difficult for water due to its poor buffering capacity. The medium 
was replaced with PBS (~ pH 7) which improved the buffering capacity. The chitosan 
did not dissolve and fiber morphology was maintained (see Figure 6.4 (B)).  
 
Figure 6.4 FE-SEM micrographs of electrospun chitosan/PEO after coupling 
reaction between O-acylisourea and chitosan. 50 mM of IAA and 50 mM of EDC in 
PBS (~ 7) were treated with 0.5024 cm2 chitosan for 2 hours (A) Reactants in water 
showing dissolved fibers at 700× (B) the reactants in PBS showing intact fiber at 
1,000×. 
 
The ninhydrin test was performed to determine the concentration of amines on 
the chitosan.  A higher absorbance would mean the inability of iodine in the IAA to 
couple to chitosan or in other words leading to an incomplete reaction. The result of 
the ninhydrin test on chitosan samples treated with IAA-EDC along with the controls 
are shown in Figure 6.5. The three samples shown on the x-axis were (1) chitosan 
treated with IAA-EDC, (2) plain paper without chitosan treated with IAA-EDC 
(negative control) and (3) chitosan treated with PBS only (positive control).  Ideally it 
was expected for chitosan sample to have a lower absorbance since the amines 
should have been coupled with the iodine. However we observed amine detection in 
A B
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decreasing order i.e. paper control, the chitosan sample and finally the chitosan 
control.   
 
Figure 6.5 Ninhydrin test kit. Determination of amines for samples (1) chitosan 
with IAA and EDC, (2) plain paper reacted with IAA and EDC (negative control) and, 
(3) chitosan treated with PBS only (positive control) treated with 50 mM IAA and 50 
mM EDC in PBS at pH 7 for 2 hours. The data points shown here are results from a 
single test only.   
 
 
The O-acylisourea intermediate is known to be unstable and undergo hydrolysis 
when it doesn’t react with amines [50]. It leads to regeneration of carboxyl group and 
un-substituted urea (see Figure 6.6). The short half-life of the O-acylisourea and 
excess unreacted amines from urea can complicate the reaction scheme. We 
suspect the ninhydrin test results to be a resultant of the unstable ester. The issue 
was overcome by combining new procedural steps which is detailed in the following 
method 2 of IAA-EDC chemistry.    
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 Figure 6.6 Hydrolysis of O-acylisourea. Short half-life of O-acylisourea can create 
unstable and unsuitable conditions for IAA-chitosan coupling reaction in the 
presence of EDC conjugate. 
 
 
6.3.1.2 Method 2: IAA-EDC conjugate in Sulfo-NHS 
The IAA-EDC chemistry was performed in the presence of Sulfo-NHS to maintain 
stable amine reactive groups for the ester intermediates. The chemistry is shown in 
Figure 6.7. The PBS was replaced with MES buffer, which has a buffering capacity 
in the desired pH range of 4-5. The low pH was a more suitable reactive pH 
condition for the EDC chemistry. The EDC reactions were quenched by adding 
mercaptoethanol that would form stable complex with carbodiimide and the excess 
reagents were removed by desalting the aqueous contents. The desalted sample 
was reacted with punched chitosan.   
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 Figure 6.7 Stabilizing the IAA – EDC ester reaction. 25 mM IAA, 25 mM EDC in 
MES buffer at pH 4-5 was reacted in the presence of 50 mM NHS. After 15 min 
reaction was quenched with 2- mercaptoethanol and desalted. The samples with 
maximum absorbance at 280 nm was collected and reacted with 0.5024 cm2 
punched chitosan (pH 7-8) to obtain IAA-chitosan complex.   
 
The ninhydrin test was performed on samples (1) chitosan treated with IAA-EDC, 
(2) plain paper without chitosan treated with IAA-EDC (negative control) and (3) 
chitosan treated with PBS only (positive control). The chitosan sample with an 
absorbance (570 nm) in between the two controls indicated the amines were 
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coupled to the iodo functional group (see Figure 6.8). The chemistry for the reaction 
is shown in Figure 6.7. It must be noted here that inconsistencies were noted in the 
ninhydrin kit test when the test was repeated for verification after a few days. The 
possible inconsistency was suspected to be the oxidation of the ninhydrin, which is 
sensitive to air. Since the test was only a validation step and not an actual procedure 
in peptide adsorption we proceeded with the peptide conjugation to iodo-substituted 
chitosan.  
 
 
Figure 6.8 Ninhydrin test kit. Determination of amines for samples 1) chitosan 
treated with IAA and EDC, (2) plain paper treated with IAA and EDC (negative 
control) and, (3) chitosan treated with PBS only (positive control 2). 25 mM IAA, 25 
mM EDC in MES buffer at pH 4-5 was reacted in the presence of 50 mM NHS. After 
15 min reaction was quenched with 2- mercaptoethanol and desalted with PBS. The 
sample with maximum absorbance at 280 nm was collected pH to 7-8 and reacted 
with punched chitosan (0.5024 cm2) or punched paper. All data points are the 
average of three separate tests and error bars represent the standard deviation. 
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We confirmed that the fibers were still present before continuing with the peptide 
adsorption using FE-SEM. The result of undamaged and smooth fiber morphology is 
shown in the Figure 6.9.  
 
Figure 6.9  FE-SEM micrographs of electrospun chitosan/PEO after the treatment of 
chitosan with stable amine-reactive Sulfo-NHS ester at 1000×. 25 mM IAA, 25 mM 
EDC in MES buffer at pH 4-5 was reacted in the presence of 50 mM NHS. After 15 
min reaction was quenched with 2- mercaptoethanol and desalted with PBS. The 
sample with maximum absorbance at 280 nm was collected pH to 7-8 and reacted 
with punched chitosan (0.5024 cm2).  
 
The conjugation of peptides on IAA-chitosan was performed by mixing with 
cysteine-terminal CWRW peptide. The reaction proceeds through substitution of 
carboxymethyl group (-CH2-COOH) of IAA for the hydrogen of the thiol group on 
cysteine with a byproduct formation of HI. The reaction is shown in Figure 6.10.  
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Figure 6.10 Conjugation of CWRW peptide to chitosan using IAA-EDC 
crosslinker. Weighed peptide was dissolved in 10 mM phosphate buffer (pH ~ 7). 
 
Peptide was prepared in 10 mM phosphate buffer (pH ~ 7). The measurement of 
only 1 mg had the possibility of encountering measurement errors. This lead us to 
create a one-time calibration curve before proceeding with the peptide coupling to 
chitosan. The calibration graph will importantly be used for estimating the peptide 
adsorbed on the chitosan membranes by injecting aqueous sample in RP-HPLC. 
The CWRW peptide stock injection at 220 nm is shown in Figure 6.11 (A) and the 
calibration graph in Figure 6.11 (C). The calibration was linear and so we continued 
to use RP-HPLC as a method to quantify the peptide.  
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Figure 6.11 CWRW peptide peak and peptide calibration data. 1 mg of peptide in 
1 ml of 10 mM phosphate buffer was prepared. (A) peptide injection at 220 nm (B) 
Samples expressed as peptide: buffer (a) 1, (b) 1:4, (c) 1:8, (d) 1:12, (e) 1:16 
injected through C18 RP-HPLC and measured for peptide peaks at 220 nm and (C) 
plot for peptide peak area vs. peptide concentration to estimate the peptide coupled 
during chitosan reaction. The data points shown here are results from a single test 
only.   
 
Approximately 1 mg of peptide was weighed, dissolved in buffer and treated with 
chitosan. After overnight contact with the chitosan, the peptide (aqueous) was 
injected and tested for peptide adsorption. The solution showed no reduction in 
peptide concentration after contact with chitosan (see Figure 6.12). The results from 
RP-HPLC along with a few inconsistent results during the ninhydrin test had not 
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provided satisfactory results. The pH for IAA-EDC carbodiimide reaction in the 
presence of Sulfo-NHS required a low pH 4-5 and the thiol substitution required a 
high pH 7-8. We hypothesized the change in pH between reactions were hindering 
the conjugation of EDC and the stability of iodo-coupled chitosan. However a clear 
understanding on the failure of this mechanism is yet to be fully understood.  
 
 
Figure 6.12 CWRW peptide after IAA-EDC reaction for peptide-chitosan 
complex. 25 μl injection of samples (a) peptide starting stock and (b) after chitosan 
contact using C18 RP-HPLC. The reaction was performed after reacting iodo coupled 
chitosan fibers with 1 mg peptide in 10 mM phosphate buffer (overnight rocking). 
 
6.3.1.3  Method 3: Maleimide crosslinker 
After no peptide was adsorbed on the chitosan through IAA-EDC chemistry, the 
maleimide chemistry from Sulfo-SMCC was investigated. The Sulfo-SMCC has a 
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peptide around pH 6.5-7.5. It allowed us to operate the amine and thiol substitution 
at a pH 7 which was not available earlier technique. The chemistry is shown in 
Figure 6.13.  
 
  
Figure 6.13 Peptide conjugation to the chitosan using Sulfo-SMCC (maleimide 
crosslinker chemistry). 4.6 mM of Sulfo-SMCC in 10 mM phosphate buffer was 
prepared (pH ~ 7) and treated with chitosan for 2 hours. The chitosan was treated 
with peptide in same buffer conditions for 3 hours.   
 
The ninhydrin test was performed with a new bottle of reagent and always stored 
under inert nitrogen to prevent oxidation. The test was performed on two samples (1) 
chitosan with Sulfo-SMCC and, (2) chitosan with PBS (positive control). The result 
was promising showing less amines on Sulfo-SMCC treated chitosan (see Figure 
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6.14) compared to control. The reduced amines on chitosan treated sample was due 
to substitution of amine on chitosan with the NHS ester group on the linker. The FE-
SEM showed undissolved fibers (Figure 6.15) and it was expected since the pH was 
maintained above 6.3 where the chitosan is soluble.  
 
 
Figure 6.14 Ninhydrin test kit for maleimide. Determination of amines for samples 
(1) chitosan treated with Sulfo-SMCC, (2) chitosan treated with PBS only (positive 
control). 4.6 mM of Sulfo-SMCC in 10 mM phosphate buffer was prepared (pH ~ 7) 
and treated with chitosan for 2 hours. The data points shown are results from a 
single test only.   
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Figure 6.15 FE-SEM micrographs of electrospun chitosan/PEO after the treatment 
of chitosan with stable amine-reactive NHS ester. 4.6 mM of Sulfo-SMCC in 10 mM 
phosphate buffer was prepared (pH ~ 7) and treated with chitosan for 2 hours. The 
chitosan was treated with peptide in same buffer conditions for 3 hours.   
 
About 0.4 mg of peptide was weighed and contacted with NHS-substituted 
chitosan for the still active available maleimide group to bind to the thiol on the 
cysteine of WRW peptide. After 2 hours the peptide solution was injected into RP-
HPLC to confirm adsorption to chitosan. The data in Figure 6.16 showed a 38% 
peak reduction which qualifies to 0.15 mg of peptide or 0.2 μmole. Our initial 
approximation of the amount of amines on the punched chitosan paper was 0.6 
μmole / paper layer. The 0.2 μmole of peptide attaching to three layers here was 
definitely an encouraging result. The important challenge overcome during the 
peptide-chitosan conjugation was the narrow pH working range and the complexities 
of the multiple reaction stages without disturbing the stability of the fibers.  
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Figure 6.16 CWRW peptide after maleimide reaction for peptide-chitosan 
complex. 25 μl injection of samples (A) peptide starting stock and (B) after chitosan 
contact using C18 RP-HPLC.  0.4 mg of peptide was weighed and treated with 
maleimide active chitosan fibers in 10 mM phosphate buffer for 3 hours.  
 
For virus removal we experimented with three layers of punched chitosan 
(0.5024 cm2) which were contacted with either virus in 10 mM phosphate buffer or 
PBS (10 mM phosphate and 150 mM NaCl). The MTT assay results are shown in 
Figure 6.17 (a) for 10 mM phosphate buffer and (b) PBS. The punched samples 
subjected to virus were (1) peptide-chitosan treated with Sulfo-SMCC, (2) peptide-
chitosan treated in 10 mM phosphate buffer or PBS (control A), (3) chitosan treated 
with 10 mM phosphate buffer or PBS only (control B), and (4) virus MTT control. 
Figure 6.17 (A) shows 1-2 LRV for sample (1) for maleimide conjugated peptide in 
10 mM phosphate buffer. The controls A and B for this experiment showed < 1 LRV. 
It can be safely accepted that the PPV removed from 10 mM phosphate buffer was 
primarily due to trimer WRW achieved from the conjugation chemistry. Figure 6.17 
(B) were the experiments performed on PBS which showed no significant difference 
between all of the samples.  
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Virus particle adhesion on membranes can be caused due to electrostatic 
charge, hydrophobic bonds, ionic strength, aggregation and ion composition. PPV is 
negatively charged at neutral pH conditions due to its pI ~ 5 [51]. The membrane is 
positively charged due to the polar basic amino acid arginine (R) on WRW 
(tryptophan-arginine-tryptophan) and the unreacted primary amines (-NH3+) on 
chitosan. The amino acid structures of WRW is shown in Figure 6.18. When the 
virus and membranes are oppositely charged the electrostatic attraction exists 
between the two surfaces due to the electrical double layer effect bringing them 
close together. The peptide ligand WRW also has 2 non-polar aromatic amino acids 
in the form of W (tryptophan) that is capable of forming hydrophobic bonds with the 
hydrophobic PPV. Viruses and bacteriophages are generally considered 
hydrophobic in nature [46, 52-54]. We hypothesize that the virus is drawn close to 
the membrane matrix due to their differential charge and then the virus adsorbs on 
the peptide majorly due to hydrophobicity of W and some due to positive charge on 
R amino acid. Hence an electrostatic enriched hydrophobic effect [55] could cause 
virus attachment to the peptide in 10 mM phosphate buffer. The dynamic binding 
effect and virus removal seems to be absent when the buffer is changed to PBS. 
The high salt conditions of PBS can cause Na+ ions to create an electrical double 
layer around the virus particles [55] leaving the virus boundary and the membrane 
surface with positive charges. The charge shielding effect will create an electrostatic 
repulsion of virus from the membrane surface causing reduced LRV as in the case of 
PPV removal in PBS < 1 LRV. An alternate hypothesis for low LRV in PBS could be 
aggregation behavior of PPV at higher salt conditions. SP and GA bacteriophage 
which are highly hydrophobic have aggregated at a wide pH range (1.5-7.5) and 
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ionic strength (1-100 mM NaNO3) [54]. The aggregation from protein-protein 
interactions could cause conformational changes in virus structure or even reduce 
hydrophobic bonding strength with the aromatic ligand W leading to reduced sorption 
of PPV on membrane surface. The hypothesis of aggregation can be further tested 
by using a filter design with solution subjected through the filter membrane pores. In 
our study we have rocked the tube contents to observe binding interactions of virus 
with peptides. If the viruses are aggregating then the virus removal in filter design 
would be achieved by size exclusion which is not in our interest. 
Virus removal of 4.5 – 5.5 LRV was achieved with trimer peptide WRW in PBS 
and blood plasma in the earlier investigation [46, 52] unlike 10 mM phosphate buffer 
in our project. The earlier study was performed on amino resin chromatographic 
column and not a membrane fiber matrix system as in our case. The peptide 
screening library for membrane fibers can be very different than column beads due 
to lack of diffusional limitation. Also the WRW peptide density in amino resin column 
was in the millimoles range [52] compared to μmoles in our approach  
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Figure 6.17 Virus removal assessment from peptide attached to chitosan using 
Sulfo- SMCC crosslinker. 6 log10 MTT50/ml 500 ?l virus solution in (A) 10 mM 
phosphate buffer (B) PBS was contacted with 3 layers of peptide conjugated 
chitosan (0.5024 cm2 ) for 3 hours. The samples subjected to virus are shown in the 
x-axis (1) peptide-chitosan treated with Sulfo-SMCC, (2) peptide-chitosan treated in 
10 mM phosphate buffer or PBS (control A), (3) chitosan treated with 10 mM 
phosphate buffer or PBS (control B), and (4) virus MTT control. The solution was 
spun in centrifuge at 5000 rpm for 3 min and supernatant was extracted for 
performing MTT assay. All data points are the average of two separate tests and 
error bars represent the standard deviation. 
 
 
 
Figure 6.18 Tryptophan (W) and arginine (R) amino acids. 
 
 
6.4  Conclusions 
Membrane surface matrix was designed for virus removal using discovered 
trimer WRW. The trimer was able to remove up to nine chromatographic column 
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surface, the trimer was expected to bind and remove PPV more effectively since the 
column porous beads do not support large virus capture.  
The crosslinking chemistry to adsorb peptides on chitosan nanofibers was 
investigated using the carbodiimide and maleimide chemistry. The peptide 
adsorption using carbodiimide chemistry was unsuccessful due to either lack of 
amine’s ability from chitosan to conjugate to the iodine required for thiol substitution 
or the lack of stability of iodo-substituted chitosan in the presence of 
mercaptoethanol during the peptide reaction. Mercaptoethanol was added for 
stabilizing the carbodiimide reaction but we suspect in the case of incomplete 
reaction the mercaptoethanol could have deactivated the iodo group. The maleimide 
chemistry was able to attach peptides and remove virus in 10 mM phosphate buffer. 
The peptides showed 1-2 LRV which is equivalent to 90-99% of virus. Higher salt 
concentration of 10 mM phosphate and 150 mM NaCl lead to almost no LRV. For 10 
mM phosphate buffer we hypothesize the electrostatic attraction between virus 
negative surface and membrane positive surface brings them close together. This is 
followed by hydrophobic bond between the aromatic amino acids of CWRW ligand 
and hydrophobic patches on the PPV. This electrostatic enriched hydrophobic 
binding pattern between the virus and membrane helped achieve a 1-2 LRV (90-
99%).  
  Nevertheless 1-2 LRV (or 90-99%) virus removal using membrane system is 
a promising start. These values can be improved to EPA standards of 4 LRV 
(99.99%) by increasing ligand density to increase hydrophobic strength and 
including spacer arm for peptides to inhibit steric hindrance effect from membrane 
surface matrix. In addition a study on virus removal studies for different salt 
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strengths may provide further understanding to improve the binding effect between 
the virus and membrane.   
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7.1  Conclusions 
This work began in Chapter 3 on the purification of PPV with chromatography.  
IEC with Q-sepharose resin was able to purify PPV from media proteins on a small 
scale and large scale column.  We were able to use the IEC purified virus to aid in 
the IHC work on the action of antiviral compounds. The purity of the PPV from media 
proteins could not be confirmed using the gold standard of SDS-PAGE due to similar 
MW of VP2 capsid protein and BSA. Virus purification was also investigated on SEC 
using sephacryl resin. The SEC was unable separate the PPV from BSA since both 
were eluting almost together with a very short time window.   
Also in Chapter 3, we examined the surface properties of PPV.  Understanding 
the hydrophobicity of a biomolecule can help in developing virus separation 
strategies. The presence of hydrophobic residues on PPV was found to be more 
than panel of proteins (insulin, lysozyme, BSA, fibrinogen, hemoglobin) by using a 
C18 RP-HPLC and evaluating on the basis of acetonitrile elution strength. To further 
prove the hypothesis that virus surface are more hydrophobic than proteins, ANS 
fluorescence was employed. PPV gave false reading due to the presence of media 
and cell proteins that were procured from the virus production process.  
In Chapter 4, we examined single virus trafficking and the exploration of virus 
capsid formation by IHC.  Single virus trafficking was studied by tagging the PPV 
with Alexa fluor 488 succinimidyl ester and observing on the virus in a time-based 
study. The multiple pathways of virus trafficking through cells made it very difficult to 
account for steady virus progress. Though trafficking studies were not successful, 
the protocol designed was used for studying the action of antiviral drugs using 
immunohistochemistry. TMAO and glycine at 0.20 M showed 4 LRV or 99.99 % 
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reduction in PPV infectivity. IHC was used to study the mechanism of action of 
osmolytes using a time-based study. IHC showed that despite the 4 LRV reduction 
the fluorescent capsid proteins were still produced at time 8, 12, 16 and 20 hours 
similar to PPV positive control. Hence we hypothesize the osmolytes are stabilizing 
the VP2 capsid proteins and preventing the virus assembly process.  
In Chapter 5, PPV was purified using an aqueous two-phase system (ATPS). A 
15 w/w% PEG 12K and 14 w/w% citrate at pH 8 was able to recover 64% infectious 
virus recovery in the PEG-rich phase of the system [1]. Citrate was chosen since it 
was proven to be a stronger hydrating salt, thus creating a large hydrophobic 
difference between the two phases. The reason for high virus recovery was 
electrostatic potential causing the negatively charged virus to move away from the 
salt-rich into the PEG-rich phase. The hydrophobic interaction between the virus 
residues and PEG-rich phase from high PEG MW allowed increased partitioning. 
The surface tension from increasing salt tends to cause the virus to be drawn into 
the interface, which was undesirable. Hence it was important to maintain a balance 
of high hydrophobicity and electrostatic potential to prevent from virus residing at 
interface. The major media protein, bovine serum albumin (BSA), was separated into 
the salt-rich phase. C18 RP-HPLC was used to validate the concentration and 
partitioning of BSA into the salt-rich phase.  
Finally, in Chapter 6, membrane filters were designed for achieving virus removal 
from potable water. The membranes were created by conjugating CWRW peptides 
to electrospun chitosan nanofibers. The conjugation of terminal amines on chitosan 
to the cysteine residue on the CWRW peptide was obtained using maleimide 
chemistry. Upon subjecting the filters to virus in 10 mM phosphate buffer, we 
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obtained 1-2 LRV or 90-99% virus removal. When PBS was used as a buffer we 
obtained almost no virus removal. We hypothesize that the virus was attracted to the 
membrane because of positive charge on residual primary amines of chitosan and 
the R amino acid. This was followed up with hydrophobic interaction between the W 
amino acid and hydrophobic PPV [2, 3].  
7.2  Recommendations  
The work has some interesting insights in improving the virus recovery for 
aqueous two-phase system and synthesizing ligands on electrospun chitosan for 
virus removal from water. In ATPS, the virus recovery was increased to 64% in the 
PEG-rich phase by controlling pH, surface tension, hydrophobicity and electrostatic 
potential. Also we showed that the removal of the major protein contaminant BSA. 
For virus removal, we were able to show 90-99% virus removal from water by 
conjugating the peptide with maleimide chemistry and using 3 layers of 0.5024 cm2 
chitosan paper circles. Based on these conclusions we can make future 
recommendations for improving the yield and purity for ATPS.  For membrane 
filtration we can make suggestions for improving the virus removal from CWRW and 
experimenting on CYKLKYY peptides for removal.  
7.2.1  Improving recovery on ATPS 
ATPS experiments were performed for virus produced from fetal bovine animal 
serum. However the current vaccine manufacturing trend is to use serum-free media 
and avoid adventitious agents [4]. Now that we have shown removal of BSA from the 
PEG-rich phase, we could next investigate to remove the host cell DNA to the FDA 
limit of 10 ng/dose [5, 6]. In our study, we still need to explore back-extraction of the 
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virus from the PEG-rich phase into the salt-rich phase and make it available for final 
use. It is possible that the PPV is encapsulated in the PEG molecules and 
understanding the PEG-virus coat will help in the designing of the recovery into salt-
phase. Our initial back-extraction of virus has shown 70-90 % recovery at low pH 5 
and there is a great potential for improving the value.  
7.2.2  Higher virus removal on affinity membrane substrate 
The EPA requires treatment technology which can reliably achieve 99.99% or 4 
LRV inactivation or removal of viruses [7, 8]. We are currently achieving 90-99% or 
1-2 LRV in 10 mM phosphate buffer. The virus removal can be increased by 
increasing peptide concentration. The current results were produced with only 0.2 
μmole of peptide attached to the membrane. Peptide WRW has demonstrated best 
virus removal ability in the presence of ethylene oxide spacer arm [9]. The spacer 
arm can facilitate increased contact between the ligand and PPV. The other peptide 
that has shown virus removal is the YKLKYY. Molecular docking study had shown 
the secondary structure of YKLKYY allowing the PPV to bind to the peptide [3]. It 
would be interesting to investigate the virus removal using CYKLKYY.  
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